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MRS 1754 – 8-4-{[(4-cyanophenyl)carbamoylmetyl]-oxy}phenyl)-1,3-di(n-
propyl)xanthine 
N-Apo – Propylnorapomorphine 
NBTI - nitrobenzylthioinosine 
NE – norepinephrine 
NECA – 5’-(N-ethylcarboxamido)adenosine 
Nic - Nicotine 
NO – Nitric oxide 
NT – Neurotransmitter 
OSA – Obstructive sleep apnoea 
PaO2 – Partial arterial pressure of oxygen 
PaCO2 - Partial arterial pressure of carbon dioxide 
PBS – Phosphate buffered saline 
PG – Petrosal ganglion 
PO2 – Partial pressure of oxygen 
RT-PCR – Real time polymerase chain reaction 
SAH – S-adenosylhomocysteine 
SAHH – S-adenosylhomocysteine hydrolase 
SAM – S-adenosylmethionine 
SEM – Standard error of the mean 
SCG – Superior cervical ganglion 
SIDS – Sudden infant death syndrome 
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SP – Substance P 
TH – Tyrosine hydroxylase 
TTX – Tetradotoxin 
UDP - uridine 5'-diphosphate 
VAChT – Vesicular acetylcholine transporter 
VAH – Ventilatory acclimatisation to hypoxia 
VEGF – Vascular endothelial growth factor 
UV – Ultra violet 
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GLOSSARY 
  
1 mmHg = 1 Torr 
α-bungarotoxin – Selective antagonist of nicotinic ACh receptors with α7 subunits 
AOPCP – Inhibitor of 5’-ectonucleotidase, inhibits ATP extracellular catabolism 
Caffeine – Non-selective antagonist of adenosine receptors 
CGS 21680 – Selective A2A adenosine receptor agonist 
Cytisine – Selective nicotinic ACh receptor agonist 
DHßE – Selective nicotinic ACh receptor antagonist 
Domperidone - Selective antagonist of D2 dopamine receptors 
DMPP - Selective nicotinic ACh receptor agonist 
DPCPX – Agonist of A1 adenosine receptors in nM concentrations, and also of 
A2B adenosine receptors in µM concentrations 
d-tubocurarine -  Non selective nicotinic ACh receptor antagonist 
Dipyridamole – Inhibitor of equilibrative nucleotide transport system 
EC50 - drug concentration that produces 50% of maximal effect 
EHNA – Inhibitor of adenosine deaminase, inhibits adenosine deamination 
Haloperidol – Selective antagonist of D2 dopamine receptors 
HE-NECA - Selective A2A adenosine receptor agonist 
IC50 - drug concentration that produces 50% of maximal inhibition 
Ionomycin - Alters cell permeability, producing an increase in intracellular Ca2+  
Mecamylamine – Non-selective allosteric inhibitor of nicotinic ACh receptors 
MRS 1754 – Selective A2B adenosine receptor antagonist 
NBTI - Inhibitor of equilibrative nucleotide transport system 
NECA – Non-selective agonist of A2 adenosine receptors 
Nicotine - Selective nicotinic ACh receptor agonist 
Propylnorapomorphine – Selective D2 dopamine receptor agonist 
SCH 58621 - Selective A2A adenosine receptor antagonist 
Sulpiride – D2-like dopamine receptor antagonist 
ZM 241385 – Selective antagonist of A2A and A2B adenosine receptors, with 
higher affinity for A2A adenosine receptors 
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ABSTRACT 
 
Carotid bodies (CB) are peripheral chemoreceptor organs sensing 
changes in arterial blood O2, CO2 and pH levels. Hypoxia and acidosis or 
hypercapnia activates CB chemoreceptor cells, which respond by releasing 
neurotransmitters in order to increase the action potential frequency in their 
sensory nerve, the carotid sinus nerve (CSN). CSN activity is integrated in the 
brainstem to induce a fan of cardiorespiratory reflex responses, aimed at 
normalising the altered blood gases. Exogenously applied adenosine (Ado) 
increases CSN chemosensory activity inducing hyperventilation through 
activation of A2 receptors. The importance of the effects of adenosine in 
chemoreception was reinforced by data obtained in humans, in which the 
intravenous infusion of Ado causes hyperventilation and dyspnoea, an effect 
that has been attributed to the activation of CB because Ado does not cross 
blood-brain barrier and because the ventilatory effects are higher the closer to 
the CB it is injected.  
The present work was performed in order to establish the functional 
significance of adenosine in chemoreception at the carotid body in control and 
chronically hypoxic rats. To achieve this objective we investigated: 1) The 
release of adenosine from a rat carotid body in vitro preparation in response to 
moderate hypoxia and the specificity of this release. We also investigated the 
metabolic pathways of adenosine production and release in the organ in 
normoxia and hypoxia; 2) The modulation of adenosine/ATP release from rat 
carotid body chemoreceptor cells by nicotinic ACh receptors; 3) The effects of 
caffeine on peripheral control of breathing and the identity of the adenosine 
receptors involved in adenosine and caffeine effects on carotid body 
chemoreceptors; 4) The interactions between dopamine D2 receptors and 
adenosine A2B receptors that modulate the release of catecholamines (CA) from 
the rat carotid body; 5) The effect of chronic caffeine intake i.e. the continuous 
blockage of adenosine receptors thereby simulating a caffeine dependence, on 
the carotid body function in control and chronically hypoxic rats. The 
methodologies used in this work included: molecular biology techniques (e.g. 
immunocytochemistry and western-blot), biochemical techniques (e.g. 
neurotransmitter quantification by HPLC, bioluminescence and radioisotopic 
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methods), electrophysiological techniques (e.g. action potential recordings) and 
ventilatory recordings using whole-body plethysmography.  
It was observed that: 1) CB chemoreceptor sensitivity to hypoxia could 
be related to its low threshold for the release of adenosine because moderate 
acute hypoxia (10% O2) increased adenosine concentrations released from the 
CB by 44% but was not a strong enough stimulus to evoke adenosine release 
from superior cervical ganglia and arterial tissue; 2) Acetylcholine (ACh) 
modulates the release of adenosine/5’-adenosine triphosphate (ATP) from CB 
in moderate hypoxia through the activation of nicotinic receptors with α4 and ß2 
receptor subunits, suggesting that the excitatory role of ACh in chemosensory 
activity includes indirect activation of purinergic receptors by adenosine and 
ATP, which strongly supports the hypothesis that ATP/adenosine are important 
mediators in chemotransduction; 3) adenosine increases the release of CA from 
rat CB chemoreceptor cells via A2B receptors; 4) the inhibitory effects of caffeine 
on CB chemoreceptors are mediated by antagonism of postsynaptic A2A and 
presynaptic A2B adenosine receptors indicating that chemosensory activity 
elicited by hypoxia is controlled by adenosine; 5) The release of CA from rat CB 
chemoreceptor cells is modulated by adenosine through an antagonistic 
interaction between A2B and D2 receptors, for the first time herein described; 6) 
chronic caffeine treatment did not significantly alter the basal function of CB in 
normoxic rats assessed as the dynamics of their neurotransmitters, dopamine, 
ATP and adenosine, and the CSN chemosensory activity. In contrast, the 
responses to hypoxia in these animals were facilitated by chronic caffeine 
intake because it increased the ventilatory response, slightly increased CSN 
chemosensory activity and increased dopamine (DA) and ATP release; 7) In 
comparison with normoxic rats, chronically hypoxic rats exhibited an increase in 
several parameters: ventilatory hypoxic response; basal and hypoxic CSN 
activity; tyrosine hydroxylase expression, CA content, synthesis and release; 
basal and hypoxic adenosine release; and in contrast a normal basal release 
and diminished hypoxia-induced ATP release; 8) Finally, in contrast to 
chronically hypoxic rats, chronic caffeine treatment did not alter the basal CSN 
chemosensory activity. Nevertheless, the responses to mild and intense 
hypoxia, and hypercapnia, were diminished. This inhibitory effect of chronic 
caffeine in CB output is compensated by central mechanisms, as the minute 
 XIX
Functional significance of adenosine in carotid body chemoreception 
PhD thesis, Silvia Vilares Conde  
 
ventilation parameter in basal conditions and in response to acute hypoxic 
challenges remained unaltered in rats exposed to chronic hypoxia. 
We can conclude that adenosine both in acute and chronically hypoxic 
conditions have an excitatory role in the CB chemosensory activity, acting 
directly on adenosine A2A receptors present postsynaptically in CSN, and acting 
presynaptically via A2B receptors controlling the release of dopamine in 
chemoreceptor cells. We suggest that A2B -D2 adenosine / dopamine 
interactions at the CB could explain the increase in CA metabolism caused by 
chronic ingestion of caffeine during chronic hypoxia. It was also concluded that 
adenosine facilitates CB sensitisation to chronic hypoxia although this effect is 
further compensated at the central nervous system.  
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RESUMO 
 
Os corpos carotídeos (CB) são pequenos orgãos emparelhados 
localizados na bifurcação da artéria carótida comum. Estes órgãos são 
sensíveis a variações na PaO2, PaCO2, pH e temperatura sendo responsáveis 
pela hiperventilação que ocorre em resposta à hipóxia, contribuindo também 
para a hiperventilação que acompanha a acidose metabólica e respiratória. As 
células quimiorreceptoras (tipo I ou glómicas) do corpo carotídeo respondem às 
variações de gases arteriais libertando neurotransmissores que activam as 
terminações sensitivas do nervo do seio carotídeo (CSN) conduzindo a 
informação ao centro respiratório central. Está ainda por esclarecer qual o 
neurotransmissor (ou os neurotransmissores) responsável pela sinalização 
hipóxica no corpo carotídeo. A adenosina é um neurotransmissor excitatório no 
CB que aumenta a actividade eléctrica do CSN induzindo a hiperventilação 
através da activação de receptores A2. A importância destes efeitos da 
adenosina na quimiorrecepção, descritos em ratos e gatos, foi reforçada por 
resultados obtidos em voluntários saudáveis onde a infusão intravenosa de 
adenosina em induz hiperventilação e dispneia, efeito atribuído a uma 
activação do CB uma vez que a adenosina não atravessa a barreira hemato-
encefálica e o efeito é quanto maior quanto mais perto do CB for a 
administração de adenosina.  
O presente trabalho foi realizado com o objectivo de esclarecer qual o 
significado funcional da adenosina na quimiorrecepção no CB em animais 
controlo e em animais submetidos a hipoxia crónica mantida. Para alcançar 
este objectivo investigou-se: 1) o efeito da hipóxia moderada sobre a libertação 
de adenosina numa preparação in vitro de CB e a especificidade desta mesma 
libertação comparativamente com outros tecidos não quimiossensitivos, assim 
como as vias metabólicas de produção e libertação de adenosina no CB em 
normoxia e hipóxia; 2) a modulação da libertação de adenosina/ATP das 
células quimiorreceptoras do CB por receptores nicotínicos de ACh; 3) os 
efeitos da cafeína no controlo periférico da ventilação e a identidade dos 
receptores de adenosina envolvidos nos efeitos da adenosina e da cafeína nos 
quimiorreceptores do CB; 4) as interacções entre os receptores D2 de 
dopamina e os receptores A2B de adenosina que modulam a libertação de 
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catecolaminas (CA) no CB de rato e; 5) o efeito da ingestão crónica de cafeína, 
isto é, o contínuo bloqueio e dos receptores de adenosina, simulando assim o 
consumo crónico da cafeína, tal como ocorre na população humana mundial e 
principalmente no ocidente, na função do corpo carotídeo em ratos controlo e 
em ratos submetidos a hipoxia crónica.  
Os métodos utilizados neste trabalho incluíram: técnicas de biologia 
molecular como imunocitoquímica e western-blot; técnicas bioquímicas, tais 
como a quantificação de neurotransmissores por HPLC, bioluminescência e 
métodos radioisotópicos; técnicas electrofisiológicas como o registro de 
potenciais eléctricos do nervo do seio carotídeo in vitro; e registros ventilatórios 
in vivo em animais não anestesiados e em livre movimento (pletismografia). 
Observou-se que: 1) a especificidade dos quimiorreceptores do CB 
como sensores de O2 está correlacionada com o baixo limiar de libertação de 
adenosina em resposta à hipóxia dado que a libertação de adenosina do CB 
aumenta 44% em resposta a uma hipóxia moderada (10% O2), que no entanto 
não é um estímulo suficientemente intenso para evocar a libertação de 
adenosina do gânglio cervical superior ou do tecido arterial. Observou-se 
também que aproximadamente 40% da adenosina libertada pelo CB provém do 
catabolismo extracelular do ATP quer em normóxia quer em hipóxia moderada, 
sendo que PO2 reduzidas induzem a libertação de adenosina via activação do 
sistema de transporte equilibrativo ENT1.  
2) a ACh modula a libertação de adenosina /ATP do CB em resposta à hipoxia 
moderada sugerindo que o papel excitatório da ACh na actividade 
quimiossensora inclui a activação indirecta de receptores purinérgicos pela 
adenosina e ATP, indicando que a adenosina e o ATP poderiam actuar como 
mediadores importantes no processo de quimiotransducção uma vez que: a) a 
activação dos receptores nicotínicos de ACh no CB em normóxia estimula a 
libertação de adenosina (max 36%) provindo aparentemente da degradação 
extracelular do ATP. b) a caracterização farmacológica dos receptores 
nicotínicos de ACh envolvidos na estimulação da libertação de adenosina do 
CB revelou que os receptores nicotínicos de ACh envolvidos são constituídos 
por subunidades α4ß2.  
3) a adenosina modula a libertação de catecolaminas das células 
quimiorreceptoras do CB através de receptores de adenosina A2B dado que: a) 
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a cafeína, um antagonista não selectivo dos receptores de adenosina, inibiu a 
libertação de CA quer em normóxia quer em resposta a estímulos de baixa 
intensidade sendo ineficaz na libertação induzida por estímulos de intensidade 
superior; b) o DPCPX e do MRS1754 mimetizaram os efeitos da cafeína no CB 
sendo o SCH58621 incapaz de induzir a libertação de CA indicando que os 
efeitos da cafeína seriam mediados por receptores A2B de adenosina cuja 
presença nas células quimiorreceptoras do CB demonstramos por 
imunocitoquímica.  
4) a aplicação aguda de cafeína inibiu em 52% a actividade quimiossensora do 
CSN induzida pela hipóxia sendo este efeito mediado respectivamente por 
receptores de adenosina A2A pós-sinápticos e A2B pré-sinápticos indicando que 
a actividade quimiossensora induzida pela hipóxia é controlada pela adenosina.  
5) existe uma interacção entre os receptores A2B e D2 que controla a libertação 
de CA do corpo carotídeo de rato uma vez que: a) os antagonistas dos 
receptores D2, domperidona e haloperidol, aumentaram a libertação basal e 
evocada de CA das células quimiorreceptoras confirmando a presença de 
autorreceptores D2 no CB de rato que controlam a libertação de CA através de 
um mecanismo de feed-back negativo. b) o sulpiride, um antagonista dos 
receptores D2, aumentou a libertação de CA das células quimiorreceptoras 
revertendo o efeito inibitório da cafeína sobre esta mesma libertação; c) a 
propilnorapomorfina, um agonista D2 inibiu a libertação basal e evocada de CA 
sendo este efeito revertido pela NECA, um agonista dos receptores A2B. O 
facto de a NECA potenciar o efeito do haloperidol na libertação de CA sugere 
que a interacção entre os receptores D2 e A2B poderia também ocorrer ao nível 
de segundos mensageiros, como o cAMP.  
6) a ingestão crónica de cafeína em ratos controlo (normóxicos) não alterou 
significativamente a função basal do CB medida como a dinâmica dos seus 
neurotransmissores, dopamina, ATP e adenosina e como actividade 
quimiossensora do CSN. Contrariamente aos efeitos basais, a ingestão crónica 
de cafeína facilitou a resposta à hipóxia, dado que aumentou o efeito no 
volume minuto respiratórioapresentando-se também uma clara tendência para 
aumentar a actividade quimiossensora do CSN e aumentar a libertação de ATP 
e dopamina. 
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7) após um período de 15 dias de hipóxia crónica era evidente o fenómeno de 
aclimatização dado que as respostas ventilatórias à hipóxia se encontram 
aumentadas, assim como a actividade quimiossensora do CSN basal e 
induzida pela hipóxia. As alterações observadas no metabolismo da dopamina, 
assim como na libertação basal de dopamina e de adenosina poderiam 
contribuir para a aclimatização durante a hipoxia crónica. A libertação 
aumentada de adenosina em resposta à hipóxia aguda em ratos hipóxicos 
crónicos sugere um papel da adenosina na manutenção/aumento das 
respostas ventilatórias à hipóxia aguda durante a hipóxia crónica. Observou-se 
também que a libertação de ATP induzida pela hipóxia aguda se encontra 
diminuída em hipóxia crónica, contudo a ingestão crónica de cafeína reverteu 
este efeito para valores similares aos valores controlo, sugerindo que a 
adenosina possa modular a libertação de ATP em hipóxia crónica. 
8) a ingestão crónica de cafeína em ratos hipóxicos crónicos induziu o aumento 
do metabolismo de CA no CB, medido como expressão de tirosina hidroxilase, 
conteúdo, síntese e libertação de CA. 
9) a ingestão crónica de cafeína não provocou quaisquer alterações na 
actividade quimiossensora do CSN em ratos hipóxicos crónicos no entanto, as 
respostas do CSN à hipóxia aguda intensa e moderada e à hipercapnia 
encontram-se diminuídas. Este efeito inibitório que provém da ingestão crónica 
de cafeína parece ser compensado ao nível dos quimiorreceptores centrais 
dado que os parâmetros ventilatórios em condições basais e em resposta à 
hipoxia aguda não se encontram modificados em ratos expostos durante 15 
dias a uma atmosfera hipóxica.  
Resumindo podemos assim concluir que a adenosina quer em situações 
de hipoxia aguda quer em condições de hipoxia crónica tem um papel 
excitatório na actividade quimiossensora do CB actuando directamente nos 
receptores A2A presentes pós-sinapticamente no CSN, assim como facilitando a 
libertação de dopamina pré-sinapticamente via receptores A2B presentes nas 
células quimiorreceptoras. A interacção negativa entre os receptores A2B e D2 
observadas nas células quimiorreceptoras do CB poderia explicar o aumento 
do metabolismo de CA observado após a ingestão crónica de cafeína em 
animais hipóxicos. Conclui-se ainda que durante a aclimatização à hipóxia a 
acção inibitória da cafeína, em termos de resposta ventilatória, mediada pelos 
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quimiorreceptores periféricos é compensada pelos efeitos excitatórios desta 
xantina ao nível do quimiorreceptores centrais.  
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RESUMEN 
 
Los cuerpos carotídeos (CB) son órganos emparejados que están 
localizados en la bifurcación de la arteria carótida común.  Estos órganos son 
sensibles a variaciones en la PaO2, en la PaCO2, pH y temperatura siendo 
responsables de la hiperventilación que ocurre en respuesta a la hipoxia, 
contribuyendo también a la hiperventilación que acompaña a la acidosis 
metabólica y respiratoria. Las células quimiorreceptoras (tipo I o glómicas) del 
cuerpo carotídeo responden a las variaciones de gases arteriales liberando 
neurotransmissores que activan las terminaciones sensitivas del nervio del 
seno carotídeo (CSN) llevando la información al centro respiratorio central. 
Todavía esta por clarificar cual el neurotransmisor (o neurotransmisores) 
responsable por la señalización hipóxica en el CB. La adenosina es un 
neurotransmisor excitatório en el CB ya que aumenta la actividad del CSN e 
induce la hiperventilación a través de la activación de receptores de adenosina 
del subtipo A2.  La importancia de estos efectos de la adenosina en la 
quimiorrecepción, descritos en ratas y gatos, ha sido fuertemente reforzada por 
resultados obtenidos en voluntarios sanos en los que la infusión intravenosa de 
adenosina induce hiperventilación y dispnea, efectos estés que han sido 
atribuidos a una activación del CB ya que la adenosina no cruza la barrera 
hemato-encefalica y el efecto es tanto más grande cuanto más cercana del CB 
es la administración.    
Este trabajo ha sido realizado con el objetivo de investigar cual el 
significado funcional de la adenosina en la quimiorrecepción en el CB en 
animales controlo y en animales sometidos a hipoxia crónica sostenida. Para 
alcanzar este objetivo se ha estudiado: 1) el efecto de la hipoxia moderada en 
la liberación de adenosina en una preparación in vitro de CB y la especificidad 
de esta liberación en comparación con otros tejidos no-quimiosensitivos, así 
como las vías metabólicas de producción y liberación de adenosina del órgano 
en normoxia y hipoxia; 2) la modulación de la liberación de adenosina/ATP de 
las células quimiorreceptoras del CB por receptores nicotínicos de ACh; 3) los 
efectos de la cafeína en el controlo periférico de la ventilación y la identidad de 
los receptores de adenosina involucrados en los efectos de la adenosina y 
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cafeína en los quimiorreceptores del CB; 4) las interacciones entre los 
receptores D2 de dopamina y los receptores A2B de adenosina que modulan la 
liberación de catecolaminas (CA) en el CB de rata y; 5) el efecto de la ingestión 
crónica de cafeína, es decir, el bloqueo sostenido de los receptores de 
adenosina, simulando la dependencia de cafeína observada en la populación 
mundial del occidente, en la función del CB en ratas controlo y sometidas a 
hipoxia crónica sostenida.  
Los métodos utilizados en este trabajo incluirán: técnicas de biología 
molecular como imunocitoquímica y western-blot; técnicas bioquímicas, tales 
como la cuantificación de neurotransmissores por HPLC, bioluminescencia y 
métodos radioisotópicos; técnicas electrofisiológicas como el registro de 
potenciales eléctricos del nervio do seno carotídeo in vitro; y registros 
ventilatórios in vivo en animales no anestesiados y en libre movimiento 
(pletismografia). 
Se observó que: 1) la sensibilidad de los quimiorreceptores de CB esta 
correlacionada con un bajo umbral de liberación de adenosina en respuesta a 
la hipoxia ya que en respuesta a una hipoxia moderada (10% O2) la liberación 
de adenosina en el CB aumenta un 44%, sin embargo esta PaO2 no es un 
estimulo suficientemente fuerte para inducir la liberación de adenosina del 
ganglio cervical superior o del tejido arterial; se observó también que 
aproximadamente 40% de la adenosina liberada del CB proviene del 
catabolismo extracelular del ATP en normoxia y en hipoxia moderada, y que 
bajas PO2 inducen la liberación de adenosina vía activación del sistema de 
transporte equilibrativo ENT1.  
2) la ACh modula la liberación de adenosina /ATP del CB en respuesta  a la 
hipóxia moderada lo que sugiere que el papel excitatório de la ACh en la 
actividad quimiosensora incluye la activación indirecta de receptores 
purinérgicos por la adenosina y el ATP, indicando que la adenosina y el ATP 
pueden actuar como mediadores importantes en el proceso de 
quimiotransducción ya que: a) la activación de los receptores nicotínicos de 
ACh en el CB en normoxia estimula la liberación de adenosina (max 36%) que 
aparentemente proviene de la degradación extracelular del ATP. Se observó 
también que este aumento de adenosina en el CB en hipoxia ha sido 
antagonizado parcialmente por antagonistas de estos mismos receptores; b) la 
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caracterización farmacológica de los receptores nicotínicos de ACh 
involucrados en la estimulación de la liberación de adenosina del CB ha 
revelado  que los receptores nicotínicos de ACh involucrados son constituidos 
por sub-unidades α4ß2.  
3) la adenosina modula la liberación de CA de las células quimiorreceptoras del 
CB a través de receptores de adenosina A2B ya que: a) la cafeína, un 
antagonista no selectivo de los receptores de adenosina, ha inhibido la 
liberación  de CA en normoxia y en respuesta a  estímulos de baja intensidad 
siendo ineficaz en la liberación inducida por estímulos de intensidad superior; 
b) el DPCPX y el MRS1754 ha mimetizado los efectos de la cafeína en el CB y 
el SCH58621 ha sido incapaz de inducir la liberación de CA lo que sugiere que 
los efectos de la cafeína son mediados por receptores A2B de adenosina que 
están localizados pré-sinapticamente en las células quimiorreceptoras del CB.  
4) la aplicación aguda de cafeína ha inhibido en 52% la actividad 
quimiosensora del CSN inducida por la hipoxia siendo este efecto mediado 
respectivamente por receptores de adenosina A2A pós-sinápticos y A2B pré-
sinápticos lo que indica que la actividad quimiosensora inducida por la hipoxia 
es controlada por la adenosina.  
5) existe una interacción entre los receptores A2B y D2 que controla la liberación 
de CA del CB de rata ya que: a) el sulpiride, un antagonista de los receptores 
D2, ha aumentado la liberación de CA de las células quimiorreceptoras 
revertiendo el efecto inhibitorio de la cafeína sobre esta misma liberación; b) los 
antagonistas de los receptores D2, domperidona y haloperidol, han aumentado 
la liberación basal e evocada de CA de las células quimiorreceptoras 
confirmando la presencia de autorreceptores D2 en el CB de rata que controlan 
la liberación de CA a través de un mecanismo de feed-back negativo; c) la 
propilnorapomorfina, un agonista D2, ha inhibido la liberación basal e evocada 
de CA sendo este efecto revertido por la NECA, un agonista de los receptores 
A2B. Ya que la NECA potencia el efecto del haloperidol en la liberación de CA la 
interacción entre los  D2 y A2B puede también ocurrir al nivel de segundos 
mensajeros, como el cAMP.  
6) la ingestión crónica de cafeína en ratas controlo (normóxicas) no ha 
cambiado significativamente la función basal del CB medida como la dinámica 
de sus neurotransmisores, dopamina, ATP y adenosina y como actividad 
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quimiosensora del CSN. Al revés de lo que pasa con los efectos básales, la 
ingestión crónica de cafeína facilitó la respuesta a la hipóxia, ya que ha 
aumentado la respuesta ventilatória medida como volumen minuto presentando 
también una clara tendencia para aumentar la actividad quimiosensora del CSN 
y aumentar la liberación de ATP y dopamina. 
7. Después de un  período de 15 días de hipoxia crónica se puede observar el 
fenómeno de climatización ya que las respuestas ventilatórias a la hipoxia 
están aumentadas, así como la actividad quimiosensora del CSN basal e 
inducida por la hipoxia. Los cambios observados en el metabolismo de la 
dopamina, así como en la liberación basal de dopamina y de adenosina 
podrían contribuir para la climatización en hipoxia crónica. El aumento en la 
liberación de adenosina en respuesta a la hipoxia aguda en ratas sometidas a 
hipoxia crónica sugiere un papel para la adenosina en el 
mantenimiento/aumento de las respuestas ventilatórias a la hipoxia aguda en 
hipoxia crónica sostenida. Se ha observado también que la liberación de ATP 
inducida por la hipoxia aguda está disminuida en hipoxia crónica y que la 
ingestión crónica de cafeína reverte este efecto para valores similares a los 
valores controlo, sugiriendo que la adenosina podría modular la liberación de 
ATP en hipoxia crónica. 
8. la ingestión crónica de cafeína ha inducido el aumento del metabolismo de 
CA en el CB en ratas hipóxicas crónicas, medido como expresión de la tirosina 
hidroxilase, contenido, síntesis y liberación de CA. 
9. la ingestión crónica de cafeína no ha inducido cambios en la actividad 
quimiosensora del CSN en ratas hipóxicas crónicas sin embargo las respuestas 
do CSN a una hipoxia intensa y moderada y a la hipercapnia están 
disminuidas. Este efecto inhibitorio que es debido a la ingestión crónica de 
cafeína es compensado al nivel de los quimiorreceptores centrales ya que los 
parámetros ventilatórios en condiciones básales y en respuesta a la hipoxia 
aguda no están modificados en ratas expuestas durante 15 días a una 
atmósfera hipóxica.  
Resumiendo se puede concluir que la adenosina en situaciones de 
hipoxia aguda así como en hipoxia crónica tiene un papel excitatório en la 
actividad quimiosensora del CB actuando directamente en los receptores A2A 
localizados pós-sinapticamente en el CSN, así como controlando la liberación 
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de dopamina pré-sinaptica vía receptores A2B localizados en las células 
quimiorreceptoras. Las interacciones entre los receptores A2B y D2 observadas 
en las células quimiorreceptoras del CB podrían explicar el aumento del 
metabolismo de CA observado después de la ingestión crónica de cafeína en 
animales hipóxicos. Por fin, pero no menos importante se puede concluir que 
durante la climatización a la  hipoxia la acción inhibitoria de la cafeína, medida 
como respuesta ventilatória, mediada por los quimiorreceptores periféricos es 
compensada por los efectos excitatórios de esta xantina al nivel de los 
quimiorreceptores centrales. 
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1. GENERAL INTRODUCTION 
  
 Oxygen is used in cells by cellular respiration to oxidize nutrients and to 
obtain the energy (ATP) required for cell function, originating CO2 and water as 
final products. The capture of oxygen from the atmosphere is done by the 
respiratory and circulatory systems. The process of breathing allows the 
continuous delivery of O2-rich fresh air into the lungs and the alveoli. When 
atmospheric air enters into the alveoli an exchange of gases is produced. The 
exchange of gases (O2 and CO2) between the alveoli and the blood occurs by 
simple diffusion: O2 diffusing from the alveoli into the blood and CO2 from the 
blood into the alveoli. Since diffusion requires a concentration gradient, the 
concentration (or pressure) of O2 in the alveoli must be kept at a higher level 
than in the blood and the concentration (or pressure) of CO2 in the alveoli must 
be kept at a lower level than in the blood. This gaseous exchange and mixing 
results in a partial arterial pressure of oxygen (PaO2) of 100 mmHg and a partial 
arterial pressure of carbon dioxide (PaCO2) of 35-45 mmHg.  
If O2 delivery to the cells is insufficient to perform all cell functions i.e. 
when cells do not have enough oxygen to function properly, we are in a 
situation of hypoxia. In its extreme form, when O2 is entirely absent, the 
condition is called anoxia. There are four types of hypoxia: hypoxic hypoxia, 
which is the most common and is caused by decreased oxygen in air or by the 
inability of oxygen to diffuse across the lungs walls; hypoxemic (anaemic) 
hypoxia that is caused by the reduction of the oxygen carrying capacity of the 
blood (low haemoglobin); ischemic (stagnant) hypoxia that is caused by 
reduced cardiac output and resultant slower blood circulation rate; and 
histotoxic hypoxia that occurs when cells are incapable of using O2. 
Physiologically, only hypoxic hypoxia could occur in a healthy animal, as all the 
other hypoxias would be pathological. Pathologically, several cardiorespiratory 
diseases result in chronic sustained or intermittent hypoxia. These include e.g. 
sleep apnoea, congestive heart failure, emphysema, chronic obstructive 
pulmonary disease (COPD) and sudden infant death syndrome (SIDS). Chronic 
exposure to hypoxia regulates the expression of numerous genes, encoding 
enzymes, growth factors, or transporters, which induce molecular and 
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histological modifications to reduce the cellular need of, and dependence on, O2 
and increase the O2 supply to the tissues (figure 1).  
 
Hypoxia  
 
 
Ion channels Transcription factors Effectors  
 
 
 Acute Effects 
Hyperventilation 
Increased cardiac output 
Pulmonary vasoconstriction 
Systemic arterial vasodilatation 
Relaxation of ductus arteriosus 
Chronic Effects 
Activation of glucose metabolism and 
transport 
Erythropoiesis 
Angiogenesis and neovascularization 
Tissue hypertrophy and remodelling 
Production of vasodilators 
 
 
 
 
 
 
Figure 1 Hypoxia signalling pathway with the major adaptive responses to acute and 
chronic hypoxia (adapted from Lopez-Barneo et al., 2004). 
 
Mammals possess regulatory mechanisms that, acting on the respiratory 
and cardiovascular systems, try to minimize hypoxia and to prevent its 
deleterious effects. The arterial chemoreceptors, aortic bodies and in particular 
the carotid bodies (CB) are the activators of those regulatory mechanisms. The 
CBs are located near the carotid artery bifurcations and sense arterial PO2 
(PaO2), arterial PCO2 (PaCO2), pH and temperature, being responsible for the 
greatest part of the hyperventilation observed during hypoxia and contributing to 
the hyperventilation that accompanies respiratory or metabolic acidosis. The 
remaining respiratory drive is due to aortic bodies in the case of hypoxia and to 
central chemoreceptors in the case of acidosis (Richerson and Boron, 2005). 
CB chemoreceptor cells are sensors that, in response to low PO2, high 
PCO2 and pH, release neurotransmitters that modify, increasing or inhibiting, 
the frequency of sensory fibres of the carotid sinus nerve (CSN). Central 
projections of the CSN terminate in the brain stem, where the firing frequency is 
integrated by the respiratory central control system, generating the 
compensatory ventilatory response. 
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Stimulation of the CB  
 
 
Cardiovascular 
responses 
Respiratory 
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Figure 2 Respiratory and 
cardiovascular responses 
to carotid body activation. 
Adapted from Fitzgerald, 
2000. 
 
 
 
 
 
 
 
 
 
Chemoreceptors also exert some actions on the cardiovascular system, 
namely the heart and the resistance and capacitance of vessels (Figure 2) (for a 
review see Gonzalez et al., 1994).  
The CBs have been known as sensory organs since 1928 (De Castro, 
1928) and in 1938 the Nobel Prize was awarded to Heymans for the discovery 
of “the aortic and sinus mechanisms of respiration”. Over the subsequent 
decades the CB was extensively studied in terms of reflex systemic responses 
resulting from CB stimulation and in terms of the physiology and pharmacology 
of neural mechanisms responsible for the action potentials generated at CSN 
level and integrated at the brain stem, producing systemic responses. Several 
theories were postulated, aimed at explaining the chemoreception process, the 
“mechanism and the substances involved” that contribute to the stimulus-
generated neural activity in the CSN.   
Adenosine is a mediator in the central and peripheral nervous system 
and it is known that it stimulates ventilation in several mammalian species, 
including humans. In the recent years an excitatory role for adenosine has been 
 3
Functional significance of adenosine in carotid body chemoreception 
PhD thesis, Silvia Vilares Conde  
 
proposed at the CB and in this context we decided to investigate the functional 
significance of this mediator in carotid body chemosensory activity, in control 
and chronically hypoxic animals. 
 
 
1.1. The carotid body: morphology 
The CB parenchyma is characterized by the existence of islets of cells, 
called clusters, glomeruli or glomoids enveloped by an extensive net of 
fenestrated capillaries and dispersed in a stroma of fibrocytes and collagen 
fibres (Figure 3C) (for a review see e.g. Verna, 1997). Each glomerulus 
contains two cell types: glomic cells (Type I cells or chemoreceptor cells) and 
Type II cells or sustentacular cells, and the surrounding capillary networks 
(Figure 3). 
 
 
 C
 
 
 
Figure 3 Drawing of the carotid artery bifurcation (A) and a cellular cluster of the 
carotid body (B); and a histological image of a slice of 10 µM of the carotid body (C). In 
A the common carotid artery (1) that divides to internal (2) and external (3) arteries. 
Sensory fibres originated in petrosal ganglion (5) reach the carotid body (4) via carotid 
sinus nerve (CSN) (6). The superior cervical ganglion (7) also innervates the carotid 
body, via the ganglioglomerular nerves (8).The nodose ganglion (9) is located 
externally to the internal carotid artery. B Cluster of parenchymatous cells of the carotid 
body, which are formed by chemoreceptor cells (1) that are partially surrounded by 
sustencular cells (2). Sensory nerve endings (4) are in contact with chemoreceptor 
cells. The clusters are surrounded by a dense net of capillaries (6). C 
Immunohistochemical image of a 10 µM section of the CB. (Adapted from Gonzalez et 
al., 1992) 
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Ultrastructural studies have demonstrated that chemoreceptor cells have 
characteristics of active secretory cells (Verna, 1979). Chemoreceptor cells are 
derived from the neural crest and possess a heterogeneous population of 
synaptic vesicles in their cytoplasm that contain some of the putative 
neurotransmitters. The neuroactive agents present in the chemoreceptors 
include acetylcholine (ACh), dopamine (DA), norepinephrine (NE) and serotonin 
(5-HT) and also several neuropeptides, like substance P (SP) and met-
encephalin (ME) and ATP (Gonzalez et al., 1994; Zhang et al., 2000; Buttigieg 
and Nurse, 2004; Conde and Monteiro, 2006). Type II cells have a glial nature 
and lack specialized organelles (Gonzalez et al., 1992) (Figure 3B).  
The proximity of capillaries to chemoreceptor cells (less than 20 µM) 
minimizes the diffusion pathway of bloodborn stimuli. 
The CSN sensory fibres come from the petrosal ganglion (PG) neurons 
and penetrate the glomeruli, ending in synaptic apposition to the chemoreceptor 
cells (Figure 3B). Beyond this sensory innervation, the CB receives sympathetic 
and parasympathetic innervation in the vessels that is originated in the neurons 
present in the superior cervical ganglion (SCG) and at the surface of the CB 
and in other neurons dispersed through CSN. These fibres are noradrenergic 
and cholinergic and control the blood rate to the CB, i.e. its functional activity 
(Verna, 1997).  
 
 
1.2. Chemotransduction mechanisms at the CB: coupling stimulation and 
secretion 
It is universally accepted that chemoreceptor cells are the initial (first) 
transducers of sensorial stimulus releasing neurotransmitters that generate 
action potentials in CSN sensitive nerve fibres, this activity being integrated at 
the brain stem to induce ventilation (Figure 4).  
 
At normal blood gas pressures and pH, chemoreceptor cells possess a 
basal activity that can be measured as basal release of neurotransmitters or as 
basal CSN electrical activity. An important role has been attributed to CB 
chemoreceptors in maintaining the resting ventilation since CB resection or 
CSN denervation produces alterations in the different resting respiratory 
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parameters, like a decrease in minute ventilation and a moderate increase of 
PaCO2 (8 - 10 mmHg) (Bisgard et al., 1976; Bisgard and Vogel, 1971; Eugenin 
et al., 1989; Feustel et al., 1981). The PaO2 threshold to hypoxia corresponds to 
70-75 mmHg (Biscoe et al. 1970; Obeso et al.; 1997b) and below this PaO2 the 
slope between PO2 and CSN discharges and minute ventilation increase 
exponentially (for a review see Gonzalez et al., 1994, Figure 6).  
 
 
 
 
 
 
 
 
 
 
 
 CSN Respiratory system 
STIMULUS 
 
1.HYPOXIC HYPOXIA 
Anemic hypoxia 
Stagnant hypoxia 
RESPIRATORY/ 
METABOLIC ACIDOSIS 
Increased temperature  
Increased osmolarity 
 
2. Metabolic poisons 
(Histotoxic hypoxia) 
Neurotransmitters 
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Blood 
TRANSDUCTION              OUTPUTS 
CHEMORECEPTOR 
CELL OUTPUT 
(Neurotransmitter 
release) 
CSN OUTPUT 
(Action potential 
frequency) 
SYSTEMIC 
OUTPUT 
(ventilation) 
Chemoreceptor cell 
 
Figure 4 Functional organization of carotid body (CB) chemoreceptors.  (Adapted from 
Gonzalez et al., 1994) 
 
   
However, for the hypercapnic stimulus the relation between the increase 
in PaCO2 and CSN discharges and release of neurotransmitters is different, 
being linear between 20-100 mmHg (Rigual et al., 1991). These relationships 
suggest that the transduction mechanisms are different for the two stimuli.  
Several studies have shown that DA is released in hypoxia and 
hypercapnia, this release being proportional to stimulus intensity and to CSN 
chemosensory activity increase and dependent on extracellular Ca2+ (Fidone et 
al., 1982; Obeso et al., 1985, 1986, 1992, 1999; Rigual et al., 1986, 1991, 2002; 
Rocher et al., 1991; Vicario et al., 2000a; Sanz-Alfayate, 2001). The same 
effect was observed with the response of CB to high K+ (depolarizing stimulus) 
(Almaraz et al., 1986). The response to hypoxia and to high K+ was sensitive to 
dihydropyridines (L-type agonists and antagonists – voltage Ca2+ channels 
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dependent), however the acidic-stimulus response was dihydropyridine 
insensitive (Obeso et al., 1992). Soon after, it was demonstrated that 
veratridine, activator of voltage-dependent Na+ channels, increases the release 
of DA, the release being dependent on Na+ and Ca2+ and sensitive to 
tetradotoxin (TTX); in addition it was shown that the release of DA induced by 
hypoxia was also TTX-sensitive. All these findings suggest that hypoxia 
depolarizes chemoreceptor cells inducing Na+ and Ca2+ entrance.  
 
PO2 diminution 
O2 sensor  
Diminution of the channels opening probability 
of K+ channels sensitive to PO2  
Depolarization 
Activation of Na+ and Ca2+ channels
Increase of intracellular Ca2+
Neurotransmitter release 
Coupling mechanisms
Increase in CSN discharges 
High 
extracellular K+
Integration in the brain stem 
Modification of respiratory and 
cardiovascular parameters 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5 Hypoxic transduction mechanism at the carotid body. In red are the steps of 
the cascade not completely defined (established) (adapted from Gonzalez et al., 1992).  
 
Next, K+ currents sensitive to PO2 that were inhibited by hypoxia were 
found in the CB chemoreceptor cells as well as voltage-dependent Na+ and 
Ca2+ channels (Lopez-Barneo et al., 1988; Lopez-Lopez et al., 1989).  
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Taken together these findings led to the transduction model of hypoxia in 
the CB (Figure 5, Gonzalez et al., 1992). Nevertheless, some steps of 
transduction cascade are still to be defined, like the nature of the O2 sensor and 
the coupling mechanisms.  
 
 
 
1.3. Function and control of the carotid body in resting conditions and in 
hypoxia 
  In normal conditions of blood gases and pH, CSN fiber discharge varies 
with the type of fiber studied. Chemoreceptor A fibres discharge between 1-15 
impulses/s and C-fibres discharge never more than 4-5 impulses/s, most of the 
time firing less than 2 impulses/s (Fidone and Sato, 1969). 
 Single nerve fiber activity is random because interspike intervals follow a 
Poison distribution; however, if resting discharges of a single nerve fiber are 
averaged over several respiratory cycles an oscillatory pattern becomes 
evident. The oscillations in CSN discharge have their origin in the periodic 
nature of breathing that produces oscillations in the alveolar PO2 and PCO2 that 
are transmitted to blood and detected by the CB.  
 The fact that in resting conditions the amplitude of the oscillations in 
relation to the mean CSN frequency is about 0.5, and the fact that CB resection 
or CSN denervation causes a decrease in resting minute ventilation and PaO2, 
and an increase in PaCO2, means that oscillations on CSN discharges are a 
sign as important as mean discharge (for a review see Gonzalez et al., 1994).  
The data shown in figure 6A indicate that there is not a true threshold for 
the CB response to low PaO2, because the CSN is already firing at PaO2 5 
times higher than the normal PaO2 of 100 mmHg. However, it is usual to talk 
about the “physiological” threshold for CSN activation. The PaO2 threshold to 
hypoxia corresponds to 70-75 mmHg (Biscoe et al. 1970; Obeso et al.; 1997b) 
and below this PaO2 the slope between PO2 and CSN discharges changes 
abruptly from linear to exponential until 10-15 mmHg (Gonzalez et al.,1994) 
(Figure 6A); at very low PO2 (<10 mmHg) the discharges may tend to level off 
or to decrease. At a PaO2 of around 75 mmHg the O2 content of the blood is 
approximately 95% of the normal, which implies that CB triggers 
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hyperventilation before real tissular hypoxia appears, the CB having a tissue 
hypoxia-preventative role.  
 
Figure 6 Carotid sinus nerve chemosensory activity during acute hypoxic stimulation. 
A) steady-state activity as a function of PaO2 in different experiments (Source: 
Mullingan et al., 1981). B and C) Comparison between carotid body and aortic bodies’ 
response in anemic hypoxia and stagnant hypoxia, respectively (Lahiri et al., 1980, 
1981). 
 
 
The relation between PaO2 and ventilation is similar to that described for 
PaO2 and CSN chemosensory activity (Weil et al., 1970; Figure 7). In humans in 
which CB have been surgically removed (common practice in the 1950´s and 
60´s to treat severe asthma) the hyperventilatory response to hypoxia was not 
observed, these individuals presenting a ventilatory response to exercise that is 
reduced by 30% when compared with control subjects. Similar results have 
been found in animals: the response to hypoxia is abolished with CSN section 
(Lahiri, 1976, Figure 7).  
 
 
 
 
 
 
 
 
 
 9
Functional significance of adenosine in carotid body chemoreception 
PhD thesis, Silvia Vilares Conde  
 
 
 
 
 
 
 
Figure 7 Effect of several hypoxic 
intensities on minute ventilation (VI; l/min) 
in a Nembutal-anesthetized cat before (∆) 
and after sectioning both carotid sinus 
nerves (▲). (Lahiri, 1976). 
 
 
 
 
 
During chronic hypoxia acclimatization appears i.e. a progressive 
increase in ventilation in response to a given level of hypoxia is observed 
(Bisgard 1994, 1995, 2000).  During the initial period of 30 min of hypoxia, there 
was an increase in ventilation that reduced PaCO2 by 1-5 mmHg and at 8 h, 
hyperventilation increased bringing PaCO2 to 8-10 mmHg. It was also observed 
that one CB is sufficient to elicit acclimatization and that the superfusion of 
intact CB with isocapnic hypoxic blood produces acclimatization, suggesting 
that CB hypoxia is the only factor required to elicit acclimatization in systemic 
hypoxia. When CSN discharges are recorded, they progressively increase 
during 5-6 h of sustained hypoxia (Bisgard 1994, 1995, 2000) with the 
acclimatization phenomena also being observed. The function and adaptation of 
the CB in response to chronic sustained hypoxia will be detailed further in 
Section 1.5.2.   
 
 The response of CB to anemic and ischemic (stagnant) hypoxia is 
physiologically unimportant. Very intense anemias and hypotension, which are 
barely compatible with life, are needed to elicit an increase in the CSN 
chemosensory activity or ventilation as long as PaO2 is normal. Nevertheless, 
the aortic chemoreceptors respond to anemic and stagnant hypoxias of 
moderate intensities (Figure 6B and C), but the effects of aortic chemoreceptor 
activation on ventilation are negligible. In fact, direct electric stimulation of the 
aortic nerve did not modify phrenic nerve output in anesthetized dogs (Hopp et 
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al., 1991). The reasons for the distinct behaviour of CB and aortic bodies is not 
known, but it has been suggested as having a basis in the higher ratio of 
parenchyma volume to blood vessels in the aortic bodies in comparison with the 
CB, which implies a much lower blood flow to the aortic bodies than to the CB 
(Kumer and Addicks, 1986). This implies that aortic bodies detect rates of O2 
delivery, this being primarily responsible for the circulatory reflex responses, 
inducing several effects in order to prevent tissular hypoxia, like tachycardia, 
increased heart rate and increased arterial pressure (for a review see Gonzalez 
et al., 1994). 
 
 
1.4. Function and control of the carotid body in hypercapnia and acidosis 
 The CB plays a homeostatic role in the responses to high PCO2 and low 
pH in conjunction with central chemorececeptors allowing the pumping out of 
CO2 at a rate matching its production, and allowing the maintenance of pH. 
Exercise is the only physiological situation associated with an increased CO2 
production and the CB plays an important role in exercise hyperventilation and 
in maintaining PaCO2. In exercise the blood gases and pH are kept normal, but 
several pathological situations exist, like respiratory and metabolic acidosis, in 
which PaCO2 and/or [H+]i increase, producing hyperventilation. Therefore, 
hypercapnia and acidosis are other natural stimuli for the CB.  
It has been postulated that CB do not only sense changes in PCO2 but in 
the [H+]i. Thus, inhibition of carbonic anhydrase, the enzyme, present in 
chemoreceptor cells, that accelerates the hydration and dehydration of CO2, 
thereby accelerating the changes in the [H+]i in response to PCO2 alterations 
(Rigual et al., 1985), abolishes the dynamic increase in CSN chemosensory 
activity produced by sudden hypercapnia in vitro (Rigual et al., 1991; Buckler 
and Vaughan Jones, 1993) and in vivo (Nye et al., 1981, 1983), without 
modifying the steady response to CO2 change. On the other hand, it is known 
that the release of CA evoked by weak acids in CB is approximately 80% 
dependent on extracellular Ca2+ (Rigual et al., 1991; Obeso et al., 1992) and 
Na+ dependent, and inhibitable by blockers of proton extruding exchangers, 
supporting the sensing of [H+]i  by chemoreceptor cells and not only the 
increase in PCO2. Electrophysiological studies in rabbit and rat chemoreceptor 
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cells have shown that acidic stimuli are capable of depolarizing chemoreceptor 
cells and generate action potentials (Buckler and Vaughan Jones, 1993; 1994; 
Rocher et al., 2005) and found that hypoxia sensitive K+ channels are also 
sensitive to acidosis (Peers and Green, 1991; Buckler et al., 2000). These 
findings lead to the conclusion that the transduction cascade in response to 
acidic stimulus-hypercapnia is as complex as the hypoxic transduction cascade.  
 
 At the level of CSN, it is known that discharges in CSN increase almost 
linearly with increasing PaCO2 (or low pH) (Ponte and Purves, 1974; Rigual et 
al., 1991) but only up to certain levels, since at very high PaCO2 (>100 mmHg) 
or very low pH (<6.9) the discharges tend to plateau. As Figure 8 shows, the 
slope of the lines relating PaCO2 and CSN discharge increases as PaO2 
decreases indicating a positive interaction between both stimuli that is 
expressed in a multiplicative manner (Fitzgerald and Parks, 1971; Lahiri and 
Delaney, 1975a).  
 
 
 
Figure 8 Relationship between afferent 
chemosensory discharge and CO2 
levels, recorded in carotid sinus nerve 
preparation. CO2 levels were varied at 
different PO2 levels. (Lahiri and 
Delaney, 1975a) 
  
 
 
 
  
The relation between ventilation and PaCO2 is similar to that 
encountered for the CSN discharge. However, in this situation, central 
chemoreceptors also contribute to the ventilatory responses. The CB has a 
lower threshold for PCO2/acidic stimulus than central chemoreceptors, and so 
the hyperventilation observed in response to mild respiratory acidosis is 
originated mostly at the CB, but at more intense respiratory acidosis the CB 
only contributes 30-40% of the hyperventilatory response (see Gonzalez et al., 
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1994). In response to a metabolic acidosis the contribution of CB is greater, 
especially in the initial periods since H+ crosses the blood brain barrier slowly 
and has difficultly in reaching central chemoreceptors and exerting its effects 
(Irsigler et al., 1980). The hyperventilation trigered by CB decreases PaCO2 and 
forces CO2 to diffuse from the cerebrospinal fluid to blood. After several days of 
acidosis the pH of cerebrospinal fluid equilibrates with the blood stimulating 
both central and peripheral chemoreceptors (Cherniak and Altose, 1987). 
 
 
1.5. Neurotransmission in the carotid body: role of adenosine, dopamine, 
ACh and ATP 
 Neurotransmission is the step by which chemoreceptor cells 
communicate with the sensory nerve endings, generating increases or 
decreases in CSN frequency activity. Neurotransmission also compromise the 
effect of neurotransmitters on the autoreceptors present in chemoreceptor cells.  
 CB contains several neurotransmitters, such as ACh, DA, ATP, 5-HT, 
substance P, endothelin-1, encephalin and nitric oxide (NO) (Buttigieg and 
Nurse, 2004; Conde and Monteiro, 2006; Gonzalez et al., 1994; Zhang et al., 
2000). 
In this section we are going to focus only on the neurotransmitters 
involved in the present work: adenosine, ATP, dopamine and acetylcholine; and 
on the effects of these mediators on chemotransduction and ventilation.   
 
 
1.5.1. Adenosine 
 Adenosine is a product of ATP metabolism, which can be recycled to 
resynthethise ATP itself. Adenosine is not stored or released as a classical 
neurotransmitter and is an ubiquitous substance, being released by almost all 
cells and involved in key pathways such as purinergic nucleic acid base 
synthesis, amino acid metabolism and modulation of cellular metabolic status 
(Stone, 1985).  Adenosine modulates the activity of several systems at 
presynaptic level (inhibiting or facilitating neurotransmitter release), at post-
synaptic or at non-synaptic level (e.g. modulating blood flow or the metabolism 
of sustentacular cells).  
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1.5.1.1. Metabolic pathways of adenosine formation and release 
 Extracellular adenosine comes from the extracellular production through 
ATP catabolism via 5’-ectonucleotidases, as well as by its intracellular 
production and release by nucleoside transport systems. Intracellular adenosine 
production is mediated by an intracellular 5’-nucleotidase that dephosphorylates 
5’-adenosine monophosphate (AMP) (Schubert et al., 1979; Zimmermann et al., 
1998) or by the hydrolysis of S-adenosylhomocysteine (Figure 9). Beyond ATP 
catabolism, another source of extracellular adenosine is cAMP that can be 
released by secretory cells and converted by extracellular phosphodiesterases 
in AMP and then by a 5’-ectonucleotidase into adenosine (for a review see 
Fredholm et al., 2001).  
Two families constitute the nucleotide transport system, which is bi-
directional: one Na+ independent and the other dependent on the same ion 
(Griffith and Jarvis, 1996). The Na+ dependent nucleoside transport system is 
concentrative, concentrating nucleosides against a concentration gradient, 
being composed of five subfamilies in accordance with the selectivity of the 
substrate. The Na+ independent family of nucleoside transporters (equilibrative 
nucleoside transport system) is formed of two different groups (es and ei), 
differentiated by their sensitivity to nitrobenzylthioinosine (NBTI) (Griffith and 
Jarvis, 1996; Cass et al., 1998, Podgorska et al., 2005). The es transport 
system is inhibited by nanomolar concentrations of NBTI and the ei requires 
micromolar concentrations to be inhibited (Griffith and Jarvis, 1996; Cass et al., 
1998; Podgorska et al., 2005). Equilibrative nucleoside transport (ENT) consists 
of 4 different types of transporters, ENT1, ENT2, ENT3 and ENT4. ENT1 and 
ENT3 are susceptible to NBTI, whereas ENT2 is insensitive. ENT4 has been 
identified recently and its transport characteristics have not yet been fully 
characterized (Podgorska et al., 2005). 
As a whole, these enzymatic transport pathways allow the conversion of 
minor changes in intracellular ATP into disproportionally large changes in 
extracellular adenosine concentrations. 
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receptor, the A2A receptor, may be coupled to different G proteins in different 
areas of the body (Kull et al. 2000). Nevertheless, in the periphery, the receptor 
is thought to be coupled to the Gs. The activation of the G proteins leads to 
effects on enzymes and ion channels (see Table 1). A1 receptors mediate 
inhibition of adenylyl cyclase, activation of several types of K+ channels, 
inactivation of N, P and Q-type Ca2+ channels, activation of phospholipase C, 
etc. The same seems to happen with A3 receptors. Both A2A and A2B receptors 
stimulate the formation of cyclic AMP, but other actions, including mobilization 
of intracellular calcium, have also been described. The distinct adenosine 
receptors, A1, A2A, A2B and A3 are activated by different endogenous adenosine 
concentrations (Fredholm et al., 1994). The disposable endogenous adenosine 
to activate these receptors and the quantity of adenosine receptors at the site of 
action help to control the distinct physiological responses to this nucleotide.  
 
Table 1 G protein coupling of the four adenosine receptor subtypes (for a review see 
Fredholm et al., 2001). 
Adenosine 
receptor subtype 
G protein Effects of G 
protein coupling 
Cellular system 
↓cAMP 
↑IP3/DAG (PLC) 
↑Arachidonate 
(PLA2) 
General, CHO cells Gi1/2/3
↑choline (PLD) DDT1MF-2 
A1
Go -  
Gs ↑cAMP General 
Golf ↑cAMP Striatum, CHO cells A2A
G15/16 ↑IP3 COS-7 
Gs ↑cAMP General A2B Gq/11 ↑IP3/DAG (PLC) HMC-1, HEK293 
Gi2,3 ↓cAMP General, CHO cells A3 Gq/11 ↑IP3/DAG (PLC) CHO cells 
 
Since adenosine plays modulatory roles in a variety of tissues and 
physiological circumstances it is expected that this nucleoside could act in 
concert with other several messengers and so, interactions between receptors 
occur. It is known that adenosine acts synergistically with other nucleotides like 
ATP and uridine 5'-diphosphate (UDP), and histamine or bradykinin (Fredholm 
et al., 2001). Interactions between A1 and D1 and NMDA receptors are also 
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described in the brain. The best-known interaction with adenosine receptors is 
the interaction between A2A and D2 receptors that is present in the basal 
ganglia, this being a promising therapeutic target for the treatment of 
Parkinson’s disease. A more detailed review concerning the interactions 
between A2A and D2 receptors is in section 1.5.2.2.. 
  
 
1.5.1.3. Physiological role of adenosine 
 Adenosine regulates many physiological processes, particularly in 
excitable tissues such as heart and brain. Many of the actions of adenosine 
either reduce the activity of excitable tissues (e.g. by slowing the heart rate) or 
increase the delivery of metabolic substrates (e.g. by inducing vasodilatation) 
and, thus, help to couple the rate of energy expenditure to the energy supply 
(refrain cell metabolism). Most often, this adenosine-mediated inhibition of cell 
metabolism is mimicked by A1 receptor agonists, which leads to the idea that 
adenosine-induced inhibition of cell metabolism is mediated by A1 adenosine 
receptors. The adenosine-mediated excitation is thought to be due to an action 
on A2 adenosine receptors. These roles of adenosine do not explain all its 
actions, as it also has several roles as an intracellular messenger.  
 Adenosine has diverse roles in normal physiology, such as promoting 
and/or maintaining sleep (Portas et al., 1997; Lin et al., 1997), regulating the 
general state of arousal (Rainnie et al., 1994) as well as local neuronal 
excitability (Fredholm et al., 2005), and coupling cerebral blood flow to energy 
demand (Phillis, 1989). Selective adenosine receptor antagonists have been 
used frequently in the past to provide evidence concerning these proposed 
roles for adenosine. The recent development of knockout mice for the A2A 
receptor, A3 receptor and A1 receptor has provided additional tools to 
characterize the functions of these receptors over the last few years (for a 
review see Fredholm et al., 2005). In pathological conditions, adenosine is a 
neuroprotective agent against hypoxic or ischemic events (for a review see 
Latini and Pedata, 2001) and seizure-induced neuronal injury (Dunwiddie, 
1999).  The fact that adenosine produced intra- or extracellularlly can be 
released from several tissues and preparations, like rat striatal slices, 
hippocampal slices and glial and PC12 cells in culture, under ischemic and 
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hypoxic conditions (Fowler, 1993; Lloyd et al.; 1993; Jin and Fredholm, 1997; 
Kobayashi et al., 2000; Koos et al., 1997; Medhji et al., 1989), leads us to 
propose that CB can also release adenosine in response to hypoxia, this 
mediator contributing to the mechanisms of chemoreception during hypoxic 
signalling.  
 
 
1.5.1.4. Adenosine in chemoreception in the carotid body  
Adenosine is capable of stimulating the CSN chemosensory activity, as 
was first described in 1981 by McQueen and Ribeiro. After that pioneer study, 
much experimental evidence has been obtained supporting the idea of an 
important role for adenosine in chemoreception. For example, adenosine 
applied exogenously to cat CB preparations increases CSN discharges both in 
vivo (McQueen and Ribeiro, 1983) and in vitro (Runold et al., 1990). In the rat, 
intracarotid injections of adenosine activate ventilation, an effect suppressed by 
CSN section and mediated by A2 receptors (Monteiro and Ribeiro, 1987); this in 
vivo excitatory effect of exogenous adenosine is mimicked by drugs that 
increase levels of endogenous adenosine, erythro-9-(2-hydroxy-3-
nonyl)adenine (EHNA) and dipyridamole, inhibitors of adenosine deamination 
and uptake, respectively (Monteiro and Ribeiro, 1989). The importance of these 
effects of adenosine on chemoreception, described in rats and cats, was 
strongly reinforced by the results obtained in humans. Intravenous infusion of 
adenosine in healthy volunteers causes hyperventilation, dyspnoea and chest 
discomfort (Watt and Routledge, 1985, Uematsu et al., 2000). This effect of 
adenosine in man is attributed to the activation of CB chemoreceptors because: 
1) adenosine, when applied intravascularly does not cross the blood brain 
barrier (Berne et al., 1974); 2) its effect on ventilation is proportionally higher the 
closer to the CB the bolus of adenosine is administered (Watt et al., 1987), and; 
3) adenosine and its antagonists modify the hyperventilatory responses to 
hypoxia that is completely mediated by the CB (Maxwell et al., 1986; Maxwell et 
al.,1987). 
The chemoexcitatory effect of adenosine appears to be mediated, at 
least in part, via modifications in cyclic AMP (cAMP) levels. Thus, adenosine 
increases cAMP content in the rat CB (Monteiro et al., 1996), and the increase 
 18
Functional significance of adenosine in carotid body chemoreception 
PhD thesis, Silvia Vilares Conde  
 
in cAMP levels (e.g. by the administration of cAMP analogs resistant to 
enzymatic degradation) potentiates the response to hypoxia (Perez Garcia et 
al., 1991). It is also known that dipyridamole, an inhibitor of adenosine uptake 
that increases the effective concentration of adenosine in the extracellular 
milieu, potentiates the augmentation of cAMP produced by hypoxia; this hypoxic 
response is blocked nearly completely by A2 antagonists (Chen at al., 1997).  
Immunocytochemical studies have demonstrated the expression of A2A 
receptors and its co-localization with tyrosine hydroxylase (TH) in rat CB 
chemoreceptor cells (Kobayashi et al., 2000a; Gauda et al., 2000), and RT-PCR 
techniques have detected the presence of mRNA for A2A and A2B receptors in 
rat CB homogenates (Kobayashi et al., 2000a). In addition, Rocher and co-
workers demonstrated the presence of A1 receptors in the rabbit CB 
chemoreceptor cells by showing that A1 agonists and antagonists are capable 
of modulating Ca2+ currents in these cells (Rocher et al., 1999). However, A1 
receptors appear to be absent in rat CB (Kobayashi et al., 2000a; Gauda et al., 
2000).  
Recently, Fitzgerald and co-workers (Fitzgerald et al., 2004) have 
suggested that adenosine effects on ventilation are due to its action as a 
modulator of the release of the classical neurotransmitters, enhancing the 
release of what is accepted as a stimulatory neurotransmitter in the cat carotid 
body, ACh, and depressing the hypoxia-induced release of a transmitter which 
is accepted to be inhibitory, DA. It is known that the release of classical 
neurotransmitters is extracellular Ca2+ dependent, and it has been 
demonstrated by Kobayashi et al. (2000b) that adenosine did not alter [Ca2+]i in 
cells exposed to normoxia. However, a recent study in rat chemoreceptor cells 
has shown that adenosine via A2A receptors triggers a small increase in 
intracellular Ca2+ levels (Xu et al., 2006), but the increase in the intracellular 
Ca2+ observed by these authors seems to be insufficient to reach the threshold 
to evoke a release of neurotransmitters (Vicario et al., 2000b), so it is hard to 
believe that adenosine effects on the CB can only be explained through the 
modulation of the release of both ACh and DA.  In fact, the excitatory role of 
adenosine in chemoreception in the CB would be reinforced if this mediator 
were also involved in the specificity of the response of CB chemoreceptors to 
acute and/or chronic hypoxia.  
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In this work we have tried to establish a role for adenosine in CB 
chemoreceptor function in response to acute hypoxia, investigating: whether 
hypoxia specifically releases adenosine from chemoreceptor cells; the effect of 
adenosine and its antagonist caffeine on the release of CA and on the CB 
output in basal and hypoxic conditions, thereby studying the identity of the 
adenosine receptors involved in adenosine and caffeine effects on CB 
chemoreceptors; and, finally, if adenosine release is modulated by other 
neurotransmitters. These points will be treated in Chapter 1, Chapter 2 and 
Chapter 3 of the present work. In order to establish a role for this 
neurotransmitter in CB chemoreception in chronic hypoxia we have 
permanently blocked adenosine receptors with a chronic caffeine treatment and 
studied CB function at several levels (see Section 1.6.2., Chapter 5 (Section 7)).  
 
 
1.5.2. Dopamine 
 Catecholamines (CA), DA, NE and epinephrine (E) are classical 
neurotransmitters of the central and peripheral nervous system. NE is a 
neurotransmitter in the brain as well as in sympathetic postganglionic neurons. 
DA is an NE precursor, being one of the main transmitters in the central 
nervous system, but it has also been reported as playing an important role in 
the peripheral system.  
 
 
1.5.2.1. CA synthesis and metabolism 
The enzymatic synthesis of CA is well characterized; it is known that TH 
is the rating enzyme for CA biosynthesis. TH is present in all cells that 
synthesize CA, being a mixed function oxidase that uses molecular oxygen and 
tyrosine as substrates and tetrahydrobiopterin as a co-factor to produce 
3,4,dihydroxy-L-phenylalanine (L-DOPA), this step being the rate limiting step in 
dopamine biosynthesis. L-DOPA is converted to DA by the amino acid 
decarboxylase (also known as aromatic amino acid decarboxylase, AADC) 
(Figure 10), this being the last step in the biosynthesis pathway in dopaminergic 
neurons. In noradrenergic and adrenergic neurons, dopamine-ß-hydroxylase 
(DBH) is the next enzyme in the pathway.  
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Figure 10 Synthesis and 
metabolism of dopamine (DA) 
in humans. Tyrosine 
hydroxylase catalyzes L-DOPA 
formation from tyrosine in 
dopaminergic presynaptic 
neurons. L-DOPA is converted 
into dopamine by amino acid 
decarboxylase (AADC) and 
incorporated into vesicles 
through the vesicular 
monoamine transporter 
(VMAT). After DA release in 
the synapse, DA returns to 
presynaptic component by 
reuptake by the DA transporter 
(DAT) (Oak and Van Tol, 
2004).  
 
 
 
 
In the same manner as TH, DBH is a mixed function oxidase that uses 
molecular O2 to form a hydroxyl group that is added to ß carbon in the lateral 
chain of DA. Ascorbate is reduced to dehydroascorbate in the reaction, giving 
an electron to the overall reaction. DBH is concentrated in the vesicles that 
contain CA, most of the time being attached to the inner vesicular membrane. 
DBH is released with CA by neurons and by cells of adrenal medulla.  
 In cells that synthesize E, the final step of the biosynthesis pathway is 
catalyzed by the enzyme phenylethanolamine-N-Methyltransferase. This 
enzyme is present in a small group of brain stem neurons that use epinephrine 
as a neurotransmitter and in cells of adrenal medulla that use epinephrine as a 
primary neurohormone.  This enzyme transfers a methyl functional group of S-
adenosyl-L-methionine to the nitrogen of NE, producing a secondary amine (for 
a review see e.g. Kuhar et al., 1999). 
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1.5.2.2. Dopamine receptors 
 Dopamine exerts its physiological actions through the DA receptors that 
are divided into two families according to their action on adenylyl cyclase (AC) 
and thereby on the levels of cAMP. Functionally, the D1-like receptors (D1 and 
D5) are coupled to Gαs proteins and can stimulate adenylyl cyclase. The D2-like 
receptors (D2, D3 and D4) are coupled to Gi/o proteins and consequently inhibit 
AC, producing a decrease in cAMP levels. While D1 receptors act almost 
exclusively through the Gαs–mediated activation of AC, the D1-like receptors 
exert their effect through other pathways like calcium channels, potassium 
channels, arachidonic acid, sodium-hydrogen exchanger, etc.. 
Through a mechanism of alternative splicing, the D2 receptor gene 
encodes two molecularly distinct isoforms, D2S (short) and D2L (large). These 
isoforms could interact differently with G proteins originating different in vivo 
effects (Picetti et al., 1997; Usiello et al., 2000). The D2S receptors would be 
present mostly presynaptically and would counteract D1-mediated effects; D2L 
receptors would be post-synaptic (Usiello et al., 2000). 
 Direct interactions between dopamine receptors and other receptors 
have also been described. For example, interactions of D1 receptors with AMPA 
receptors modulating synaptic plasticity in the hippocampus (Gao et al. 2006); 
and between D2 receptors and A2A receptors in the striatum and hippocampus, 
these interactions giving the possibility of therapeutic targets for disorders like 
Parkinson’s disease, Huntington’s disease and schizophrenia (for a review see 
Sebastiao and Ribeiro, 2000; Fredholm et al., 2005).  
These interactions between A2A and D2 receptors exist in several central 
dopaminergic systems. For example, in the rat striatum it was observed that A2A 
adenosine receptor activation diminished the affinity of D2 receptors for its 
agonists (Ferré et al., 1991). It was also observed that A2A receptor agonists 
diminished the coupling of D2 receptors to G proteins (Ferré et al., 1993) and 
that activation of D2 receptors antagonized A2A signalling (Fuxe et al., 2001). In 
addition, an augmentation in the interaction A2A-D2 in the rat striatum after 
depletion of striatum dopamine or chronic treatment with D2 antagonists has 
been demonstrated (Ferré and Fuxe, 1992; Ferré et al., 1994). These data 
suggest there is a molecular basis for these A2A-D2 interactions at the cell 
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membrane level. The evidence of this interaction between A2A-D2 receptors is 
supported by in situ hybridization studies and confocal microscopy that suggest 
that these 2 types of receptors are collocated in the cell membranes and that 
chronic exposure to D2 and A2A agonists lead to co-aggregation, co-
internalization and co-desensitization of both receptors (Hillon et al., 2002).  
Both A2A and D2 receptors are coupled to adenylyl cyclase, and so the 
interaction between these two neurotransmitters can also be seen at second 
messenger levels and through other intracellular transducer signalling systems, 
like c-fos and jun-B (for a review see Xu et al., 2005).  
 
 
1.5.2.3. Dopamine effects on chemoreception and ventilation 
 The detection of high levels of dopamine within the CB of all mammalian 
species led several research groups to study the effects of this amine on 
chemoreflexes and chemosensory activity. Concerning the effects of dopamine 
and its agonists and antagonists on ventilation, we must distinguish peripheral 
effects from central effects. Initial studies on the effect of DA on ventilation have 
suggested an excitatory effect of this amine on ventilation in dogs (Black et al., 
1972; Jacobs and Comroe, 1968). However, later publications indicate that 
intravenous or intracarotid injections or infusions of DA mostly depress 
ventilation in cats, dogs, rats, goats and newborn lambs (for a review see 
Zapata, 1997), with the effect disappearing after CSN section. Thus, ventilatory 
depression was attributed to the reflex effects of DA on chemosensory 
impulses. It has also been described that the application of domperidone, a D2 
dopamine receptor antagonist, that does not cross the blood brain barrier, 
produces, via an action on CB pre- and post-synaptic receptors (Dinger et al., 
1981b; Mir et al., 1984), an increase in ventilation (Bee and Pallot, 1995) and in 
the CSN chemosensory activity (Fidone et al., 1997; Hsiao et al., 1989; Iturriaga 
et al., 1994; Tatsumi et al., 1995b), these actions being in accordance with an 
inhibitory effect of DA at the CB. Nevertheless, it is known that low doses of DA 
depress CSN activity but high doses have an excitatory effect (Zapata 1975, for 
a review see Zapata, 1997). The physiological importance and the reasons for 
these differences of effect have been discussed in terms of presence and 
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function of the distinct types of receptors present in the CB and in terms of 
signal transduction pathways associated with these receptors.  
Contrary to what happens with a peripheral administration, increases in 
ventilation were observed with intracerebroventricular application of D2 receptor 
agonists in the rat (Hedner et al., 1982). Intracerebroventricular administration 
of domperidone and haloperidol, other antagonists of D2 receptors, which cross 
blood brain barrier, inhibit normoxic ventilation (Hedner et al., 1982). 
It is described that CA synthesis, particularly of DA, increases in 
response to acute (Fidone et al., 1982) and chronic hypoxia (Pequinot et al., 
1987) suggesting an increase of its utilization in response to the CB 
physiological stimuli. As previously described in section 1.1, it is known that all 
the stimuli that activate CB (hypoxia, hypercapnia, cyanide, high extracellular 
K+) release DA in all mammalian species, the release being proportional to 
stimulus intensity, to the increase in CSN activity and dependent on 
extracellular Ca2+ (Figure 11) (Fidone et al., 1982; Obeso et al., 1985, 1986, 
1992, 1999; Rigual et al., 1986, 1991, 2002; Rocher et al., 1991; Vicario et al., 
2000a; Sanz-Alfayate, 2001). 
 
 
 
Figure 11 Effects of 
different stimuli on the 
release of 3H-DA and 
CSN activity in an in 
vitro preparation of cat 
carotid bodies. 
(Gonzalez et al., 1992). 
 
 
 
 
 
The DA released from CB acts on DA autoreceptors present in the organ. 
Autoradiographic, immunohistochemical, in situ-hibridization and RT-PCR 
studies have demonstrated the presence of D2 dopamine receptors on sensorial 
nerve endings and in type I cells of distinct species (Bairam et al., 1997; Dinger 
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et al., 1981b; Gauda et al., 1994, 2000; Mir et al., 1984). The two isoforms of D2 
dopamine receptors are expressed in chemoreceptor cells, the D2L isoform 
being predominant (Bairam and Khandjian, 1997). Knowing that D2S are located 
presynaptically and D2L are almost exclusively post-synaptic, it is postulated that 
DA released by chemoreceptor cells is controlled by a concentration-dependent 
negative feedback mechanism mediated by D2S autoreceptors (Bairam et al., 
2000). 
Concerning D1 dopamine receptors, their presence in the CB has been 
described (Almaraz et al., 1991; Bairam et al., 1998). Nevertheless their levels 
of expression are much lower than for D2 receptors, and they also present a 
lower affinity for dopamine (Bairam et al., 1998). The effects of dopamine on 
chemoreception are reinforced by the observation that the activation of both D1 
and D2 receptors modulates cAMP levels in chemoreceptor cells: D1 agonists 
increase cAMP (Almaraz et al., 1991) and D2 agonists decrease it (Batuca et 
al., 2003).  
 Regarding the interactions between A2A and D2 receptors in the CB, 
Ribeiro and McQueen (1983) in their pioneer study on the effects of adenosine, 
had observed some kind of interaction between the dopaminergic and 
adenosinergic systems, since adenosine potentiates the inhibitory effects of 
dopamine on CSN discharges in the cat. Strong evidence for the existence of 
these interactions has been observed more recently in vivo in the rat CB, since 
adenosine heightens the inhibitory effect of dopamine in ventilation mediated by 
CB chemoreceptors, the adenosine A2 antagonist DPSPX decreases this 
inhibitory dopamine effect, and domperidone, which is a D2 antagonist, reduces 
the excitatory effect of adenosine on ventilation (Monteiro and Ribeiro, 2000). It 
was also observed by these authors that in ischemic conditions, where 
endogenous adenosine levels are increased, the inhibitory effect of D2 agonists 
can be attenuated by the blockage of A2 receptors, converting the dopaminergic 
effect into an increase in ventilation (Monteiro and Ribeiro, 2000). 
 As described in section 1.5.1.4., it was suggested by Fitzgerald et al. 
(2004) that the effects of adenosine in ventilation are due to the modulation of 
the release of several neurotransmitters, like ACh and DA. Following this line of 
thought we decided to investigate the effects of adenosine on the release of CA 
and, since interactions between A2 and D2 receptors are described in the CB, to 
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investigate whether they could modulate this release. This point will be 
addressed in Chapter 4 of the thesis. 
  
 
1.5.3. ATP 
 Adenosine triphosphate (ATP) has a fundamental intracellular role as the 
universal source of energy for all living cells. The demonstration of its release 
into the extracellular space and the identification and localisation of specific 
receptors on target cells have been essential in establishing its extracellular 
physiological roles. It is now accepted that ATP is a genuine neurotransmitter 
both in the central and peripheral nervous systems. As a classical 
neurotransmitter, the release of ATP by nerve terminals is produced by 
exocytosis. Recent evidence, however, suggests that in some non-neuronal 
cells, ATP could also be released by a carrier-mediated transport and would 
involve ATP-binding cassette proteins (ABC), an ubiquitous family of transport 
ATPases (for a review see Bodin and Burnstock, 2001). 
ATP exerts its physiological actions through the activation of its 
receptors, that are divided in two families: P2X if the receptor is ionotropic and 
P2Y if is metabotropic. This nomenclature has been widely adopted and 
currently there are seven P2X (P2X1-P2X7) subtypes described and eight P2Y 
(P2Y1, P2Y2, P2Y4, P2Y6, P2Y11, P2Y12, P2Y13, P2Y14) subtypes (King and 
Burnstock, 2002; North, 2002).  
 
 
1.5.3.1. Role of ATP in chemoreception in the carotid body 
Recently ATP has been assigned an important role in chemotransduction 
in the CB, as an excitatory neurotransmitter. The first study on the effects of 
ATP on CSN activity, by McQueen and Ribeiro (1983), observed that this 
nucleotide increased CSN activity in a dose-dependent manner. However, this 
effect was attributed to adenosine formed by the catabolism of ATP, since the 
non-hydrolysable agonist of ATP, α,ß-MethyleneATP (10 - 100 µg i.c.), did not 
produce the same effect and in fact had diminished the CSN activity. Spergel 
and Lahiri (1993) have shown that ATP and 5’-γ-thio-triphosphate (ATP-γ-S) 
induce increases in cat CSN chemosensory activity with the response being 
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very transient. However, the possibility cannot be excluded that these 
compounds can suffer hydrolysis to form adenosine. In 1998, in a study 
designed to investigate whether the activation of P2X receptors associated with 
vagal afferent could induce a Bezold-Jarisch reflex (triad of apnoea, bradycardia 
and hypotension) in the rat, it was observed that α,ß-MethyleneATP, a non-
hydrolysable agonist which is relatively selective for particular subtypes of P2X 
receptor, and ATP excited CB, causing reflex hyperventilation (McQueen et al., 
1998). More recently, Zhang and co-workers (Zhang et al., 2000) have 
demonstrated in co-cultures of chemoreceptor cells and “juxtaposed” petrosal 
neurons that the co-application of hexamethonium and suramin, blockers of 
nicotinic and P2X receptors, respectively, completely abolished spontaneous 
post synaptic activity in response to hypoxia, suggesting a possible co-
transmission of ATP and ACh in chemoreceptor cells. This theory of ATP acting 
as co-transmitter was supported by the presence of P2X2 and P2X3 protein in 
many petrosal somas and CB afferent terminals in situ (Prasad et al., 2001). 
The idea that ATP has an excitatory effect on chemoreception was supported 
by the finding that mice deficient in P2X2 showed a markedly attenuated 
ventilatory response to hypoxia (Rong et al., 2003), and by the finding that ATP 
is released from rat CB in hypoxia (Buttigieg and Nurse, 2004, Conde and 
Monteiro, 2006), this release being proportional to hypoxia intensity (Conde and 
Monteiro, 2006). 
Adenosine is both a catabolic product and a precursor of ATP. Therefore, 
it was important to discern whether the effects of hypoxia and ACh on the 
release of adenosine from CB observed in this work were due to a release of 
adenosine by itself or due to a release and consequent hydrolysis of ATP. 
These points are dealt with in Chapters 1 and 2.  
Since ATP is nowadays considered one of the excitatory 
neurotransmitters that contribute to CB chemoreception in acute hypoxia 
(Zhang et al., 2000; Rong et al., 2003; He et al., 2005; Zapata, 2007) we have 
also investigated the effects of chronic hypoxia and chronic caffeine treatments 
in its release from CB.  This point will be addressed in Chapter 5, Section 7 of 
this work.  
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1.5.4. Acetylcholine 
 Acetylcholine was the first neurotransmitter ever identified as being a 
chemical transmitter in both the central and parasympathetic nervous systems.  
Chemically, acetylcholine is an ester of acetic acid and choline - 
CH3COOCH2CH2N+(CH3)3. It is a very effective deliverer of sodium ions, which 
depolarise and stimulate muscle contractions and excite nerves. Acetylcholine 
(ACh) is synthesized from choline and acetyl-CoA through the action of choline 
acetyltransferase (ChAT) (Figure 12). When ACh is released it must be 
removed rapidly in order to allow re-polarisation to take place; this step is 
carried out by hydrolysis by the enzyme acetylcholinesterase (AChE). The 
acetylcholinesterase found at nerve endings is anchored to the plasma 
membrane through a glycolipid.  
 
 
 
 
 
 
Figure 12 Biosynthesis pathway of 
acetylcholine formation. 
 
 
  
 
 
ACh is involved in key functions in the body. It is the key mediator of 
electrical transmission creating the skeletal muscle tone at the neuromuscular 
junction; it is involved in several processes connected to cognitive functions, 
learning and memory, arousal, reward, motor control and analgesia in 
autonomic basal ganglia and cholinergic neurons through CNS; and in 
regulating the synaptic release of itself and other important neurotransmitters 
(for a review see e.g. Jensen et al., 2005).  
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1.5.4.1. Acetylcholine receptors 
Two main classes of ACh receptors have been identified on the basis of 
their responsiveness to the toadstool alkaloid, muscarine, and to nicotine. They 
are, respectively, the muscarinic receptors and the nicotinic receptors. Both 
receptor classes are abundant in the human brain. Although the 
pharmacological differences between nicotinic and muscarinic receptors are 
quite substantial, they are both stimulated by acetylcholine, and by carbachol. 
Nicotinic receptors are pentameric subunit ion channels (Alexander at al., 2004; 
Karlin, 2002; Unwin, 2005) and muscarinic receptors are metabotropic 
receptors, and so, coupled to G-proteins (Alexander et al., 2004).  
Muscarinic receptors are divided into five subtypes (M1–M5) that emerged 
from cloning experiments (Bonner et al., 1987), with differential coupling to G-
proteins (M1, M3, M5 to the Gq/G11 family, and M2, M4 to the Gi/Go family), and, 
to some degree, differential sensitivities to some antagonists (Caulfield and 
Birdsall, 1998; Alexander et al., 2004). Muscarinic receptors are involved in a 
great variety of central functions, like basal ganglia motor activity, analgesia and 
hypothalamic function (temperature, feeding) (Brown, 2006). 
Nicotinic receptors are ligand-gated ion channels mediating fast synaptic 
transmission of the neurotransmitter. The nicotinic receptors present in 
neuromuscular junctions are located mainly postsynaptically. However, 
neuronal nicotinic receptors are both presynaptic and postsynaptic, the 
presynaptic nicotinic receptors regulating the synaptic release of ACh and the 
release of other neurotransmitters such as DA, NE, 5-HT, glutamate and 
gamma aminobutyric acid (GABA) (for a review see e.g. Jensen et al., 2005).  
Due to their modulatory role, nicotinic receptors have been proposed as 
potential therapeutic targets to treat pain, epilepsy, and a wide range of 
neurodegenerative and psychiatric disorders.   
The nicotinic ACh receptors are ligand-gated ion channels composed of 
pentameric assemblies of subunits surrounding a central aqueous pore gating 
the flux of cations (Na+, K+ and Ca2+). Seventeen nicotinic ACh receptors have 
been cloned. The subunits are divided into muscle type (α1, ß1, δ, γ, ε) and 
neuronal type (α2-α10 and ß2-ß4).  
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Table 2 Functional characteristics of selected nicotinic AChR ligands at neuronal 
nicotinic ACh receptors (Adapted from Jensen et al., 2005). 
 
 α3ß2 α4ß2 α2ß4 α3ß4 α4ß4 α7 
Agonists       
ACh 
443, 
126/150%, 
26/100% 
68, 
100/172% 83 
203, 
163/100% 20 180 
(S)-nicotine 
 132 5.5 21 8 5.0 113 
(-)-cytisine 
 67 2.7 39 72 0.9 2.6 
(()-
epibatidine 
0.443/163
% 
0.043/117
% 
0.010/115
% 0.15/267% 
0.038/99
% 0.072/97% 
DMPP 
 56 18 23 19 19 31 
A-85380 
  0.7/185%  0.8/100%  8.9/100% 
tebanicline  0.27/100%  0.20/116%  56/83% 
Altinicline 
 3.2 0.32 3.2 10 2 >10 
NFEP 
  0.013  0.32  25 
GTS-21 
  >10  >10 >10 6 
Antagonists       
α-
bungarotoxin >1 >1 >1 >1 >1 0.005 
DH ß E 
 1.6, 87 0.11, 2.7 3.6, 5.1 14 0.01 20 
d-
tubocurarine 2.4, 0.23 3.2, 7.6 4.2, 2.3 2.2, 0.73 
0.21, 
0.86 3.1 
MLA 
 >1 >1 >1 >1 >1 0.0017 
A-186253 
  0.96  9.2  8.5 
MG624 
  3.2    0.11 
Allosteric 
inhibitors       
mecamylami
ne 0.28 0.78 3.1 1.4 0.56 12.3 
Bupropion 
 ≈1 ≈10  1.8 14 ≈50 
EC50 and Rmax values are given for the agonists (in µM and in % of the Rmax of ACh or (S)-
nicotine) and Ki or IC50 values are given for the antagonists (in µM). The data have been 
obtained in electrophysiological recordings on nAChRs expressed in Xenopus oocytes or in 
mammalian cells by Ca2+ measurements using fluorescent dyes or in 86Rb+ efflux assays. The 
data are primarily from recombinant human nAChRs, although data from studies using 
recombinant rat or chick nAChRs or cell lines expressing native nAChRs have also been 
included. nd: not determinable 
 
On the basis of their gene structures and protein sequences their 
subunits have been grouped into 4 subfamilies (I-IV), with subfamily 3 being 
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subdivided into three tribes: a) family I is composed of α9 and α10; b) family II 
is composed of α7 and α8; c) family III is subdivided into 1 (α2, α3, α4 and α6), 
2 (ß2 and ß4) and 3 (ß3 and α5); d) family IV is composed of α1, ß1, δ, γ and ε 
(for a review see Jensen et al., 2005). Numerous compounds have been 
identified that act as either agonists or antagonists of cholinergic neurons (see 
Table 2). 
The principal action of cholinergic agonists is the excitation or inhibition of 
autonomic effector cells that are innervated by postganglionic parasympathetic 
neurons and, as such, are referred to as parasympathomimetic agents. The 
cholinergic agonists include choline esters (such as ACh itself) as well as 
protein- or alkaloid-based compounds (Table 2). The responses of cholinergic 
neurons can also be enhanced by administration of AChE inhibitors (Zwart et 
al., 2000). 
 
 
1.5.4.2. Effects of ACh on carotid body chemoreception 
Among the hypotheses proposed to account for stimulus-generated 
neural activity from the carotid body, the Cholinergic Hypothesis was the first 
(Heymans, 1936).  
Several authors have described the presence of ACh in the carotid body 
(Eyzaguirre et al., 1965; Fidone et al., 1976; Hellstrom, 1977) and demonstrated 
that section of CSN did not lower the ACh content of CB (Fidone et al., 1976), 
suggesting that ACh is present almost exclusively in the CB. Along the same 
line of observation, Hellstrom (1977) showed that the removal of SCG does not 
modify the CB ACh levels and Shirahata et al. (1996) observed that ACh is 
released from both cat and pig chemoreceptor cells in culture, although, in 
these cultures, the release from other cell types cannot be excluded. Taken 
together these results indicate that the ACh present in the CB would be in 
chemoreceptor cells or in type II cells.  Immunocytochemical studies have 
demonstrated the presence of ChAT in cat and rabbit chemoreceptor cells 
(Wang et al., 1991). However, Almaraz's cat studies in 1983 did not observe 
ACh synthesis or ChAT activity. Regarding the presence of choline, a precursor 
of ACh, a large amount is described in CB preparations (Fidone et al., 1987; 
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Fitzgerald, 2000).  More recently, Nurse and Zhang (1999) have described the 
expression of ChAT and AChE in the chemoreceptor cells, indicating that 
enzymatic machinery for the generation and inactivation of ACh is present in the 
CB chemoreceptor cells. Despite all these findings regarding the presence of 
the enzymes involved in the biosynthesis pathway of ACh, Gauda (Gauda, 
2002; Gauda et al., 2004a) has reported that chemoreceptor cells are negative 
for ChAT and also to vesicular ACh transporter (VAChT), suggesting that ACh 
comes from nerve endings or other cell types instead of chemoreceptor cells. 
These controversial findings can be explained if chemoreceptor cells undergo 
phenotypical changes in co-cultures. 
Hypoxia results in a modest release of ACh from cat CB (Fitzgerald at el., 
1999). In rat and rabbit CB, hypoxia inhibits the basal release of ACh via 
activation of muscarinic and dopaminergic autoinhibitory receptors in the CB 
(Kim et al., 2004). These results are in agreement with earlier studies in the 
central and peripheral nervous system in which it was observed that hypoxia 
inhibits ACh release (Chleide and Ishikawa, 1990; Gibson and Peterson, 1982).  
Concerning the presence of nicotinic ACh receptors at the CB, it is 
known that they are present in chemoreceptor cells (Dinger et al., 1981a; Dasso 
et al., 1997; Obeso et al., 1997a) and in nerve fibres (Shirahata et al., 1998).  
Immunohistochemical and RT-PCR techniques in the cat have shown the 
presence of α3, α4 and β2 subunits in chemoreceptor cells (for a review see 
Higashi et al., 2003) and α7 subunits in nerve fibres surrounding the 
chemoreceptor cells (Shirahata et al., 1998). In mice, transcripts of six nicotinic 
ACh receptor subunits, α3, α4, α5, α7, β2 and β4, were detected in carotid body 
total RNA (Cohen et al., 2002).  The physiological function of these receptors is 
not completely understood but they may be involved in the hyperpnoea caused 
by exogenous nicotine (Fernández et al., 2002). Until the nineties nicotinic 
receptors were not considered fundamental for the O2 sensing mechanism at 
the CB because classical nicotinic blockers suppressed the excitatory actions of 
nicotinic agonists, but only reduced the activation produced by natural stimuli by 
a variable percentage (McQueen 1977; 1983).  More recently, Nurse and co-
workers (Zhang et al., 2000) showed that the application of nicotinic ACh 
antagonists, like mecamylamine or hexamethonium, in co-cultures of glomus 
cells and “juxtaposed” petrosal ganglions only partially inhibits the hypoxia 
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evoked excitatory postsynaptic responses. Nevertheless, it is agreed that 
nicotinic ACh receptors in glomus cells act as modulators, increasing [Ca2+]i 
(Dasso et al., 1997) and inducing the release of neurotransmitters at the CB, 
such as dopamine (Obeso et al., 1997). 
 ACh was the first neurotransmitter proposed in CB synapsis. 
Nonetheless, the incomplete blockage of nicotinic antagonists in hypoxic CB 
response and the absence of expression of enzymes essential for the ACh 
biosynthesis pathway in the CB, leads us to question the Cholinergic 
Hypothesis (see Zapata, 2007). However, the excitatory effects of ACh on CB 
could involve the release of other excitatory neurotransmitters and the 
importance of adenosine/ATP in CB chemotransduction would be reinforced if it 
were also involved in the chemotransduction mechanism originated by 
substances like nicotine/ACh that apparently mimic the excitatory effect of 
hypoxia on CSN activity and/or ventilation. This point will be addressed in 
Chapter 2, Section 4 of the present work. 
 
 
1.6. Effects of chronic hypoxia 
Chronic hypoxia must be divided into intermittent and sustained hypoxia.  
Chronic intermittent hypoxia is characterized by transient episodes of hypoxia of 
small duration. People who reside at or near the sea level are more 
predisposed to recurrent episodes of hypoxia than to sustained hypoxia. 
Transient episodes of hypoxia can occur, for example, with air swallowed during 
meals that results in an elevation of the diaphragm. Episodic or intermittent 
hypoxia is associated with many pathophysiological situations including sleep 
apnoeas and apnoeas of prematurity. Chronic intermittent hypoxia leads to 
systemic hypertension, myocardial and brain infarctions, cognitive dysfunction 
and sudden death in the elderly (for a review see Prabhakar, 2001; Prabhakar 
et al., 2001). 
On the other hand, in chronic sustained hypoxia (CSH), the low PO2 
exposure lasts for hours to days to months or years. CSH induces gene 
expression, leading to profound morphological as well as biochemical changes 
in the CB. It has been demonstrated that chronic sustained hypoxia induces an 
increase in the sensitivity of CB chemoreceptors to acute hypoxia (Barnard et 
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al., 1987) and this mechanism plays a significant role in the time-dependent 
increase in ventilation in breathing on ascent to high altitude, which is termed 
ventilatory acclimatization to hypoxia (Bisgard 1994, 1995, 2000; Powell et al., 
2000a; Powell, 2007). Chronic sustained hypoxia is also involved in pathological 
conditions, for example in humans CSH is associated with chronic obstructive 
pulmonary disease (COPD), asthma or pulmonary fibrosis originating 
pulmonary hypertension, and in infants it is associated with SIDS.   
Early theories and experiments on ventilatory acclimatization to hypoxia 
(VAH) focused on changes in the pH of cerebrospinal fluid as a stimulus for 
central chemoreceptors. However, time-dependent changes in this parameter 
do not explain VAH (Forster and Dempsey, 1981), and lead to the idea of neural 
plasticity i.e. that central nervous system processing of afferent information is 
enhanced by CSH. Nowadays, it is known that plasticity occurs both in 
peripheral and central chemoreceptors (for a review see Powell, 2007).   
Chronic sustained hypoxia has been shown to increase oxygen 
sensitivity in the CB, as it increases the CSN discharges in response to hypoxic 
tests in several species, such as goats (Nielsen et al., 1988), cats (Banard et 
al., 1987; Vizek et al., 1987), as well as rats (Chen et al., 2002b; He et al., 2005, 
2006). This increase is a major factor for the increased hypoxic ventilatory 
response (HVR) observed with CSH, as shown by Bisgard et al. (1986a, 1986b) 
in goats, in a preparation where CB are isolated from systemic circulation, and 
in which 6 hours of isolated CB hypoxia increased ventilation above the acute 
HVR (Busch et al., 1985), demonstrating that the response is specific to the CB 
and not due to central chemoreceptors. This plasticity induced by decreased 
PO2 in the CB during the first hours explains VAH. Nevertheless, other 
mechanisms, like the CNS plasticity seen in longer hypoxic exposures, must be 
involved (Powell et al., 2000b).   
Chronic sustained hypoxia does not alter the CB sensitivity to pH in the 
rat (Banard et al., 1987) or cat (Lahiri and Delaney, 1975a). 
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1.6.1. Morphological changes in the carotid body induced by chronic 
sustained hypoxia  
 Chronic sustained hypoxia induces enlargement of the CB (Lahiri, 2000). 
Hypertrophy and hyperplasia of CB chemoreceptor cells was observed following 
CSH (Laidler and Kay, 1978; McGregor et al., 1984; Pequinot et al., 1984; 
Heath et al., 1985). Animals and humans that permanently live at high altitude 
have a frequency of chemodectomas (CB tumours) that exceeds that found at 
sea level. Accompanying the increase in CB size, it appears that the size of 
dense core vesicles in cytoplasm of chemoreceptor cells is increased (Laidler 
and Kay, 1978; Pequinot et al., 1984; Pallot et al. 1986), with density being 
decreased (Laidler and Kay, 1978; Pallot et al. 1986).  
Regarding the morphological alterations in blood vessels produced by 
CSH, it was observed that CSH induces intense CB vasodilatation and 
formation and enlargement of new vessels, increasing the vascular volume 10 
times after 10 days of CSH (Laider and Kay, 1975) (Figure 13).  
 
 
Figure 13 Staining of rat carotid body in control conditions (normoxia – on the left) and 
when rats were exposed to 1 week of chronic hypoxia. Note that chronic hypoxia 
induces an increase in the area of the section occupied by vessel lumen in the CB 
(Wang and Bisgard, 2002). 
 
This increase in vascular volume preferentially involves the large vessels 
(Clarke et al., 2000). It has been suggested that this increase in vascular 
volume could be related to an increased expression of vascular endothelial 
growth factor (VEGF) and thus involves the growth of new vessels, as the 
VEGF and its receptor Flk-1 are upregulated by CSH. Other authors consider 
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that CSH does not alter the number of blood vessels but may promote vascular 
remodelling and proliferation of endothelial cells of the existent vessels (for a 
review see Wang and Bisgard, 2002).  
 
 
1.6.2. Neurochemical changes in the carotid body in response to chronic 
sustained hypoxia 
 CA are the CB neurotransmitters most studied and well characterized, 
also having been used several times to assess the function of CB measured as 
the capacity of chemoreceptor cells to synthesise, store and release CA.  
CA metabolism in basal conditions and in response to acute stimulus 
application, like hypoxia and hypercapnic-acidosis, is extensively described in 
several mammalian species (Gonzalez et al., 1994; Conde et al., 2006a). In 
chronic hypoxia some studies have been performed in order to characterize the 
CA metabolism, but much information about CA metabolism during chronic 
hypoxia is lacking.  Chronic hypoxia increases the level of DA and NE and their 
turnover rates in the CB (Hanbauer, 1981; Olson et al., 1983; Pequignot et al., 
1987; Hui et al., 2003). The increase in the DA content elicited by chronic 
hypoxia can be seen in the CB after 2 days of hypoxia (Hanbauer et al., 1981). 
The mRNA coding for TH and the immunoreactivity for the same enzyme are 
upregulated in CB chemoreceptor cells within the first few hours of hypoxia 
(Czyzk-Krzeska et al., 1992; Hui et al., 2003). Using techniques of 
immunocytochemistry (Wang et al., 1998) and RT-PCR (Wang and Bisgard, 
2002; Ganfornina et al., 2005) it has also been demonstrated that TH 
expression and mRNA coding for TH, respectively, increased approximately 3 
times in the CB with chronic hypoxia exposure. In addition, it has also been 
seen that TH activity is increased in chronic hypoxia; in the carotid body 
(Hanbauer, 1977, Gonzalez et al., 1979a, 1979b, 1981) and in PC12 cells 
(Millhorn et al., 1997). The fact that chemoreceptor cells cultured in hypoxia 
during 7 days increase their DA basal release (Jackson and Nurse, 1997) 
suggests that chronic hypoxia increases DA production and release 
independently of neuronal or hormonal factors. It is known that D2 dopamine 
receptors are present in the CB (Dinger et al., 1981; Bairam and Khandjian, 
1997; Gauda et al.1994, 2000) and is thought that they can modulate the 
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hypoxic ventilatory response. It has been observed that after two days of 
hypoxia, the mRNA that codes for D2 receptors decreases. Nevertheless, after 
7 days of exposure to hypoxia, the CB D2 mRNA levels increase (Huey and 
Powell, 2002). These alterations in the mRNA levels of D2 receptors are in 
accordance with the DA-mediated inhibition of ventilatory response induced by 
chronic hypoxia (Huey et al., 2000).  
 Acetylcholine is another mediator involved in neurotransmission in the 
CB and is described as being excitatory in the process of CB chemoreception 
(Fitzgerald, 2000). It has been described that ACh may regulate the release of 
DA from CB during chronic hypoxia (Jackson and Nurse, 1998) and that ACh 
induces a higher response in the CSN chemosensory activity after chronic 
hypoxia, and that it is almost completely blocked by mecamylamine (He et al., 
2005). However, nicotinic and muscarinic receptor antagonists failed to 
decrease the CSN chemosensory activity induced by acute hypoxia and 
hypercapnia after chronic hypoxia exposure, suggesting that cholinergic 
transmission in not involved in acclimatization (He et al., 2005).  
As described in section 1.5.4., it has recently been suggested by Zhang 
et al. (2000) that ATP and ACh are co-released from CB chemoreceptor cells, 
being the primarily mediators of chemotransmission in the CB. In a recent 
manuscript by He et al. (2006) it was demonstrated that immunoreactivity to 
P2X2 receptors in chemoreceptor cells and in PG were marginally elevated and 
maintained, respectively, after chronic hypoxia exposure. These same authors 
showed that the effectiveness of P2 receptor blockers in decreasing the CSN 
chemosensory activity induced by hypoxic tests in chronically hypoxic rats is 
greater than in normal preparations (when the CSN frequency is expressed as 
absolute magnitude), suggesting that ATP acting on P2X2 receptors contributes 
towards adjusting chemoreceptor activity after chronic hypoxia (He et al., 2006). 
However, when the data are expressed as a percentage of nerve activity, the 
effect of the P2 antagonists was less effective in chronic hypoxia than in normal 
preparations (He et al., 2006) indicating that more experiments have to be 
performed in order to establish the role of ATP in VAH during chronic hypoxia. 
He et al. (2006) also suggest that, as P2X2 receptor antagonists failed to 
completely block the acute hypoxia-evoked CSN activity, another 
neurotransmitter, such as 5-HT, could be involved (He et al., 2006). However, it 
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has been shown that chronic hypoxia does not modify 5-HT immunoreactivity in 
the CB (Kameda et al., 1998) and functional studies on the role of 5-HT in 
hypoxic ventilatory response during chronic hypoxia are lacking.  
 Adenosine A2A receptors are expressed in rat CB chemoreceptor cells 
(Gauda et al., 2000) and are up-regulated by chronic hypoxia in PC12 cells 
(Kobayashi et al., 2000a). It has also been shown that chronic hypoxia 
enhances adenosine release in PC12 cells by altering adenosine metabolism 
and membrane transport (Kobayashi et al., 2000b) suggesting that adenosine 
has a role in chronic hypoxia adaptive responses. Nevertheless, little is known 
about the functional significance of adenosine in chronic hypoxia in the CB. 
After chronic exposure to 10% O2 a moderate down-regulation of adenosine A2B 
receptor was observed (Ganfornina et al., 2005). Recently, it has been shown 
that 8-SPT, an antagonist of adenosine receptors, attenuates the increase in 
respiratory frequency elicited by acute hypoxic tests in rats exposed to an 
atmosphere of 12% O2 for 7 days (Walsh and Marshall, 2006). These authors 
suggested that adenosine in acute hypoxia stimulates A2 receptors to increase 
respiration in chronically hypoxic rats.  
 Also, CB cells exhibit upregulation of angiotensin AT1 receptor in 
response to chronic hypoxia, with the additional observation that chronic 
hypoxia also enhanced AT1 receptor-mediated excitation of CB afferent activity 
(Leung et al., 2000) and intracellular Ca2+ elevation induced by endothelin-1 
and upregulation of endothelin-1 ETA receptor (Chen et al., 2002a, 2002b). 
These effects can be important in the modulation of cardiorespiratory function 
as well as fluid and electrolyte homeostasis and in mitogenesis, respectively, 
during chronic hypoxia. Another peptide that is present is the CB is SP. 
However, it is not probable that SP contributes to an increase in the sensitivity 
of CB to hypoxia, since SP immunoreactivity in chemoreceptor cells is 
diminished during chronic hypoxia (Wang et al., 1998). 
In this work we will focus on the effects of chronic sustained hypoxia in 
the carotid body and on the role of adenosine in this response. In order to 
investigate the role of adenosine in this paradigm we have blocked all 
adenosine receptors using a chronic treatment with caffeine, a non-selective 
antagonist of adenosine receptors. This has allowed us to study the CB function 
at several levels: assessing the expression of TH; monitoring the ability of 
 38
Functional significance of adenosine in carotid body chemoreception 
PhD thesis, Silvia Vilares Conde  
 
chemoreceptor cells to store and synthesise CA and release CA, adenosine 
and ATP; measuring the CSN chemosensory activity in response to different 
stimuli; and measuring ventilation by whole-body plethysmography.    
 
 
1.6.3. Chemoreceptor function blunting after prolonged hypoxia 
 Humans who are native to high altitudes or living at high altitudes for 
many years may have subnormal or complete loss of the ventilatory response to 
acute hypoxia, commonly referred to as a “blunted” response to hypoxia (Lahiri 
et al., 2000). This effect has been attributed to a loss of responsiveness of the 
CB to hypoxia. Some authors have reported a decreased carotid body hypoxic 
sensitivity in response to a prolonged exposure to hypoxia (3-4 weeks at an 
altitude of 5500 m or breathing 10% O2) that contributes to the decreased 
hypoxic ventilatory response in chronic hypoxia (Tatsumi et al., 1995a; Wach et 
al., 1989), this effect being mediated by dopamine, since domperidone and 
haloperidol lead to increases in CSN chemosensory activity and ventilation 
(Tatsumi et al., 1995b) in response to acute hypoxia. These authors suggest 
that this decreased response to acute hypoxia is due to an excess of 
dopaminergic activity in CB that may interact with ion channels making 
chemoreceptor cells less excitable (Wyatt et al., 1995; Peers et al., 1996; 
Carpenter et al., 1998). In fact it was observed by Carpenter et al. (1998) that 
adult rat dissociated CB chemoreceptor cells undergo selective suppression of 
Ca2+-insensitive voltage gated K+ currents in response to a 3 week period of 
hypoxia (10% O2) exposure in vivo, conditioning the depolarisation of 
chemoreceptor cells in response to acute hypoxia and the release of 
neurotransmitters. Wang and Bisgard (2002) have suggested that an excess of 
CB dopaminergic activity cannot be responsible for the blunting after prolonged 
hypoxia, because excessive CB dopaminergic activity seems to begin before 
blunting has developed, at a time when the CB still responds to acute hypoxia. 
Recently it has been shown that T-type Ca2+ channels are up-regulated in 
hypoxia in PC12 cells and probably in other tissues (Del Toro et al., 2003) and it 
has been suggested that upregulation of these channels may contribute to 
cellular functions susceptible to modulation by low O2 concentrations, like 
cellular excitability, differentiation, growth and proliferation. Given the broad 
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distribution of these channels, they could have a major role in cell adaptation to 
chronic hypoxia (Lopez- Barneo et al., 2004). 
 
 
1.7. Caffeine  
 Caffeine is the most widely consumed behaviourally active substance in 
the world. All caffeine comes from dietary sources, the majority coming from 
coffee, tea and also from soft drinks and chocolates. Coffee consumption from 
all sources can be estimated to be around 70-76 mg/person/day in the world, 
but in countries like the USA, Canada, Sweden, Finland or United Kingdom the 
values increase (for a review see e.g. Fredholm et al., 1999). Acute and, 
especially, chronic caffeine intake appears to have minor negative 
consequences on health. Nevertheless, in the nineties, caffeine was described 
as a “model drug of abuse” (Holtzman, 1990).  
 At a cellular level caffeine can act through three distinct mechanisms: 1) 
releasing Ca2+ from intracellular deposits probably via ryanodine receptors, 
which occurs with millimolar concentrations of caffeine; 2) inhibiting cAMP 
phosphodiesterases, which occurs with high micromolar concentrations of 
caffeine, higher than those attained with standard human caffeine consumption; 
and 3) inhibiting adenosine receptors and antagonising of the actions of 
adenosine, the natural agonist of these receptors, this being the only 
mechanism significantly affected with the standard doses of human caffeine 
consumption (Fredholm et al., 1999, Figure 14).  
 
 
 
Figure 14 Caffeine effects on different 
biochemical targets in relation to its levels in 
humans. Note that caffeine can inhibit adenosine 
receptors after a single cup of coffee. To inhibit 
cAMP phosphodiesterases a concentration 20 
times higher is required, and to mobilize Ca2+ from 
the intracellular deposits a concentration 100 
times higher is required. (Fredholm et al., 1999) 
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Of the four adenosine receptor subtypes, caffeine and theophylline are 
most potent at A2A receptors, followed closely by A1 receptors and then A2B 
receptors in humans (Klotz et al., 1997) (Table 3). At human A3-receptors 
caffeine is a weak antagonist. Since caffeine is an antagonist, not an agonist, at 
adenosine receptors, one would expect no pharmacological effects unless the 
receptor is being activated by endogenous adenosine. 
Some years ago it was thought that concentrations of adenosine existent 
in physiological conditions only activate A1 and A2A receptors, A2B (or A3) being 
activated in pathophysiological conditions, such as ischaemia or convulsions, 
when adenosine levels are higher. For this reason, during many years it was 
thought that blockade of A1 and A2A receptors could be the most likely 
mechanism of action for caffeine under normal physiological conditions in the 
brain.  
 
Table 3 Potency of caffeine at rat and human adenosine receptor subtypes.  
Receptor subtype Rat (Kd)  µM Human (Kd) µM 
A1 20 12 
A2A 8.1 2.4 
A2B 17 13 
A3 190 80 
 
 
Nevertheless, Fredholm (2006, personal communication) recently suggested 
that the activation of adenosine receptors does not depend only on the 
concentrations of adenosine, but also on the density of the receptor subtypes 
existent in the site of action. This means that caffeine can also block A2B 
adenosine receptors in physiological concentrations. 
 
 
1.7.1. Effects of acute caffeine treatment on ventilation 
 It is known that methylxanthines, particularly caffeine, stimulate 
ventilation and decrease apnoeic episodes in premature infants (Aranda and 
Turmen, 1979; Bairam et al., 1987), caffeine being a drug of choice to treat the 
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apnoea of prematurity (Comer et al., 2001). This analeptic effect of caffeine is 
due to the blockade of inhibitory A1 adenosine receptors in central respiratory 
neurons (Gautier and Bonora, 1982; Mazzarelli et al., 1986; Herlenius and 
Lagercrantz, 1999). However, Wilson and co-workers (2004) have recently 
demonstrated the modulation of the GABAergic inputs affecting respiratory 
timing and inspiratory drive in the medulla oblongata of neonatal piglets by A2A 
adenosine receptors. Yet, adenosine at the peripheral chemoreceptors is a 
stimulating agent (see section 2.1.4.) and in un-anaesthetised adult monkeys, 
caffeine significantly attenuated the CB-mediated hyperventilation occurring 
while the animals were breathing 10% O2 (Howell and Landrum, 1995). It was 
also observed that bolus caffeine infusion induces a rapid increase in ventilation 
that is abolished with peripheral chemodenervation (Blanchard et al., 1986) and 
that administration of aminophylline after carotid body chemodenervation does 
not prevent the profound respiratory depression elicited by hypoxia in 
chemodenervated piglets (Cattarossi et al., 1995). In any case, these last 
findings suggest that endogenous adenosine contributes to the activation of the 
CB chemoreceptors during hypoxia. However, Bairam et al. (1997) concluded 
that, although caffeine stimulates CSN discharge, the effect is short lived and 
appears not to be dependent on dopaminergic mechanisms or adenosine A2-
receptor antagonism and suggested that the effect on CSN is through a 
modification of carotid chemoreceptor blood flow associated with the change in 
blood pressure.  
These findings on the effects of caffeine on peripheral control of 
breathing are contradictory and the identity of the adenosine receptors involved 
in adenosine and caffeine effects on CB chemoreceptors remains to be 
established.  
 
 
1.7.2. Chronic treatment with caffeine 
Adaptive changes to chronic caffeine treatment are very dramatic, being 
not only quantitatively different from but often opposite to the acute effects of 
caffeine on normal and pathological conditions.  
Chronic treatment with caffeine can result in alterations in adenosine 
receptors and other receptors. “Up-regulation” of A1-adenosine receptors, 
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serotonin receptors, GABAA receptors, muscarinic receptors and δ-opioid 
receptors and the ”down-regulation” of β-adrenergic receptors and 
‘desensitization' of nicotine receptors occurs after chronic caffeine in the cortex 
and striatum of mice (Shi and Daly, 1999). An increased density of L-Type 
channels (Shi and Daly, 1999) has also been observed. In the striatum in the 
rat, a down-regulation of A2A adenosine receptors (Svennigsson et al., 1999) 
has been seen, but in human platelets chronic caffeine intake “up-regulates” A2A 
receptors, this effect being accompanied by sensitisation to HE-NECA, a 
selective A2A adenosine receptor agonist (Varani et al., 1999). It has also been 
observed that chronic caffeine intake down-regulates the metabotropic 
glutamate receptors in the rat heart (Iglesias et al., 2006). Such alterations 
might be relevant to chronic consumption of caffeine in humans and might in 
humans, as in mice, affect responses to agents acting through such receptors. 
However, these adaptive changes do not indicate what the primary targets are 
during acute treatment with caffeine. For example, dopamine receptors appear 
to be unaffected by chronic caffeine (Shi et al., 1993, 1994), but considerable 
evidence suggests a role for dopaminergic systems in the positive effects of 
caffeine in humans and animals (see Ferré et al., 1997; Garrett and Griffiths, 
1997). Recently, in other preparations, PC12 cells and striatal cultures, it was 
observed that chronic treatment with caffeine stimulates D2 mRNA expression, 
these effects being abolished by treatment with CGS21680, an A2A agonist 
(Stonehouse et al., 2003) suggesting that, in part, the effects of caffeine on D2 
receptors are mediated via A2A receptors. In pathological conditions, a 
correlation between caffeine intake and the increased adrenergic tone 
(increased NE levels) in humans with sleep apnoea is also described (Bardwell 
et al., 2000). 
Long-term treatment with caffeine decreases locomotor activity 
(Nikodijeviç et al., 1993) while an acute treatment stimulates locomotor 
behaviour in rodents. In the same way, caffeine long-term treatment leads to an 
improved spatial learning capacity and acute treatment does not. Chronic 
administration of caffeine (or theophylline) leads to significant protection against 
seizures, whether they are induced by NMDA or by GABAA receptor 
antagonists. These data reflect the fact that the effect of chronic caffeine is not 
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related to any specific seizure, but is more general, occurring without any 
change in A1 receptors (Georgiev et al., 1993; Jacobson et al., 1996).  
In pathological conditions, for example in ischaemia, long-term caffeine 
treatment leads to a decreased susceptibility to ischemic brain damage 
(Rudolphi et al., 1989) and acute treatment exacerbates the damage (Dux et al., 
1990). 
All these results indicate that the long-term treatment with caffeine in 
doses similar to those habitually consumed by humans can induce adaptive 
changes in the brain and possibly in the whole body. 
Nothing is known about the chronic effects of caffeine on the activity of 
CB chemoreceptors. This point can be important because patients with 
obstructive sleep apnoea (OSA) are use high amounts of caffeine to fight 
sleepiness and caffeine could modify chemoreflexes in OSA and thereby 
increase or decrease the sensitivity of CB to hypoxia.                     
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2. GENERAL AND SPECIFIC AIMS 
 
The general aim of this PhD thesis was to establish the functional 
significance of adenosine in chemoreception at the carotid body in 
control and chronically hypoxic rats.  
 
To achieve this objective we investigated: 
1) The release of adenosine from a rat carotid body in vitro preparation in 
response to moderate hypoxia and the specificity of this release. We also 
investigated the metabolic pathways of adenosine production and release in the 
organ in normoxia and hypoxia; 
2) The modulation of adenosine/ATP release from rat carotid body 
chemoreceptor cells by nicotinic ACh receptors; 
 3) The effects of caffeine on peripheral control of breathing and the identity of 
the adenosine receptors involved in adenosine and caffeine effects on carotid 
body chemoreceptors;  
4) The interactions between dopamine D2 receptors and adenosine A2B 
receptors that modulate the release of CA from the rat carotid body; 
5) The effect of chronic caffeine intake i.e. the continuous blockage of 
adenosine receptors and thereby simulating a caffeine dependence, on the 
carotid body function in control and chronically hypoxic rats. 
 
 
 
 
 
 
 
 
 
 
 
 
 45
Functional significance of adenosine in carotid body chemoreception 
PhD thesis, Silvia Vilares Conde  
 
3. CHAPTER 1 – STUDY OF THE EFFECT OF HYPOXIA ON THE RELEASE 
OF ADENOSINE FROM THE RAT CAROTID BODY  
 
 
3.1 Introduction and aim 
As described in section 1.5.1.4. of the general introduction, excitatory 
effects of adenosine on CB chemosensory activity have been described. The 
role of adenosine in chemoreception will be reinforced if this mediator is 
involved in the specificity of the response of CB chemoreceptors to acute 
hypoxia. Knowing that the threshold tissue PO2 for carotid sinus nerve 
discharge to increase oscillates between 55-65 mmHg, which corresponds to 
arterial blood PO2 values of 70-75 mmHg (Obeso et al., 1997), we hypothesise 
that arterial chemosensitivity could be associated with a low threshold to 
released adenosine in response to hypoxia. In order to study the specificity of 
the release of adenosine from CB chemoreceptor cells by hypoxia, other 
tissues, namely SCG and arterial tissue, were used as controls. In the current 
chapter, we have also investigated the metabolic pathways of adenosine 
production and release in the organ. 
 
 
3.2. Material and methods  
3.2.1. Tissue preparation and experimental conditions 
Wistar rats (200-300 g) from the Faculty of Medical Sciences animal 
house kept at a constant temperature (21ºC) and a regular light (08.00-20.00h) 
and dark (20.00-08.00h) cycle, with food and water ad libitum were used 
throughout the experiments. The rats were anaesthetized with sodium 
pentobarbital administered intraperitoneally (60 mg/kg, i.p.). After tracheostomy, 
CB, SCG and common carotid artery bifurcations were removed under a Nikon 
SMZ-2B dissection scope and placed in 500 µL of ice-cold 95% O2 + 5% CO2 
equilibrated incubation medium containing different drugs in accordance with 
the protocol used. The incubation medium was a modified Krebs solution 
(Perez-Garcia et al., 1990) composed of (mM): NaCl 116; NaHCO3 24; KCl 5; 
CaCl2 2; MgCl2 1.1; HEPES 10; glucose 5.5; pH 7.42. Due to the small 
dimensions of the CB (≈ 50 µg) four CBs were used in each experiment. In all 
experiments, before the incubation periods, the CBs, SCG and common carotid 
 46
Functional significance of adenosine in carotid body chemoreception 
PhD thesis, Silvia Vilares Conde  
 
artery bifurcation samples were submitted to a 30 min period of pre-incubation 
in hyperoxia (95% O2 + 5% CO2) at 37º C. This allowed recovery from the 
ischemia to which these preparations were submitted when removed (see e.g.  
Perez-Garcia et al. 1990). The experiments were performed under either 
hypoxic or normoxic conditions, meaning that tissues were incubated in media 
equilibrated with 10% O2 : 5% CO2 : 85% N2 or 20% O2 : 5% CO2 : 75% N2  
respectively. After removal of the tissues, the animals were killed by an 
intracardiac injection of a lethal dose of pentobarbital in agreement with the 
directives of the European Union (Portuguese law nº 1005/92).  
 
 
3.2.2. Characterization of the content and release of adenosine in rat 
carotid bodies 
The CBs were incubated for either 10 or 30 min under hypoxic or 
normoxic conditions in medium containing an inhibitor of adenosine 
deamination, EHNA (2.5 µM). After incubation the CBs were removed from the 
medium, and the amount of adenosine released was measured. CBs were 
further used to quantify adenosine content. For these determinations CBs were 
submitted to a 30 min period of normoxic or hypoxic incubation. After incubation 
the CBs were removed from the incubation medium and were immersed in ice-
cold perchloric acid (3M during 10 min), homogenized in an Ultra-Turbax (IKA 
Laborthecnik, Staufen, Germany) and maintained at 0º C for 30 min. The 
samples were further centrifuged at 12000 g for 5 min (4º C) and adenosine 
was extracted from the supernatant. 
 
 
3.2.3. Characterization of the release of adenosine from SCG and arterial 
tissue  
For characterization of adenosine released from these tissues two 
parameters were studied, the time dependence on this release and the effect of 
different percentages of oxygen (2%, 5% and 10%). For the temporal study on 
adenosine release, SCG and arterial tissue were submitted to an incubation 
period of 10 or 30 min in 10% O2 or normoxia in a medium containing EHNA 
(2.5 µM). The effects of different percentages of oxygen on the release of 
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adenosine were studied incubating SCG and arterial tissue during 10 min in a 
incubation medium containing EHNA (2.5 µM) and equilibrated with 2%, 5% and 
10% O2 plus 5% CO2. After the incubation period the tissues were weighed and 
the nucleotides released were extracted from the incubation medium. 
 
 
3.2.4. Effect of adenosine transporter inhibitors 
Two inhibitors of the ENT system were used in these experiments: 
dipyridamole and NBTI (Dunwiddie and Diao, 1999; Leung et al., 2001). The 
CBs were incubated for 30 min under either hypoxic or normoxic conditions in 
medium containing EHNA (2.5 µM) plus dipyridamole (50 µM) or NBTI (5 µM). 
After the incubation period the CBs were removed and the nucleotides 
extracted from the medium. 
 
 
3.2.5. Metabolic pathways of adenosine production at the rat carotid body  
The metabolic pathways of adenosine production were studied in the 
presence of inhibitors of adenosine catabolism and transport, and inhibitors of 
the ecto-5´-nucleotidases. Experiments were carried out with CBs incubated for 
30 min in normoxic or hypoxic conditions: in the presence of EHNA (2.5 µM) 
only; in the presence of EHNA (2.5 µM) and NBTI (5 µM); in the presence of 
EHNA (2.5 µM) and AOPCP (100 µM) – inhibitor of ecto-5´-nucleotidases and in 
the presence of EHNA (2.5 µM), NBTI (5 µM) and AOPCP (100 µM). After the 
incubation period the CBs were removed and adenosine extracted from the 
incubation medium.  
 
 
3.2.6. Nucleotide extraction  
Nucleotides were extracted from the incubation medium following a 
previously described protocol (Cunha et al., 1994) and aliquots of the 
neutralized supernatants were collected and kept at –20º C until subsequent 
analysis by high-performance liquid chromatography (HPLC). 
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3.2.7. HPLC analysis  
The HPLC system consisted of an LC 9-A solvent delivery pump 
(Shimadzu Corporation, Kyoto, Japan), an 7725i injector (Shimadzu 
Corporation, Kyoto, Japan), an SPD-6 AV UV-VIS wavelength detector 
(Shimadzu Corporation, Kyoto, Japan) and Shimadzu Class VP software to 
analyse the chromatograms. The analytical column was a Lichrospher 100 RP-
18 (125×4 mm, I.D, particle size 5 µm, Merck) protected by LichroCART 4-4 
guard-columns (Merck). The columns and guard-columns were incorporated 
into the HPLC system through a ManuCART (Merck). Isocratic elution was 
used: the mobile phase consisted of a solution of KH2PO4 100 mM with 15% of 
methanol, pH 6.5 run at a flux of 1.75 mL/min. This method for adenosine 
quantification was adapted from that described by Cunha et al. (Cunha et al., 
1989). Standards were prepared under the same conditions as the biological 
samples.  
 
 
Figure 15 HPLC setup constituted of, from the 
bottom to the top, a degasser, solvent mixer, 
pump, automatic injector and a UV-detector. At 
the right of the HPLC tower components, we 
can observe a manual injector.  
 
 
 
 
 
 
 
 
 
 
 
 
Three calibration curves performed in triplicate were used. The 
identification of the peaks in the biological samples was made by comparison 
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with the retention times of the standards. Chromatograms of the incubation 
medium with EHNA and dipyridamole or NBTI were also obtained under the 
same conditions in order to identify the peaks of these drugs in the 
chromatograms. To confirm the presence of adenosine in the chromatograms, 
experiments were performed in which the CBs were incubated with adenosine 
deaminase (EC 3.5.4.4, 2 U/mL, Sigma) in normoxia, then submitted to the 
same experimental conditions described above. 
Cellular viability of the CBs in hypoxia and normoxia was assessed 
measuring lactate dehydrogenase (EC 1.1.1.27) activity at 365 nm in samples 
incubated under the same conditions used for the quantification of adenosine 
released by CBs, using a standard optimised commercial kit (MPR1, Roche 
Sistemas de Diagnóstico, Linda-A-Velha, Portugal). 
Protein concentration was quantified (Peterson, 1977) in the samples, 
CBs and incubation medium after nucleotide extraction, to confirm the absence 
of proteins before HPLC analysis.  
 
 
3.2.8. Drugs 
Adenosine, sodium pentobarbital, erythro-9-(2-hydroxy-3-nonyl)adenine 
(EHNA), dipyridamole, α,β-methylene ADP (AOPCP), S-(p-nitrobenzyl)-6-
thioinosine (NBTI), adenosine deaminase were all from Sigma (St Louis, MO, 
USA). Dipyridamole and NBTI were dissolved in dimethylsulphoxide in a 2 and 
10 mM stock solution, respectively. 
 
 
3.2.9. Data analysis  
The amount of adenosine released by the CBs and the adenosine 
content of the CB content, quantified by HPLC, was expressed in pmol/CB after 
division of the absolute values obtained from the chromatograms by four (four 
CBs were used in each incubation) and correction for the volume used. The 
weight of CBs in adult rats varies between 40-55 µg (McDonald, 1980, Conde et 
al., 2006a), and adenosine concentrations in the present work were around 100 
pmol/CB. The variability in CB weight introduces a maximal error of 1.5 pmol if 
expressed in pmol/mg tissue. Adenosine values released by SCG and arterial 
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tissue were expressed in pmol/mg of tissue. Data were evaluated using Graph 
Pad Prism software, version 3 and were presented as mean ± SEM values. The 
significance of the differences between the groups means were calculated by 
the unpaired Student’s t test and by one-way analysis of variance (ANOVA) with 
Dunnett´s multiple comparison test. Values of P < 0.05 were considered as 
representing significant differences. 
 
 
3.3. Results 
 
3.3.1. Adenosine quantification  
The chromatograms corresponding to standard samples of adenosine (3-
5000 nM) used in the preparation of calibration curves showed concentration-
dependent peaks with retention times of 2.25 ± 0.04 min (n = 33). Figure 16A 
represents an example of adenosine chromatograms obtained with four 
different concentrations inside the range used for calibration. In order to verify 
whether these peaks correspond to adenosine, chromatograms of the 
incubation medium of CBs containing adenosine deaminase (2 U/mL) were 
performed. In these chromatograms the peaks corresponding to the retention 
time of adenosine were abolished (Figure 16B). 
Calibration curves showed a linear relationship (r > 0.99) between the 
area of the peak and the concentration of adenosine injected (3-5000 nM). The 
limit of detection, defined as the lowest concentration of a test substance that 
the analytical process can reliably differentiate from background levels (Shah et 
al., 1991), was 10 nM. The limit of quantification, defined as the lowest 
concentration that can be measured with a stated level of confidence (Shah et 
al., 1991), was 0.2 pmol/mL. 
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Figure 16 
Chromatograms of 
adenosine obtained by 
reverse phase HPLC. 
(a) Juxtaposition of the 
chromatograms 
obtained with four 
different concentrations 
of standard adenosine 
solutions (30, 300, 1000 
and 3000 nM) in 
incubation medium with 
EHNA (2.5 µM); (b) 
Juxtaposition of the 
chromatograms of 
adenosine released by 
carotid bodies submitted 
to hypoxia (10 % O2, 30 
min) in the absence ( ) 
and in the presence ( ) 
of adenosine deaminase 
(2 U/mL). 
 
a)  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.2. Adenosine content and release from carotid bodies during hypoxia  
Adenosine has a short half-life (<10 s) (Moser et al., 1989) and is 
converted by adenosine deaminase (EC 3.5.4.4) to inosine. To avoid the 
degradation of adenosine released from the CB, the adenosine deaminase 
inhibitor EHNA (2.5 µM) was present throughout the experiments. Adenosine 
was detected in the incubation medium during normoxia, and hypoxia caused a 
statistically significant increase in release of the nucleoside (Fig. 17A). The 
accumulation of adenosine released by the CB during hypoxia was time-
dependent (Figure 17A) (P < 0.05, adenosine concentrations released by CBs 
during 30 min versus 10 min).  The increases in adenosine release during 10 
and 30 min of hypoxic incubation were 34.1% and 44%, respectively (Figure 
17A).  
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The effect of hypoxia on the adenosine content of the CBs was also 
quantified.  After 30 min of exposure to hypoxia a dramatic reduction in 
adenosine content was observed (Figure 17B).  
Analysis of cellular viability of the CBs in hypoxia and normoxia has 
showed that although they were both in the reference domain (< 240 U/L), i.e. 
above the allowed limit of cellular death, cellular viability in normoxia (42.85 U/ 
L) was higher than in hypoxia (127.7 U/ L). 
 
 
A                                                                        B 
 
Figure 17 Effect of hypoxia (10% O2) on adenosine levels (A) released by the carotid 
bodies (CBs) and (B) quantified in the CBs after the incubation period. A) Effect of two 
different periods of incubation, 10 min and 30 min, on the release of adenosine by the 
CBs. B) Adenosine content in CBs after an incubation period of 30 min (n = 9-12). All 
the experiments were performed in the presence of EHNA (2.5 µM) and 5% CO2. * P < 
0.05; unpaired Student’s t test corresponding to adenosine concentrations released by 
CBs in normoxia (20% O2) versus hypoxia.  ** P < 0.0001; unpaired Student’s t test 
corresponding to the differences between the content of adenosine in the CBs after 
normoxia and hypoxia. Vertical bars represent mean ± SEM. 
 
 
3.3.3. Adenosine released by SCG and arterial tissue 
The effect of different percentages of oxygen (2, 5 and 10%) and 
different times of CB incubation on the release of adenosine was also tested in 
the same experimental conditions in other preparations: arterial tissue (common 
carotid arteries) and SCG. In the presence of EHNA (2.5 µM), adenosine 
release during 10 min by SCG was about 3-4 times higher than that released 
from arterial tissue (Figure 18). After 10 min of exposure to 10% O2, the amount 
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of adenosine released by the SCG and arterial tissue did not change 
significantly (P > 0.05) (Figure 18).  
 
 
B A    
 
 
 
 
 
 
 
 
 
 
 
 
Figure 18 Adenosine released from (A) rat superior cervical ganglions (SCG) and (B) 
arterial tissue (common carotid artery bifurcations) during 10 and 30 min periods of 
normoxia (20% O2) and hypoxia (10% O2). All the experiments were performed in the 
presence of EHNA (2.5 µM) and 5% CO2. No significant statistical differences (P > 
0.05; unpaired Student’s t test) were observed between adenosine released from the 
tissues in the two different incubations times, nor between normoxia and hypoxia. 
Vertical bars represent mean ± SEM. 
 
Incubation of the CBs during longer periods of moderate hypoxia (30 min) did 
not modify adenosine concentrations released in normoxic and in hypoxic 
conditions (Figure 18).  
After 10 min of exposure to more intense hypoxia, 5% and 2% O2, 
adenosine release from SCG and arterial tissue was enhanced (Figure 19).  
 
 
Figure 19 Adenosine released by 
superior cervical ganglia (SCG) and 
arterial tissue (common carotid arteries), 
in response to different percentages of 
oxygen. All the experiments were 
performed in the presence of EHNA (2.5 
µM) and 5% CO2 during incubation 
periods of 10 min. * P < 0.05; ANOVA with 
Dunnett’s multiple comparison test 
between adenosine concentrations 
released in 20% O2 and other 
percentages of oxygen. Vertical bars 
represent mean ± SEM. 
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The increases in adenosine achieved during 5% O2 was not statistically 
significant (P > 0.05) in either tissue, but in response to 2% O2 statistically 
significant increases of 44.8% in SCG and 44.4% in arteries were observed 
(Figure 19). 
 
 
3.3.4. Effect of adenosine transport inhibitors 
The effect of moderate hypoxia (10% O2) on the release of adenosine 
from CBs was studied in the presence of two equilibrative nucleosides transport 
system inhibitors, dipyridamole and NBTI. As illustrated in Figure 20, the 
increase in adenosine concentrations induced by hypoxia (30 min) remained 
when nucleoside transport was inhibited. The presence of dipyridamole (50 
µM), or NBTI (5 µM) did not significantly modify the amount of adenosine 
released from CBs either in normoxic or hypoxic conditions (Figure 20).  
 
 
Figure 20 Effects of nucleoside transport 
inhibitors, dipyridamole (50 µM) and 
NBTI (5 µM), on adenosine released by 
carotid bodies (CBs) in normoxia (20% 
O2) and hypoxia (10% O2).  In all 
experiments the CBs were submitted to 
30 min incubation periods in the 
presence of EHNA (2.5 µM) and 5% 
CO2. * P < 0.05 hypoxia vs. normoxia 
(ANOVA with Dunnett’s multiple 
comparison test). Vertical bars represent 
mean ± SEM. 
 
 
 
 
3.3.5. Metabolic pathways of adenosine production at the rat carotid body 
The contribution of two adenosine production pathways – ATP 
extracellular catabolism and specific release of adenosine through the 
equilibrative nucleoside transport system – to adenosine released by the CB 
during normoxia and hypoxia (10% O2) were investigated. Experiments were 
performed in the presence of the inhibitor of ecto-5’-nucleotidase, AOPCP, 
alone or plus NBTI (Figure 21). In normoxia (Figure 21A), NBTI (5 µM) alone 
neither modified (P > 0.05) adenosine concentrations (as previously shown in 
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Figure 20) nor did it modify the effect of AOPCP (100 µM). In contrast, AOPCP 
(100 µM) reduced adenosine release from the CBs by 44.7% (P < 0.01) in 
normoxia (Figure 21A) and by 43.7% in hypoxia (Figure 21B). 
 
 
A B  
 
  
 
 
 
 
 
 
 
 
Figure 21 Effects of an inhibitor of nucleoside transport systems, NBTI (5 µM), and an 
inhibitor of ecto-5’-nucleotidase, AOPCP (100 µM), on adenosine release by carotid 
bodies (CBs) (A) in normoxia (20 % O2) and (B) hypoxia (10 % O2). The CBs were 
incubated for 30 min in the presence of 5 % CO2. * P < 0.01; ANOVA with Dunnett’s 
multiple comparison test between drug treated groups and control values (adenosine 
released in the presence of EHNA 2.5 µM). Vertical bars represent mean ± SEM. 
 
During hypoxia, when the extracellular pathway of ATP catabolism was 
intact, NBTI (5 µM) did not modify adenosine concentrations released by the CB 
(Figs. 20 and 21B). However, in the presence of AOPCP, NBTI caused a further 
decrease in adenosine concentrations (Figure 21B). Inhibition of the two 
pathways of adenosine production at the CB with AOPCP plus NBTI reduced 
the concentrations of adenosine released in response to hypoxia by 78% (P < 
0.01) (Figure 21B). 
 
 
3.4. Discussion 
 
The current study is the first to quantify the release of adenosine from the 
CB during hypoxia. Hypoxia (10% O2) induced the release of adenosine from 
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rat CBs, but was not a powerful enough stimulus to evoke the release of 
adenosine from SCG or carotid arterial tissue.  
Because neither the vascular nor the autonomic component of the CB 
were as sensitive to oxygen levels as the whole CB, we can postulate that CB-
chemosensitive cells are probably mainly responsible for adenosine production 
in response to moderate hypoxia. Accumulation of extracellular adenosine in 
response to hypoxia (<10% O2) has been shown in PC12 oxygen-sensitive cells 
(Kobayashi et al., 2000b). 
In this study we did not measure CB tissue PO2. However, considering 
that tissue PO2 values obtained in CBs perfused with air-equilibrated saline (≈ 
20% O2, ≈ 133 mmHg PO2) presented a mean value of 113 mmHg, we can 
assume that 10% O2 (≈ 66 mmHg) may determine mean tissue PO2 values of 
approximately 55 mmHg, consistent with the threshold tissue PO2 (55-65 
mmHg) for carotid sinus nerve discharge (Obeso et al., 1997b).  
Comparison among the absolute values of adenosine produced by the 
CBs, SCG and carotid bifurcations revealed that the CB produced more 
adenosine (≈ 100 pmol/CB, corresponding to 3nmol/mg tissue for a 50 µg CB) 
than the SCG (≈ 800 pmol/mg tissue) or the arteries (≈ 200 pmol/mg tissue). 
The existence of adenosine in normoxic conditions can be explained 
because the rate of adenosine production is higher than its degradation. In the 
classical works of Schrader and co-workers, particularly in the study describing 
the short half-life of adenosine in human and dog plasma, a large turnover of 
plasma adenosine (0.5-1.5 nmol/min ml/blood) was also calculated (Moser et 
al., 1989). 
In basal conditions, adenosine can be produced by intra- and extra-
cellular degradation of ATP. It is consensual that physiological levels of 
adenosine are in the range 0.1-1 µM and they have always been quantified in 
basal conditions in different preparations (Phillis et al., 1989; Fowler, 1993; 
Cunha, 1997; Jin and Fredholm 1997; Saito et al., 1999; McLean et al., 1998; 
Dale et al., 2000). Moreover, degradation of adenosine in in vitro preparations 
and in the presence of EHNA (current work) is slower than in the presence of 
blood and preserved adenosine deaminase activity. 
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The amount of adenosine released by CBs, SCG and arterial tissue 
showed a clear linear correlation with the duration of the hypoxic exposure: 
higher concentrations were observed after 30 min than after 10 min. However, 
after 30 min of hypoxia (10% O2) almost no adenosine was detected in rat CBs. 
Interestingly, the amount of adenosine released into the incubation medium 
during 30 min of 10% O2 and the reduction in adenosine content measured in 
the same CBs were similar (≈ 50 pmol/CB). 
Depletion of adenosine from the CB by hypoxia may be compatible with 
an initial acute increase of intracellular adenosine due to ATP degradation 
followed by a massive release of adenosine by the transporters and the 
incapacity to replenish its source, ATP. However, to confirm this mechanism, 
kinetic studies on ATP degradation and adenosine production should be done in 
this preparation.   
 
The amount of adenosine released by the CBs during normoxia and 
hypoxia was not modified by the two ENT inhibitors, dipyridamole and NBTI, 
used in supramaximal concentrations (Clanachan et al., 1987; Lynge et al., 
2001), but was reduced by the blockade of ATP extracellular catabolism with 
AOPCP.  It was apparent that, at the CB, approximately 40% of extracellular 
adenosine came from the extracellular catabolism of ATP. The relative 
contribution of the extracellular catabolism of ATP to the total extracellular 
levels of adenosine was similar in both normoxic and hypoxic conditions, 
although more adenosine was produced during hypoxia. 
Equilibrative nucleoside transporters are bi-directional (Cass et al., 1998) 
and the absence of effects of NBTI and dipyridamole during normoxia and 
hypoxia suggest that the transporter is in equilibrium or does not play a 
significant role in the maintenance of extracellular adenosine concentrations in 
basal conditions.  
The former interpretation is more probable because equilibrative 
nucleoside transporter proteins were cloned and functionally characterised in 
the rat (Yao et al., 1997) and the accumulation of extracellular adenosine during 
the 30 min in the presence of an inhibitor of its degradation (EHNA) facilitates 
its uptake.  Another finding that supports this mechanism is that when AOPCP 
was added to the medium, the contribution of the ENT to adenosine production 
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at the CB was clearly different in normoxia and hypoxia. In these experiments, 
in which extracellular ATP did not contribute to adenosine production and 
extracellular adenosine concentrations were lower, the transporter apparently 
remained in equilibrium while normoxic conditions maintain the balance 
between ATP synthesis and its catabolism.  However, under hypoxic conditions 
intracellular degradation of ATP clearly caused adenosine release despite its 
extracellular accumulation.  
The effects of NBTI on hypoxia-induced release of adenosine have not 
previously been described, but enhancement of hypoxia-evoked release of 
adenosine by the other ENT blocker, dipyridamole, was observed in vivo in the 
rat cerebral cortex (Phillis et al., 1989) and in vitro in the rat hippocampal slice 
(Fowler, 1993). In the current CB preparation, dipyridamole was not used in the 
experiments with AOPCP because some controversy exists concerning its 
effects in the rat: dipyridamole does not inhibit rat nucleoside transport proteins 
in vitro (Yao et al., 1997) but modifies adenosine concentrations in vivo 
(Monteiro and Ribeiro, 1989; Phillis et al., 1989) or in in vitro functional studies 
in the rat (Fowler, 1993).    
A significant amount of extracellular adenosine was detected in the CB 
when both ENT and ecto-5’-nucleotidase were inhibited. No dose-response 
curves for AOPCP or NBTI were performed, but the concentrations used were 
1000 times the IC50 for ENT1 (Yao et al., 1997) and 10 times higher than the 
concentration that inhibits 90% of AMP hydrolysis by the ecto-5’-nucleotidase 
(Meghji and Burnstock, 1995). It is probable that other mechanisms, such as 
inhibition of adenosine deaminase and S-adenosyl homocysteine hydrolysis, 
are involved in adenosine production and release by the CB in normoxia and 
hypoxia.  
One of the main findings of the present work was the role of the NBTI-
sensitive ENT during hypoxia. In addition to extracellular adenosine production 
that occurs equally in normoxia and hypoxia, low PO2 triggers adenosine efflux 
through activation of NBTI-sensitive ENT. This finding was predictable because 
most studies in the central nervous system demonstrate intracellular formation 
of released adenosine under ischemic or hypoxic conditions (for a review see 
Latini and Pedata, 2001). In these in vitro studies hypoxic conditions include 
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perfusions with 0% O2. Therefore, the comparison of the pathways of adenosine 
production in vascular tissue and SCG did not seem to be relevant.  
In the CB, the finding that hypoxia activates adenosine release per se 
supports the hypothesis that adenosine is one of the important excitatory 
mediators that increase ventilation via activation of through carotid sinus 
chemosensory nerves. This work also confirms ATP as an important source of 
extracellular adenosine production, although the contribution to adenosine 
production is similar in normoxia and in hypoxia. ATP produced at the CB can 
activate P2X2/P2X3 receptors (McQueen et al., 1998; Prasad et al., 2001), and 
ATP’s metabolite, adenosine, can also increase CSN activity.  
The experiments described in this work were performed in whole CBs, 
which have a complex fine structure with glomus (type I) cells, sustentacular 
(type II) cells, capillaries, carotid sinus nerve sensitive fibres, autonomic nerve 
endings, etc. (Verna, 1997). It is not possible to assess the contribution of each 
of these structures to the production and release of adenosine during moderate 
hypoxia. The cellular origin of ATP (and its metabolite, adenosine) could be 
different than that of adenosine. ATP is co-stored with catecholamines in 
glomus cells (Eyzaguirre and Zapata, 1984) and co-released with ACh (Zhang 
et al., 2000), which is not synthesized in glomus cells but may be made in, and 
released from, nerve fibres (Gauda, 2002).  
In summary, evidence for two metabolic sources of extracellular 
adenosine, catabolism of ATP by ecto-5’-nucleotidase, and adenosine transport 
by ENT, were obtained for the rat carotid body.  Hypoxia can trigger the release 
of adenosine by itself through an ENT sensitive to NBTI. Arterial tissue and 
SCG were less sensitive to hypoxia in terms of adenosine release. We 
postulate that specific CB cells (e.g. type I, type II or CSN endings) may have a 
low threshold for the release of adenosine in response to hypoxia, and this may 
contribute to the regulation of CB chemoreceptor sensitivity. 
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4. CHAPTER 2 – EFFECT OF ACTIVATION OF NICOTINIC ACH 
RECEPTORS WITH α4 SUBUNITS ON ADENOSINE RELEASE AT THE RAT 
CAROTID BODY 
 
 
4.1 Introduction and aim 
 As previously described in section 1.5.4.2. of the general introduction, 
ACh nicotinic receptors are present at the CB in glomus cells (Dinger et al., 
1981a; Dasso et al., 1997; Obeso et al., 1997) and in nerve fibres (Shirahata et 
al., 1998) and it is agreed that nicotinic ACh receptors in glomus cells act as 
modulators, increasing [Ca2+]i (Dasso et al., 1997) and inducing the release of 
neurotransmitters at the CB, such as dopamine (Obeso et al., 1997a). Since 
ATP and adenosine are released from rat CB in response to hypoxia (Buttigieg 
and Nurse, 2004; Chapter 1 of this thesis) and have been proposed as 
excitatory neurotransmitters at the CB in animal models, we postulate that the 
excitatory effects of ACh at the CB could involve the release of other excitatory 
neurotransmitters. In this chapter we investigate if the activation of nicotinic ACh 
receptors can stimulate adenosine release at the CB. To test this hypothesis 
whole CBs from rats were used and a pharmacological functional 
characterisation of the nicotinic receptors was performed. Since adenosine at 
the CB can originate both from release through nucleoside transporters and 
extracellular catabolism of ATP, the contribution of extracellular ATP 
degradation to adenosine production induced by nicotinic stimulation was also 
studied.  
 
 
4.2. Material and methods  
4.2.1. Animals and surgical procedures 
Experiments were performed in Wistar adult rats (250-350 g) from the 
Faculty of Medical Sciences animal house, kept at a constant temperature 
(21ºC) and a regular light (08.00-20.00h) and dark (20.00-08.00h) cycle, with 
food and water ad libitum. All the surgical procedures were performed as 
previously described in section 3.2.1. After 30 min in hyperoxia (95% O2 + 5% 
CO2) (recovery period) at 37º C the CBs were incubated for 10 min in Tyrode 
solution equilibrated with 20% O2 + 5% CO2 (normoxia) or 10% O2 + 5% CO2 
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(hypoxia) and in the presence of 2.5 µM of EHNA, an inhibitor of adenosine 
deaminase, to avoid adenosine degradation.  
 
 
4.2.2. Effect of ACh nicotinic receptor agonists on adenosine released 
from carotid body 
The effect of ACh nicotinic receptor agonists was assessed in normoxic 
conditions (20% O2 + 5% CO2). Nicotinic receptor agonists used were ACh 
(30µM), cytisine (Cyt) (0.01-10 µM), dimethylphenylpiperazinium (DMPP, 0.1 – 
300 µM) and nicotine (0.1 – 100 nM). In each experiment only one agonist 
concentration was tested and added to the incubation medium that contained 
2.5 µM of EHNA, in the last 3 minutes of the incubation period (10 min) to avoid 
nicotinic ACh receptor desensitisation. In the experiments with ACh, an inhibitor 
of AChE, physostigmine was added to the incubation medium and two different 
concentrations (30 and 300 µM) were tested.  
After the incubation period, the CBs were removed from the medium and 
the nucleotides were extracted from the incubation medium. 
 
 
4.2.3. Effect of ACh nicotinic receptor antagonists on adenosine released 
from carotid body 
The effect of ACh nicotinic receptor antagonists was assessed in hypoxic 
conditions (10% O2 + 5% CO2). Endogenous ACh released by the CB in 
response to its physiological stimulus, hypoxia, may activate nicotinic ACh 
receptors different from those stimulated by exogenously applied agonist. 
However, only characterisation of nicotinic ACh receptors that are involved in 
the release of adenosine under physiological conditions was considered here. 
The dose-response curves for the effects of d-tubocurarine (0.001 – 200 µM), 
mecamylamine (0.001 – 100 µM), di-hydro-β-erythroidine (DHβE, 0.001 – 100 
µM) and α-bungarotoxin (0.001 - 10 µM) on the release of adenosine were 
performed in CBs stimulated by 10 min of hypoxia. The ACh nicotinic receptor 
antagonists were included in the medium at the beginning of the recovery 
period in hyperoxia, in order to try to obtain an adequate diffusion of the drug 
and the block of the nicotinic receptors. After the incubation period in hypoxia, 
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the CBs were removed and the nucleotides were extracted from the incubation 
medium. 
 
 
4.2.4. Pharmacological demonstration of the involvement of neuronal 
nicotinic acetylcholine receptors  
To demonstrate the involvement of neuronal nicotinic receptors, the 
effect of the selective nicotinic receptor antagonist, DHβE, on the release of 
adenosine from CBs was assessed by incubating CBs with a maximal dose 
(100 µM) of DHβE in normoxia (20% O2 + 5% CO2) for 10 min in the presence 
of nicotine (0.1 - 1 µM). After the incubation period, the CBs were removed and 
the nucleotides were extracted from the incubation medium. 
 
 
4.2.5. Effect of extracellular ATP catabolism inhibitor on the release of 
adenosine evoked by nicotine 
The effect of the AOPCP on the release of adenosine from CBs was 
assessed by incubating CBs with 100 µM of AOPCP in normoxia (20% O2 + 5% 
CO2) for 10 min in the presence of 100 nM of nicotine. After the incubation 
period, the CBs were removed and the nucleotides were extracted from the 
incubation medium. 
 
 
4.2.6. Nucleotide extraction and HPLC analysis 
Nucleotides were extracted from the medium as previously described in 
section 3.2.6. Aliquots of neutralised supernatant were collected and kept at –
20ºC until analysis by HPLC. The samples were analysed in triplicate by 
reverse-phase HPLC with UV detection at 254 nm as described in section 3.2.7.  
 
 
4.2.7. Drugs and chemicals 
ACh, adenosine, AOPCP, α-bungarotoxin, cytisine, DHβE, DMPP, 
EHNA, mecamylamine, nicotine, d-tubocurarine, physostigmine, and Sigmacote 
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were all from Sigma. Cytisine and physostigmine were made up in a 5 and 30 
mM stock solution in DMSO and ethanol, respectively. All stock solutions were 
stored as frozen aliquots at –20ºC. Dilutions of stock solutions were made in 
Tyrode solution in accordance with the drug concentration used.  
 
 
4.2.8. Data analysis 
The amount of adenosine present in the incubation medium was 
expressed in pmol/CB. Data were evaluated using Graph Pad Prism Software, 
version 4 and were presented as mean ± SEM. The significance of the 
differences between the means was calculated by unpaired Student’s t test. P 
values of 0.05 or less were considered as representing significant differences. 
 
 
4.3. Results 
 
4.3.1. Demonstration of the involvement of neuronal nicotinic 
acetylcholine receptors and characterisation of nicotinic receptors that 
modulate the release of adenosine from the rat carotid body  
The basal levels of adenosine released from rat CBs during 10 min of 
normoxia were 113.3 ± 11.77 pmol/CB (n = 5). The effect of ACh on the amount 
of adenosine released from the intact rat CB in normoxia is shown in Figure 22. 
ACh (30 µM) plus physostigmine (300 µM) for 10 min caused a slight but 
statistically insignificant increase to 122.75 ± 15.33 pmol/CB (n = 5), which 
corresponds to an increase of 8.34% in adenosine concentrations (Figure 22). 
Since it has been previously shown that this AChE-inhibiting drug, 
physostigmine, in high concentrations (>100 µM) is a competitive ligand of ACh 
on α4-containing nicotinic ACh receptors (Zwart et al., 2000) a lower 
concentration (30 µM) was tested. 
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Figure 22 Effect of acetylcholine (ACh, 30 
µM) on adenosine concentrations released 
from rat carotid bodies (CB) in the 
presence of distinct concentrations of 
physostigmine  (30 and 300 µM, n = 5). All 
the experiments were performed in 
normoxia and in the presence of EHNA 
(2.5 µM). 0% increases correspond to 
adenosine concentrations of 113.30 ± 
11.77 pmol/CB (n = 5) in normoxia.* 
P<0.05; unpaired Student’s t test 
corresponding to the differences in the 
effects of distinct doses of physostigmine. 
Bars represent means ± SEM. 
 
 
As can be observed in Figure 22, ACh (30 µM) induced a statistically 
significant increase of 20.2 ± 3.3 % (n = 5) in the concentration of adenosine 
released in the presence of 30 µM of physostigmine. To avoid the interaction of 
AChE inhibitors with nicotinic receptors, more stable agonists of nicotinic ACh 
receptors, namely cytisine, dimethylphenylpiperazinium (DMPP) and nicotine 
were tested.  
Cytisine (0.01 – 10 µM), DMPP (0.1 – 300 µM) and nicotine (0.1 – 100 
nM) increased the release of adenosine in the CBs in normoxia in a 
concentration-dependent manner (Figure 23).  
 
 
Figure 23 Dose-response curves 
for the effects of nicotinic ACh 
receptor agonists, cytisine (n = 5), 
dimethylphenylpiperazinium 
(DMPP, n = 6) and nicotine (n = 5 -
7) on adenosine concentrations 
released from rat carotid bodies in 
normoxia. 0% increases 
correspond to adenosine 
concentrations of 113.3 ± 11.77 
pmol/CB (n = 5) in normoxia. 
Vertical bars represent means ± 
SEM. 
 
 
 
Maximal increases (Emax) in the release of adenosine occurred with 
concentrations of 10 µM cytisine, 100 µM DMPP and 100 nM nicotine. The EC50 
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(drug concentration that produced 50% of maximal effect), and Emax, obtained 
from dose-response curves of nicotinic agonists, are represented in Table 4.  
 
Table 4 Efficacy and potency of nicotinic ACh receptor agonists in stimulating 
adenosine release at the carotid body.  
 
Agonist Emax (% effect) EC50
Cytisine (n = 5) 34.15 ± 6.8 0.54 µM 
DMPP (n = 6) 28.27 ± 4.1 5.8 µM 
Nicotine (n = 5/7) 35.63 ± 6.0 1.2 nM 
DMPP: dimethylphenylpiperazinium. Emax: maximal increase (%) in the release of adenosine 
(mean ± SEM). EC50: drug concentration that produced 50% of maximal effect.  
 
The effect of nicotinic ACh antagonists on the amount of adenosine 
released from rat CBs was assessed during physiological stimulation of 
chemoreceptor cells with hypoxia (10% O2). Dose-response curves for the 
effect of three nicotinic ACh receptor antagonists, d-tubocurarine, di-hydro-β-
erythroidine (DHβE) and α-bungarotoxin as well for the effect of the allosteric 
inhibitor of nicotinic ACh receptor, mecamylamine, on adenosine release from 
rat CBs elicited by hypoxia are shown in Figure 24. As had been previously 
shown (Chapter 1, Section 3 of the current work), hypoxia by itself increased 
the release of adenosine in the CB to 152.1 ± 5.2 pmol/CB (0% effect, n = 5). D-
tubocurarine (0.001 – 100 µM), mecamylamine (0.001 – 100 µM), DHβE (0.001 
– 100 µM) and α-bungarotoxin (0.001- 10 µM) caused a concentration-
dependent decrease in adenosine concentrations released from the rat CBs in 
response to hypoxia, with the effect of α-bungarotoxin being very small (Emax= 
22.2 ± 3.4%, Figure 24). The maximal inhibitory effect (Emax) on adenosine 
release was obtained with 100 µM of DHβE (Emax = 70.39 ± 2.4%, Figure 24). 
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Figure 24 Effects of nicotinic ACh 
receptor antagonists, α-
bungarotoxin, d-tubocurarine, and di-
hydro-β-erythroidine (DHβE) and of 
the allosteric inhibitor, 
mecamylamine, on the release of 
adenosine from rat CBs stimulated 
by hypoxia (10% O2). 0% effect 
corresponds to adenosine 
concentrations of 152.1 ± 5.2 
pmol/CB (n = 5) in response to 
hypoxia. Data are means ± SEM (n = 
5-6). 
 
 
 
 
IC50 (drug concentrations that caused 50% of maximal inhibition) and 
Emax values obtained from the dose-response curves for the nicotinic ACh 
receptor antagonists are represented in Table 5. These results showed a rank 
order of potency with DHβE > mecamylamine > d-tubocurarine > α-
bungarotoxin. 
 
 
Table 5 Efficacy and potency of nicotinic ACh antagonists in inhibiting the release of 
adenosine in CBs stimulated by hypoxia. 
 
Antagonist Emax (% effect) IC50 (µM) 
α - bungarotoxin -22.2 ± 3.4 _________ 
d-tubocurarine  -52.56 ± 2.7 1.06 
Mecamylamine  -45.03 ± 2.8 0.10 
DHβE  -70.39 ± 2.4 0.067  
DHβE: di-hydro-β-erythroidine. Emax: maximal % of inhibition (mean ± SEM). IC50: drug 
concentrations that caused 50% of the maximal inhibition.  
 
To demonstrate the involvement of neuronal nicotinic receptors, the 
effect of the selective nicotinic receptor antagonist, DHβE on the release of 
adenosine from CBs evoked by nicotine was studied. It was observed that 
DHβE inhibits the effect of nicotine on adenosine release from CB, and this 
inhibition was complete when the concentration of nicotine (100 nM) that 
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produces the maximal effect on adenosine release from CB was used.  To 
observe increases in adenosine release from CB evoked by nicotine in the 
presence DHβE, it was necessary to increase the dose of nicotine applied 
(Figure 25). Looking at Figure 25, it seems that the inhibition by DHβE moves 
the dose-response curve for the release of adenosine evoked by nicotine to the 
right.  
 
 
 
 
Figure 25 Effect of the 
selective nicotinic receptor 
antagonist, di-hydro-β-
erythroidine (DHβE; 100 µM) 
on the release of adenosine 
evoked by nicotine (0.1 - 1 µM) 
during normoxia (20% O2 + 5% 
CO2). Values represent means 
± SEM (n = 5). 
 
 
 
 
 
4.3.2. Effect of inhibition of ATP catabolism on the release of adenosine 
evoked by nicotine on carotid body 
In order to investigate whether nicotinic ACh receptor activation induced 
the release of adenosine per se or induced the release of ATP (this being the 
nucleotide that is further metabolised into adenosine) experiments in CBs 
stimulated by nicotine (Nic) in a concentration (100 nM) that induced a maximal 
release of adenosine were performed in the presence of the inhibitor of ecto-5’-
nucleotidase, AOPCP. AOPCP (100 µM), used in a concentration 10 times 
higher than that which inhibits 90% of AMP hydrolysis by ecto-5’-nucleotidases 
(Meghji and Burnstock, 1995), reduced the release of adenosine by 72% (P < 
0.001) in the CBs stimulated by nicotine (Figure 26). 
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Figure 26 Effect of 100 µM of α,β-
methylene ADP (AOPCP) on the release 
of adenosine in CBs stimulated by 100 
nM of nicotine in normoxia. *** P<0.001; 
unpaired Student’s t-test corresponding 
to the differences observed in the 
presence or absence of AOPCP. Data 
are means ± SEM (n = 5). 
 
 
 
 
 
4.4. Discussion 
Activation of ACh nicotinic receptors at the CB in normoxia stimulated the 
release of adenosine that apparently comes mainly from extracellular 
degradation of ATP. The increase in the amount of adenosine at the CB 
induced by hypoxia was partially antagonized by ACh nicotinic receptor 
antagonists. The rank order of potency for the effect of nicotinic agonists and 
antagonists on the release of adenosine was, respectively: nicotine > cytisine > 
DMPP and DHβE > mecamylamine > d-tubocurarine > α-bungarotoxin.  
The characterisation of nicotinic receptor subunits in the CB of the rat 
has never been performed. However, in the cat, immunohistochemical and RT-
PCR techniques have reported the presence of α3, α4 and β2 subunits in glomus 
cells (for a review see Higashi et al., 2003) and α7 subunits in nerve fibres 
surrounding the glomus cells (Shirahata et al., 1998). In this work we have 
described the involvement of neuronal nicotine ACh receptors in stimulating the 
release of adenosine from CBs and characterized the nicotinic ACh receptor 
involved. The effect of the endogenous agonist, ACh, was mimicked by nicotine 
(nicotinic ACh receptor agonist), used in a concentration that induces a maximal 
release of adenosine, this effect being antagonized by DHβE (a selective 
nicotinic ACh receptor antagonist), demonstrating the involvement of a neuronal 
nicotinic ACh receptor in the induction of adenosine release from rat CBs. The 
rank order of potency obtained for the nicotinic ACh receptor agonists studied is 
compatible with nicotinic receptors that contain subunits α4β2 (Nic > cyt > 
DMPP) (Alexander et al., 2004). The presence of nicotinic receptors containing 
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α2, α3 subunits can be excluded, since receptors containing α2 subunits have a 
comparable affinity for cytisine and nicotine and lower affinity for DMPP, and 
receptors containing α3 subunits have a higher affinity for DMPP than for 
cytisine (Alexander et al., 2004; Jensen et al., 2005). Concerning the effect of 
the nicotinic receptor antagonists, a rank order of potency of DHβE > d-
tubocurarine > α-bungarotoxin was observed for the inhibition of the release of 
adenosine from CB during hypoxia. Mecamylamine was excluded from this 
pattern since it is a non-selective allosteric inhibitor of nicotinic receptors with 
major affinity for nicotinic receptors containing α3 subunits (Jensen et al., 2005). 
As was found for the agonists, the pattern of inhibition is compatible with the 
presence of nicotinic receptors with α4β2 subunits (Jensen et al., 2005). The 
absence of consistent effects of α-bungarotoxin inhibiting the release of 
adenosine from CB during hypoxia excludes the presence of nicotinic receptors 
with α7, α8, α9 and α10 subunits. These findings agree with the description of 
both α4 and β2 subunit transcription in total CB RNA in mice (Cohen et al., 2002) 
and in glomus cells (Higashi et al., 2003) and with nicotinic ACh receptor α4β2 
subunits modulating the release of neurotransmitters in the human central 
nervous system (Champtiaux et al., 2003).  
The experiments herein described were performed in whole CBs and do 
not provide evidence concerning the cell origin of adenosine and/or nicotinic 
receptor localization, but previous evidence suggests that they are present in 
glomus cells. Nicotinic ACh receptors with α4 and β2 subunits were described in 
glomus cells (Higashi et al., 2003) and could act as modulators, increasing 
[Ca2+]i (Dasso et al., 1997) and inducing the release of several 
neurotransmitters at the CB, like DA (Obeso et al., 1997a) and ATP.  Adenosine 
can be produced by different cells at the CB in response to nicotinic activation. 
However, in response to acute moderate hypoxia (10% O2) significant increases 
in the amount of adenosine were found at the CB but not in other structures - 
arterial tissue or superior cervical ganglions - present at the CB and devoid of 
chemosensitive properties (Chapter 1, Section 3), suggesting that adenosine 
originates from glomus chemosensitive cells. 
The maximal increase in the release of adenosine (36%) induced by 
nicotinic agonists was similar to that (35%) caused by acute moderate hypoxia 
in the same conditions, but nicotinic antagonists do not completely abolish the 
 70
Functional significance of adenosine in carotid body chemoreception 
PhD thesis, Silvia Vilares Conde  
 
stimulatory effect of hypoxia on adenosine production. This evidence together 
with the differences between the Emax found for d-tubocurarine and for DHβE 
could indicate that other, different nicotinic receptor subunits could be involved. 
For example, there might be α4 and β2 subunits associated with α5 subunits, as 
is described in central nervous system in cells that release dopamine 
(Champtiaux et al., 2003). Another interpretation is that hypoxia can trigger 
adenosine production through two different mechanisms: one independent and 
another dependent on nicotinic receptor activation. Further investigation and 
more specific drug tools are needed to clarify this point but promising data can 
be advanced based on adenosine concentrations obtained during hypoxia and 
nicotinic activation when extracellular catabolism of ATP was inhibited with 
AOPCP. Inhibition of ecto-5’-nucleotidases with AOPCP reduced the amount of 
nicotine-induced extracellular adenosine by 72% (present work), but in the 
same experimental conditions caused a reduction of only 44% in adenosine 
production in response to hypoxia (Chapter 1, Section 3). Adenosine is a 
common pathway of the CB response to both hypoxia and nicotinic activation, 
but while moderate hypoxia stimulates both intracellular production of 
adenosine and the release of ATP (Chapter 1, Section 3), nicotinic activation 
preferentially induced the release of ATP. The proportion of ATP molecules that 
can stimulate P2 receptors before being deactivated by ecto-nucleotidases is not 
known, but the classical studies performed by McQueen and Ribeiro (1983; 
1986) strongly support the theory that part of the excitatory effects of ATP on 
carotid sinus nerve is mediated by its metabolite adenosine. 
The reduction in adenosine release induced by ACh that is caused by 
high concentrations of physostigmine, and previous indications that 
physostigmine is a competitive ligand of ACh on nicotinic receptors that contain 
α4 subunits (Zwart et al., 2000), together support the characterisation of the α4β2 
nicotinic receptor as containing subunits that stimulate adenosine release at the 
CB. 
Interactions between adenosine and ACh in the central nervous system 
and peripheral nerve endings have been described (for a review see e.g. 
Ribeiro et al., 1996). It is generally accepted that adenosine acts as a modulator 
of ACh release: selective activation of A1 and A2 adenosine receptor subtypes 
causes respectively inhibitory and excitatory effects on ACh release (Ribeiro et 
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al., 1996). In whole cat carotid bodies it was recently shown that exogenous 
adenosine stimulates the release of ACh in hypoxic (4% O2) or hyperoxic (40% 
O2) conditions (Fitzgerald et al., 2004).  This work does not provide evidence on 
the type of adenosine receptors, mechanisms or cell types involved (Fitzgerald 
et al., 2004), but is consistent with the hypothesis that the effects of both 
excitatory transmitters – adenosine/ATP and ACh - act by synergistic 
mechanisms at the CB. The characterisation of A2 receptors at the CB, 
localized in several structures (glomus cells, vessels, nerve endings) was 
extensively done in vitro (Gauda et al., 2000; Kobayashi et al., 2000; Monteiro 
et al., 1996) and in vivo (McQueen and Ribeiro, 1986; Ribeiro and Monteiro, 
1991). It was recently demonstrated that, at the CB, ACh apparently comes 
from nerve endings instead of glomus cells (Gauda et al., 2004a), which is 
compatible with its action on nicotinic receptors with α4 subunits in glomus 
cells, stimulating the release of ATP/adenosine.  In contrast to the well-known 
modulatory role for adenosine in cholinergic transmission, we are not aware of 
the information relating to the consequences of nicotinic receptor activation on 
adenosine release in other preparations. However, in chromaffin cells or PC12 
cells, preparations with great similarities to the carotid bodies, it is known that 
nicotinic activation induces the release of ATP (Rojas et al., 1985) and 
catecholamines (Courtney et al., 1991; Nagayama et al., 1999).  
Although the involvement of nicotinic ACh receptors in hypoxia signalling 
is not a novel concept, here we demonstrate for the first time that α4 subunits 
present at the CB are functionally active during hypoxia and that activation of 
these receptors by ACh induce the production of adenosine originating mainly 
from extracellular catabolism of ATP through the action of ecto-5’-
ectonucleotidases. These findings suggest that the excitatory effects caused by 
ACh in chemosensory activity include indirect activation of purinoreceptors by 
adenosine and ATP, which strongly supports the hypothesis that 
ATP/adenosine are important excitatory mediators in chemotransduction. 
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5. CHAPTER 3 – ACUTE EFFECTS OF CAFFEINE ON RAT CAROTID BODY 
CHEMORECEPTOR FUNCTION 
 
5.1. Introduction and aim 
 As discussed in the general introduction, caffeine has been described as 
having both excitatory and inhibitory effects on ventilation. It is also known that 
adenosine in peripheral chemoreceptors is a stimulating agent (see e.g.: 
Monteiro and Ribeiro, 1987, 1989; Runold et al., 1990). Caffeine at low 
concentrations, those obtained with common coffee intake, is an antagonist of 
adenosine receptors.  The aim of this chapter is to investigate the effects of 
acute administration of caffeine on peripheral control of breathing and the 
identity of adenosine receptors involved in the effects of adenosine and caffeine 
on the chemoreceptors of the rat CB. For that we have used a combination of 
neurochemical and pharmacological techniques to assess the effect of caffeine 
and specific adenosine antagonists on CSN chemosensory activity and on the 
release of CA from rat CB. We also used immunocytochemical techniques to 
locate specific adenosine receptors involved in caffeine effects on 
chemoreceptor cells of rat CB.  
 
 
5.2. Material and methods 
5.2.1. Animals and surgical procedures 
Experiments were performed in Wistar adult rats of both sexes (250-350 
g) obtained from animal house of the Faculty of Medicine of the University of 
Valladolid. The Institutional Committee of the University of Valladolid for Animal 
Care and Use approved the protocols. Rats were anaesthetized with sodium 
pentobarbital (60 mg/kg i.p.), tracheostomized and the carotid arteries were 
dissected past the carotid bifurcation.  
For the release of CA experiments (4-12 CBs/experiment) and for cell 
dissociation (4 CB/experiment), the CBs were cleaned free of CSN and nearby 
connective tissue following the procedures previously described (Vicario et al., 
2000a). For the recording of CSN activity, the preparation CB-CSN was 
identified under a dissecting microscope and a block of tissue, including the 
carotid bifurcation and the glossopharyngeal nerve, was removed and placed in 
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a Lucite chamber in ice-cold 100% O2-equilibrated Tyrode (in mM: NaCl 140; 
KCl 5; CaCl2 2; MgCl2 1.1; HEPES 10; glucose 5.5, pH 7.40) for further 
dissection of tissue surrounding CB and CSN. The preparation CB-CSN was 
digested for 3-5 min with collagenase type I (1mg/ml) to loosen the perineurium 
(Rigual et al. 2002). The CB-CSN preparation was maintained in ice-cold 100% 
O2-equilibrated Tyrode until it was transferred to the recording chamber. In all 
instances animals were killed by intracardiac overdoses of sodium pentobarbital 
until the beating of their hearts ceased. 
 
 
5.2.2. Labelling of catecholamine stores: release of 3H-CA 
 To monitor the release of CA we used a radioisotopic method as 
described by Fidone et al. (1982) and Vicario et al. (2000a). The stores of CA in 
the CB were labelled by incubating the organs in a solution containing tyrosine, 
the natural precursor of CA, labelled with tritium (3,5-3H-tyrosine, Amersham). 4 
to 12 CBs were placed in small glass vials containing 0.5 ml of Tyrode solution 
and placed in a shaker bath at 37 ºC. The concentration of 3H-tyrosine was 30 
µM and its specific activity was 45 Ci/mmol. In addition, the incubating solution 
contained 100 µM 6-methyl-tetrahydropterine and 1 mM ascorbic acid, cofactors 
for tyrosine hydroxylase and dopamine-β-hydroxylase, respectively (Fidone and 
Gonzalez, 1982). Incubation lasted 2h. After the labelling period, individual CBs 
were transferred to vials containing 4 ml of precursor-free Tyrode-bicarbonate 
solution (composition as above except for the substitution of 24 mM of NaCl for 
24 mM of NaHCO3). Solutions were continuously bubbled with 20%O2/5% 
CO2/75% N2 saturated with water vapour, except when hypoxic stimuli were 
applied. The solutions of the initial incubation periods (3x20min) were discarded 
to washout the precursor and the readily releasable pool of labelled CA 
(Almaraz et al., 1986), and were thereafter renewed at fixed times (every 2 to 
10 min; see Results) and collected for subsequent analysis of their 3H-CA 
content. Specific protocols for stimulus and drug applications are provided in the 
Results. Stimuli included hypoxias of two intensities (10 and 5% O2-equilibrated 
solutions) and high external K+ (30 and 50 mM). In addition to caffeine (0.01-10 
mM) we used: 2-p-(2-carboxyethyl)phenethyl-amino-5’-N-ethyl-carboxamido-
adenosine hydrochloride (CGS 21680, an A2A agonist; 1µM), 8-cycle-1,3-
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dipropylxanthine (DPCPX, an A1 and A2B antagonist; 0.15 and 1.5 µM), 2-
hexynyl-5’-ethylcarboxamidoadenosine (HE-NECA, an A2A agonist; 2 µM), 8-[4-
[((4-cyanophenyl)carbamoylmethyl)oxy]phenyl]-1,3-di(n-propyl)-xanthine (MRS 
1754, an A2B antagonist; 2, 20 and 200 nM), 5’-(N-ethylcarboxamido)adenosine 
(NECA, an adenosine A2 agonist; 1 µM) and SCH 58621 (an A2A antagonist; 20 
and 200 nM).  
Collected solutions were acidified with glacial acetic acid to pH = 3 and 
maintained at 4º C until analysis to prevent 3H-CA degradation. 3H-CA present 
in the incubating solutions was analysed by adsorption onto alumina at alkaline 
pH (pH = 8.6) and bulk elution with hydrochloric acid (1 N) and quantified by 
scintillation counting. CB were homogenised (glass to glass; 4 ºC) in 200 µl of 
perchloric acid 0.6 M and centrifuged for 10 min (4º C; 12000 g), in a microfuge 
(Beckmann, Madrid). Supernatants were analysed for their 3H-catechol content 
as described above for the incubating solutions. Previous HPLC analyses have 
shown that over 90% of the 3H-catechols present in the alumina eluate 
corresponds to 3H-DA and its catabolite 3H-DOPAC (Vicario et al., 2000a). 
 
 
5.2.3. Recording of carotid sinus nerve activity 
The CB-CSN preparation (Figure 27B) was transferred to a recording 
chamber mounted on a dissection microscope (Nikon Corporation, Tokyo, 
Japan) and superfused (37 ºC) with bicarbonate/CO2 buffered saline (in mM: 
NaCl 120; NaHCO3 24; KCl 3; CaCl2 2; MgCl2 1.1; glucose 10, pH 7.40). 
Recordings of either a single or a few fibres of CSN were made using a suction 
electrode. The pipette potential was amplified (Neurolog Digimiter, 
Hertfordshire, England), displayed on an oscilloscope and stored on computer 
(200 Hz acquisition rate, Axonscope, Axon Instruments, USA). Chemoreceptor 
activity was identified (spontaneous generation of action potentials at irregular 
intervals) and confirmed by its increase in response to hypoxia (normoxia: 20% 
O2 + 5% O2 + 75% N2; hypoxia: either 0% or 5% O2 + 5% CO2 + balanced N2). 
CSN activity was digitalized, summed every second and converted into a 
voltage proportional to the sum. The effects of caffeine (1 nM to 10 mM), SCH 
58621 (20-200nM) and ZM 241385 (300nM) on the CSN activity were studied 
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while perfusing the preparations with normoxic (20% O2-equilibrated) and 
hypoxic (5% O2-equilibrated) solutions.  
 
 
 
 
 
 
 
 
 
B
200µM 
Glosopharyngeal 
nerve 
Petrosal 
Ganglion 
CSN
CB 
A
Figure 27 A. Setup for carotid sinus 
nerve (CSN) chemosensory activity 
recordings: the perfusion chamber and 2 
electrodes, the suction electrode to 
register the frequency of action potentials 
in the CSN, and the other to hold the CB 
into the recording chamber. B. 
Microphotography of CB-CSN 
preparation after cleaning and digestion. 
The CB, the CSN, the glossopharyngeal 
nerve and the petrosal ganglion can be 
observed. 
 
 
5.2.4. Carotid body cell dissociation and culture, and 
immunocytochemistry 
 CBs were enzymatically digested in 5 ml conical tubes in two 
consecutive steps: incubation with solution 1 containing collagenase 2.5 mg/mL 
(EC 3.4.24.3) and albumin 6mg/mL (15 min, 35º C) and incubation with solution 
2 containing trypsin 1 mg/mL (EC 3.4.21.4) and albumin 6 mg/mL (20 min, 37 
ºC); both solutions were prepared in 0 Ca2+ and 0 Mg2+ Tyrode. After the 
second incubation the organs were allowed to sediment, the enzymatic solution 
was removed, 1 ml of Dulbecco’s modified Eagle’s medium (DMEM) at 4 ºC 
was added and the CBs were mechanically dispersed with a polished Pasteur 
pipette at room temperature. The samples were centrifuged for 8 min at 2000 
rpm and the supernatants were eliminated. The pellet was re-suspended in 50 
µL of DMEM medium and plated on poly-L-lysine coated glass coverslips in 
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drops of about 15-20 µl.  After 30 min incubation (37º C, 5% CO2), when the 
cells were attached, 500 µL of DMEM medium was added to the wells 
containing the coverslips. CB cells were kept in the incubator for 8 to 24 hours 
until used.  
For immunocytochemistry of A2B adenosine receptors and its co-
localization with TH in chemoreceptor cells of CB, specific antibodies to these 
two proteins were used: a mouse anti-TH, monoclonal antibody against TH 
(Abcam, Cambridge, UK) and rabbit anti-A2B, polyclonal antibody against 
Adenosine A2B receptors (Chemicon International, Temecula, CA, USA). 
Coverslips were washed with phosphate buffer solution (PBS; 2 x 5 min) and 
fixed with 4% paraformaldehyde in PBS at room temperature (15 min) and 
finally the fixative was washed away with PBS at room temperature (3 x 5 min). 
Cells were then exposed to a blocking-permeabilising solution containing 2% of 
goat serum and 0.1% of Triton X-100 in PBS for 20 min at room temperature, 
followed by an overnight incubation at 4º C in a humidified chamber with the 
following cocktail of primary antibody: mouse anti-TH (1:1000) and rabbit anti-
A2B (1:50). The primary antibody was diluted in PBS containing 0.6 M NaCl, 
0.1% Triton X-100 and 2% of goat serum.  Thereafter, coverslips were washed 
with PBS (3 x 10 min) and incubated for 1 hour and 30 min at room temperature 
with secondary antibodies. These consisted in goat anti-mouse IgG conjugated 
to FITC (1:1000, Sigma ImmunoChemicals, Madrid, Spain) and goat anti-rabbit 
conjugated to Alexa 594 (1:2000, Molecular Probes, Oregon, USA). Secondary 
antibodies were diluted in PBS containing 0.6 M NaCl, 0.1% Triton X-100 and 
2% of goat serum. After incubation with secondary antibodies the cells were 
washed with PBS (3 x 10 min) and with distilled water and covered with an 
aqueous mounting medium Vectashield (Vector Laboratories, Burlingame, CA, 
USA). In control experiments, omission of the primary antibody resulted in the 
abolition of staining in all cases.  
 
 
5.2.5. Drugs and Chemicals 
6-methyl-tetrahydropterine, ascorbic acid, bovine serum albumin, 
caffeine, collagenase (EC 3.4.24.3), CGS 21680, DPCPX, HE-NECA, MRS 
1754, NECA, trypsin (EC 3.4.21.4), were all obtained from Sigma (Sigma-
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Aldrich, Spain). Collagenase type I (292 U/mg) was obtained from Worthington 
(Lakewood, NJ, USA). ZM 241385 was obtained from AstraZeneca (UK). 3H-
tyrosine was obtained from Amersham (Madrid, Spain). SCH 58621 was kindly 
offered by Dr. L. V. Lopes (School of Medicine, University of Lisbon). HE-NECA, 
NECA, SCH 58621 and ZM 241385 were prepared as 5 mM stock solutions in 
DMSO; the final concentration of DMSO was always below 1/500 which, by 
itself, lacks effects on our preparations.  The rest of the chemicals used were 
from Merck, Darmstadt, Germany. 
 
 
5.2.6. Data analysis 
Data were evaluated using Graph Pad Prism Software, version 4 and 
were presented as mean ± SEM. Dose-response curves were fitted to 
Michaelis-Menten curves in order to obtain the 0% effect of the drug in each 
situation and the IC50 and Emax values obtained directly from the Michaelis-
Menten equations.  The significance of the differences between the means was 
calculated by unpaired Student’s t test and by One and Two-Way Analysis of 
Variance (ANOVA) with Dunnett’s and Bonferroni multiple comparison tests, 
respectively. P values of 0.05 or less were considered as representing 
significant differences. 
 
 
5.3. Results 
 
5.3.1. Effect of caffeine on the basal release of 3H-CA 
After the initial washout period (see Materials and Methods) the basal-
normoxic (20% O2 equilibrated solutions; PO2 ≈130 mmHg) release of 3H-CA 
follows a monotonic slow decay (Almaraz et al., 1986). Figure 28A shows that 
the addition of caffeine (10 mM) to the incubating solutions produced a marked 
inhibition of this basal release that recovered slowly after the elimination of the 
drug, the inhibition being nearly identical in Ca2+-free solutions.  
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Figure 28 Effect of caffeine on the basal (normoxic) release of catecholamines (CA) 
from the intact rat carotid body in vitro and its Ca2+ dependency. A. Mean (n=4) time 
course of the basal release of catecholamines. Each column represents the 3H-CA 
(dpm) present in the incubating solution collected every 3 min. The incubating solutions 
correspondent to the fraction marked in grey contained 10 mM caffeine. Ca2+-free 
solutions were used during the marked periods. B. Dose-response curve for the 
inhibitory effect shown in part A. Inhibition was statistically significant at caffeine 
concentrations of 10−4 M and higher (p < 0.01). C. Inhibitory effect of caffeine at 1 and 
10 mM in normal (empty columns) and Ca2+-free solutions. 0% inhibition corresponds, 
in each CB, to the control value previous to the application of caffeine (2.13 ± 0. 32 % 
from total 3H-CA content). There were no statistical differences between 1 and 10 mM 
effects in the presence or absence of Ca2+ or between the two groups. 
 
A full dose-response curve for this effect in Ca2+-containing solutions 
showed that the caffeine concentration threshold required to inhibit basal 3H-CA 
release was 10−5 M. Overall, the curve fitted a sigmoid with an IC50 of 210 µM, 
and maximal inhibition reached 55.8% (Figure 28B).  
Since a common target of caffeine in many cell types are ryanodine 
receptors located in the endoplasmic reticulum, and the action of caffeine on 
this target is Ca2+-dependent, we also tested caffeine in Ca2+-free solutions.  
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Figure 28C compares mean percentage inhibition of the basal release produced 
by 1 and 10 mM caffeine in normal and 0 Ca2+-containing solutions obtained in 
a group of 4 CBs for each concentration. The absence of statistical differences 
would indicate a minimal or no contribution of intracellular Ca2+ deposits to the 
inhibitory effect of caffeine. 
 
 
5.3.2. Effect of caffeine on the release of 3H-CA induced by hypoxia and 
high external K+
 In next series of experiments we tested caffeine for its effect on the 
release of 3H-CA elicited by natural hypoxic stimuli of mild and severe 
intensities (10 min incubation with solutions equilibrated with 10 and 5% O2; 
PO2 ≈ 66 and 33 mmHg, respectively), and by a depolarising stimulus, high 
extracellular K+ (2 min incubation with 30 and 50 mM K+). 
 In both cases caffeine (1mM) was present in the incubating solutions 
prior to and during the application of the stimuli. Figure 29 shows the data for 
the hypoxic stimuli. Figures 29A and B present mean time courses of the 3H-CA 
release for both intensities of stimulation, and in both cases the inhibitory effect 
of caffeine on the basal release is evident. However, although caffeine was very 
effective in inhibiting the release evoked by the mild hypoxia, it did not 
statistically change the release response elicited by the stronger hypoxic 
stimulus. Figure 29C shows the mean evoked response (equivalent to the area 
under the curve in panel A): caffeine diminished the release of 3H-CA evoked by 
mild hypoxia from 2.02 ± 0.20 (n = 9) to 0.79 ±  0.21 (n =7) percent of tissue 
content, equivalent to an inhibition of the release response of a 69% (p < 0.01), 
and did not alter the response elicited by the stronger hypoxic stimulus (7.80 ± 
1.62 (n= 9) in control CBs and 9.91 ± 1,23 (n =8) in the presence of caffeine; p 
> 0.05).  
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Figure 29 Effect of 1mM of caffeine on 
the release of CA from rat carotid body 
induced by hypoxia. A and B show the 
time courses for the release of 3H-CA 
in response to a 10 min incubation with 
solutions equilibrated with 10 and 5% 
O2, respectively. Caffeine was applied 
20 min prior to as well as during the 10 
min of the hypoxic stimulation. Note 
also the inhibitory effect of caffeine on 
the basal release of 3H-CAs. In part A, 
the dotted lines going from the control 
fraction prior to the application of the 
hypoxic stimulus to the post-stimulus 
period when the release returned to 
basal, define the stimulus induced 
release of 3H-CA. To calculate the 
release as percentage of the total 
tissue content, the dpm as 3H-CA in 
each collected fraction (or the evoked 
release) were divided by the dpm of 
3H-CA present in the tissue at any 
given moment in the experiment (i.e. 
dpm present in the tissue at the end of 
the experiment plus dpm present in the 
fractions collected after the one under 
consideration). C. Mean (± SEM) 
evoked release by 10 and 5% O2. 
**p<0.01; two-way ANOVA with 
Bonferroni multi-comparison test. 
 
 
 
 
An equivalent group of experiments performed with high levels of 
external K+ of moderate and strong intensities yielded comparable results 
(Figure 30) i.e. in the time course of the experiments with both concentrations of 
K+ the inhibitory effect of caffeine on basal release is evident (Figure 30A and 
B). The inhibition of the release induced by 30 mM K+ (Figure 30A) and the lack 
of statistically significant effect of caffeine on the response elicited by 50 mM K+ 
(figure 30B B) is also evident. Mean inhibition produced by 1 mM of caffeine on 
the response elicited by 30 mM K+ amounted to 64% (Figure 30C; p < 0.01). 
Increasing the concentration of caffeine to 10 mM did not augment the inhibition 
on the release elicited by hypoxic and high K+ stimulus (not shown). These 
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findings indicate that the inhibitory effect of caffeine on the release of CA from 
CB depends on the intensity of the applied stimulus. 
 
 
 
Figure 30 Effect of 1mM of caffeine on 
the release of CAs from rat carotid body 
induced by 30 and 50 mM of 
extracellular K+. A and B show time 
courses of the release of 3H-CA. 
Caffeine and high K+ were present in the 
incubating solutions at the times marked 
in the drawing. Note that with high K+ as 
stimulus the incubating solutions were 
collected for their analysis in 3H-CA 
content every 2 min. Also note that in 
spite of the large ordinate scale in this 
figure, still is possible to observe the 
inhibitory effect of caffeine on the basal, 
pre-stimulus samples. C. Mean (± SEM) 
evoked by 30 and 50 mM extracellular 
K+. **p<0.01; two-way ANOVA with 
Bonferroni multi-comparison test. 
 
 
 
 
 
 
 
 
 
 
 
 
5.3.3. Pharmacological characterisation of adenosine receptors involved 
in the inhibitory effect of caffeine on the release of 3H-CA from the carotid 
body 
The Ca2+ independence of the effect of caffeine on the basal release and 
its range of effective concentrations suggested that caffeine effects were 
mediated via adenosine receptors (Fredholm et al., 1999). Therefore we 
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investigated the type(s) of adenosine receptors involved in the inhibitory action 
caffeine.  
First we tested NECA (1 µM), an A2 agonist, on basal and low PO2-
induced release of 3H-CA. Figure 31 shows the results. Figure 31A shows the 
time course of the release in preparations continuously incubated with 20% O2 
or with 10% O2. First, notice that the time course is similar in both incubating 
conditions, except for the higher rate of release with the lower PO2, and second, 
notice that in both cases NECA produced an increase in the release of 3H-CA 
that returned to prior time course after removal of the drug. Figure 31B shows 
mean effects obtained in groups of 3-6 CB. At both PO2, NECA increased the 
ongoing release of 3H-CA, the increase being higher in normoxia but not 
significantly different (P=0.13) than in moderate hypoxia amounting to a 54% 
and a 25% increase over the correspondent control, respectively. 
 
 
 
 
 
 
 
 
 
Figure 31 Effects of NECA, an A2 adenosine receptor agonist, on the release of 3H-CA 
from rat carotid body. A. Time courses of the release of 3H-CA from CBs incubated with 
20% (normoxic) and 10 % O2 (hypoxic) solutions. NECA (1 µM) was applied as shown 
in the drawing. B. Percentage increase in the release of 3H-CA elicited by NECA. Data 
represent means ± SEM. 
 
In a second group of experiments presented in Figure 32A (and 32B) we 
intended to reverse the effects of caffeine on basal release of 3H-CA with two 
A2A agonists, CGS 21680 and HE-NECA. From both figures it is evident that 
neither of the agonists altered the ongoing time course of the release, and also, 
that neither of them prevented the inhibition of the release produced by caffeine. 
Complementary experiments on the possible involvement of A2A receptors are 
shown in Figures 32C and 32D. When SCH 58621 (20 and 200 nM), a specific 
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antagonist of A2A adenosine receptors, was tested on the release of 3H-CA 
elicited by 30 mM K+ it was evident that it altered neither the time course (Figure 
32C) nor the magnitude (Figure 32D) of the release response.  
 
Figure 32 Effect of A2A adenosine agonists and antagonists on the release of 3H-CA 
and on the inhibition of the release produced by caffeine in the rat CB. A and B, CGS 
21680 (1 µM) and HE-NECA (2 µM), two A2A adenosine agonists, did not alter basal 
release nor modify the inhibition of the release produced by caffeine (1 mM). Data are 
normalised to the release of 3H-CA present in the samples immediately prior to the 
introduction of any drug to emphasise the parallelism between control (drug free) and 
experimental data. 100% was in all cases the release obtained immediately prior to the 
application of the drugs C. Effect of SCH58621, an A2A adenosine receptor antagonist, 
on the time course of the release of 3H-CA evoked by 30 mM K+. High K+ and SCH 
58621 were present in the incubating solutions at the concentrations and times marked 
in the drawing.  D. Mean evoked release elicited by 30 mM in control conditions and in 
the presence of 20 and 200 nM SCH 58621. Data represent means ± SEM. 
 
 
Following identical protocols we studied the effects of two other 
adenosine receptor antagonists, DPCPX and MRS 1754. DPCPX at low 
concentrations (low nM) is an antagonist of A1 adenosine receptors, but at 
higher concentrations it also interacts with A2B adenosine receptors (Fredholm 
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et al., 2001). Consistent with this profile of affinities, when DPCPX was applied 
at a 150 nM concentration (thereby preferentially inhibiting A1 adenosine 
receptors), it produced a non-significant tendency to inhibit the release of 3H-CA 
evoked by 30 mM of extracellular K+ in the CB. However, at a concentration 10 
times higher (1.5 µM) it inhibited the release of 3H-CA elicited by the same 
stimulus by 58.96% (Figure 33A). MRS 1754, a specific A2B adenosine receptor 
antagonist, inhibited the release of 3H-CA elicited by 30 mM in a dose 
dependent fashion, reaching the maximal inhibition of 51.48 and 52.44% at 
concentrations of 20 and 200 nM, respectively (Figure 33B). 
 
 
Figure 33  Effect of DPCPX (an 
A1 and A2B antagonist, A) and 
MRS1754 (an A2B antagonist, B) 
on the release of 3H-CA evoked 
by 30 mM extracellular K+ in the 
rat carotid body. Experimental 
protocols as in previous figure. 
DPCPX was used at 
concentrations of 0.15 and 1.5 
µM; only the higher concentration 
produced a significant inhibition of 
the high K+ evoked release of 3H-
CA. MRS1754 was used at 
concentrations of 2, 20 and 200 
nM; the highest concentrations 
produced a nearly identical 
inhibition of the high K+ evoked 
release of 3H-CA.   Data 
represent means ± SEM. * p< 
0.05, **p< 0.01; one-way ANOVA 
with Dunnett’s multi-comparison 
test.  
 
 
The findings with CGS 21680, HE-NECA and SCH 58621 indicate that 
A2A receptors do not mediate the inhibition of the release of 3H-CA produced by 
caffeine. On the other hand, the effect of NECA and the fact that the percentage 
of inhibition attained with caffeine, DPCPX at high concentration and MRS 1754 
are comparable would indicate that the inhibitory action of caffeine is mediated 
by A2B receptors located in chemoreceptor cells.  
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5.3.4. Immunocytochemical demonstration of A2B adenosine receptors in 
chemoreceptor cells 
Previous studies from Kobayashi et al. (2000a) have shown the 
expression of the gene for A2B adenosine receptors in homogenates of rat CB, 
but their location at the cellular level was not established. As our results strongly 
suggest that the location of this subtype of receptors is in chemoreceptor cells, 
we performed immunocytochemical studies aimed to confirm this suggestion. 
Figure 34 shows that indeed A2B receptors co-localize in fresh cultures of 
dissociated CB with TH, a specific marker for chemoreceptor cells. In Figure 
34A there is a bright field image of a 20 h old culture; Figures 34B and C show, 
respectively, TH+ chemoreceptor cells and A2B receptor positive cells in the 
same microscopic field; Figure 35D shows the image resulting from 
superimposition of images in panels B and C.  
 
Figure 34 Immunocytochemical demonstration of A2B adenosine receptors in 
dissociated CB cells in culture. A-D correspond to a microscopic field of a culture with 
fully dispersed cells. A shows the bright field image, B shows the cells that are 
immunopositive for tyrosine hydroxylase representing chemoreceptor cells, C shows 
the cells that are immunopositive for A2B receptors and D shows the image of B and C 
merged. E-H correspond to a microscopic field containing a glomoid from a partially 
dispersed CB in culture. Images show an identical distribution to that in the prior series. 
Calibration bars, 20 µm. 
 
 
Overall it is evident that all TH+ chemoreceptor cells are also positive to 
A2B receptors. In addition, many TH− cells that are immunoreactive to A2B 
receptors are present, as well as some cells that are unreactive to either 
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antibody. Panels E to H of Figure 34 show images obtained from a culture in 
which the mechanical dispersion during the dissociation of the CB was 
minimised to obtain complete clusters of chemoreceptor cells. Once again it is 
evident that the entire glomoid is positive to TH and to A2B receptors, with some 
dispersed cells also present, that being negative to TH, are positive or negative 
to A2B receptors. 
 
 
5.3.5. Actions of caffeine on the carotid sinus nerve activity: a mixed A2A 
and A2B receptor mediated effect 
The next group of experiments was designed to assess the effect of 
caffeine on the overall output of the CB measured as chemosensory activity 
(action potential frequency) in the CSN. Figure 35 shows the results obtained 
when caffeine was used at a concentration of 10 mM. In Figure 35A it is evident 
that caffeine markedly inhibited the hypoxic (perfusion with a 5% O2-equilibrated 
solution) augmentation of the CSN action potential frequency, without 
apparently modifying the basal normoxic activity of the CSN. Mean inhibition of 
the peak hypoxic response was 50.40% as the ∆CSN frequency reached 82.91 
± 13.53 (n=9) impulses/sec in the control preparations and only 41.78 ± 9.32 
(n=8) in the preparations superfused with the same hypoxic solution containing 
10 mM caffeine (Figure 35B); caffeine did not modify basal activity. Caffeine did 
not delay the onset of the response (latency of the response) but significantly 
augmented the time to reach maximal activity (time to peak; Figure 35C). 
Sample neurograms obtained at different moments of the experiment marked in 
Figure 35 are shown at the top of that Figure. 
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Figure 35 Effect of caffeine on the carotid sinus nerve activity (CSN) elicited by 
hypoxia (5% O2). A. Typical recording of the effect of caffeine (10 mM) on the 
frequency of CSN action potentials during superfusion with a solution equilibrated in 
response to 5% O2. The control response to hypoxia is shown in black and the effect of 
caffeine on the hypoxic response in grey; the responses were obtained from the same 
CB and caffeine was present in the superfusing solution for the 5 min prior to and the 3 
min of hypoxic stimulation. Sample neurograms obtained at the times indicated in A are 
shown at the Figure. B and C show, respectively, mean peak frequencies and latencies 
and times to peak, in control (empty bars) and in caffeine-treated preparations (black 
bars). Data represent means ± SEM. *p< 0.05, Student’s t test; **p < 0.01; two-way 
ANOVA with Bonferroni multi-comparison test. 
 
 
As maximal inhibition of the CSN activity produced by 10 mM caffeine 
was comparable to the inhibition of the basal as well as mild hypoxic stimulus 
and 30 mM K+ induced release of 3H-CA, we tested whether the full dose 
response curve was also comparable i.e. we tested if the entire inhibitory action 
of caffeine on CSN activity could be attributed to its presynaptic effect via A2B 
receptors. We found (Figure 36A) that the action of caffeine on the CSN elicited 
by hypoxia has two clear components, one of low affinity for caffeine produced 
at the same range of concentrations affecting the release of 3H-CA, and the 
other of high affinity for caffeine, thereby produced by much lower 
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concentrations of the drug. In fact, when the full dose-response curve was 
analysed it was found that it could be defined by the sum of two Michaelis-
Menten equations:  
 
%Inhibition = {(Imax1•[Caff])/(Km1 + [Caff])} + {(Imax2•[Caff])/(Km2 + [Caff])} 
 
The high affinity component had a Km (Km1) 17.90 x 10−9 M and produced 
a maximal inhibition (Imax1) of 29.81%. The low affinity component had Km and 
Imax of 160 x 10−6 M and 21.35%, respectively. The resulting maximal effect of 
caffeine on the CSN activity elicited by hypoxia was 51.16%. Interestingly 
enough the Km of the low affinity component is quite similar to that found for 
caffeine at the presynaptic level (210 x 10−6 M; Fig. 28B). Comparable IC50 
(11.78 nM and 171.0 µM; r = 0.999) were obtained if the data were fitted to a 
two-site competition curve using the Graph Pad Prism Software.  
 
 
Figure 36 Kinetic and 
pharmacological analysis of the 
effects of caffeine on the carotid 
sinus nerve response to hypoxia 
(5% O2). A shows, in black, the 
dose-response curve for caffeine 
inhibition of the chemosensory 
activity elicited by hypoxia in the 
carotid sinus nerve, and, 
superimposed in grey, the effects of 
caffeine on the release of 3H-CA. B. 
Percent inhibition of the response 
elicited by hypoxia in the carotid 
sinus nerve produced by an A2A 
antagonist (SCH 58621) and a 
mixed A2A and A2B antagonist (ZM 
241385). Data represent means ± 
SEM. **p< 0.01; ***p < 0.001; one-
way ANOVA with Dunnett’s multi-
comparison test.   
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A pharmacological analysis of the effect of caffeine on the activity of the 
CSN (Figure 36B) revealed that the high affinity component of the caffeine 
effect was mediated by A2A adenosine receptors, because SCH 58621 at 
concentrations of 200 nM (over 10 times higher than its Kd for A2A receptors) 
inhibited hypoxic CSN activity by 29.53 ± 2.73% (n= 5). The mixed A2A + A2B 
antagonist, ZM 241385, at concentrations of 300 nM (nearly 75 times higher 
than the Kd for A2A and 10 times the Kd for A2B) produced an inhibition of the 
CSN hypoxic activity of 61.22 ± 5.83%, which is comparable to the maximal 
inhibition produced by caffeine (n=4). This last result suggests that the low 
affinity component of caffeine action on CSN activity is mediated by A2B 
receptors. 
 
 
5.4. Discussion 
Using a combination of neurochemical, pharmacological and 
immunocytochemical techniques we have demonstrated the presence of A2B 
receptors in chemoreceptor cells, demonstrating that they control the capacity 
of the cells to release neurotransmitters, assessed as the release of CA, in 
conditions of normoxia and low intensity of stimulation. We have also shown 
that the chemosensory activity elicited by hypoxia in the CSN is controlled by 
adenosine, with this last effect mediated by a cooperative action between A2A 
and A2B receptors. 
At the outset of the discussion we would like to point out that the release 
of CA has been used exclusively as an index of the chemoreceptor cell activity 
(Fidone et al., 1982; Gonzalez et al., 1992; Montoro et al., 1996) without any 
implication on its significance regarding the genesis of the activity in the CSN. In 
fact, there are now two laboratories that have shown a lack of parallelism 
between CA release and the CSN chemosensory responses (Donnelly, 1996; 
Iturriaga et al., 1996; 2000). Furthermore, since we have been measuring the 
actions of adenosine receptor antagonists throughout our study, our findings 
suggest that adenosine is being endogenously released and therefore our 
observations result from the inhibition of its physiological action.  
In accordance with these statements, our observation that caffeine, a 
non-specific adenosine receptor antagonist, inhibits normoxic release of CA as 
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well as the release elicited by stimuli of low intensity, would imply that in these 
conditions we are preventing the actions of adenosine that is concomitantly 
released, and therefore, that the physiological effect of adenosine is an 
activation of the release of CA acting on A2B receptors (see below). Therefore, 
in the rest of the discussion we will refer in an undifferentiated fashion to the 
inhibitory effect of caffeine or the excitatory effect of adenosine. It is worth 
noting that there is a significant normoxic release of endogenous adenosine and 
that the peak release is attained at low levels of hypoxic stimulation 
(superfusion with 10% O2) decreasing with higher intensities of hypoxic 
stimulation (Chapter 1 of this work; Conde and Monteiro, 2006). This pattern of 
adenosine release would explain our observation that the A2 agonist, NECA, 
seems to be more effective in activating the release of 3H-CA in normoxia than 
in moderate hypoxia, when adenosine receptors would be more occupied by 
endogenous adenosine. 
In spite of the fact that the pharmacological analysis we have performed 
substantiates that caffeine effects are mediated via adenosine receptors, we 
would like to point out that literature and our previous observations also support 
this contention. Thus, the concentrations at which caffeine produces its effects 
on the release of CA in the CB are below those required to activate ryanodine 
receptors (Xu et al., 1998), and, in addition, the usual effect of caffeine acting 
via ryanodine receptors is an activation of the Ca2+-dependent responses, 
including the release of neurotransmitters and hormones (Johnson et al., 2000). 
In this context it should be noted that neither thapsigargin nor ryanodine, which 
also act on intracellular Ca2+ deposits, were capable of modifying the release of 
CA in rat chemoreceptor cells or the release of CA and intracellular free Ca2+ in 
rabbit chemoreceptor cells (Vicario et al., 2000b; Conde et al., 2006a). At the 
concentrations used, caffeine might inhibit phosphodiesterases and thereby 
promote an increase in cAMP levels (Fredholm et al., 1999), however the 
expected effect of caffeine acting at this target would be an increase in the 
release, particularly during hypoxic stimulations of any intensity (Perez-Garcia 
et al., 1991; Chen et al., 2000). Our pharmacological analysis indicates that 
caffeine inhibition of the release of CA is mediated by A2B receptors. In our 
analysis we have selected concentrations of all agents in such a way that at 
least one of the concentrations tested is ≥10 times higher than the described Kd 
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for the agents (www.iuphar.org), and therefore we are confident that both the 
inhibition or stimulation of each receptor subtype was maximal. Consistent with 
the pharmacological data, our immunocytochemical studies demonstrate, for 
the first time, that chemoreceptor cells express A2B receptors. It should be 
noted, however, that for every cell identified as a chemoreceptor by their being 
positive to tyrosine hydroxylase, there are many other cells in the primary 
cultures of the CB that also express A2B receptors, confirming the PCR studies 
of Kobayashi et al. (2000) that show a high level of receptor expression in whole 
CB homogenates. It should mentioned, however, that this inhibitory effect of 
caffeine on rat CB chemoreceptor cells seems to be species specific since in 
previous studies performed in rabbit, cat and kitten CBs, this xanthine altered 
neither the basal release of CA from CB (Vicario et al., 2000b) nor the CSN 
neural discharge (Bairam et al., 1997). 
The fact that caffeine (and the other agents tested) produces identical 
effects in the response elicited by high K+ (a non-specific depolarising stimulus) 
and hypoxia would suggest that A2B receptors are coupled towards the last 
steps in the stimulus-secretion coupling.  Thus, it is generally accepted that in 
chemoreceptor cells the stimulus-secretion coupling in response to hypoxic 
stimulus occurs according to following steps (Gonzalez et al. 1992; see also 
Lahiri et al., 2006): (1) O2-sensing at an O2-sensor (not fully identified) ? (2) 
activation of coupling mechanisms with K+ channels ? (3) change in kinetics of 
these K+ channels resulting in a decrease in their opening probability ? (4) cell 
depolarisation ? (5) activation of voltage operated channels ? (6) Ca2+ entry 
and increase in intracellular free Ca2+ ? (7) activation of exocytosis and 
neurotransmitter release. As the transduction of high K+ into the exocytosis of 
neurotransmitters follows the same path starting at step (4), the modulatory 
action of adenosine should occur at between steps 4 and 7. However, 
clarification of the intimate mechanisms of adenosine (caffeine) actions on the 
exocytotic process would require additional experiments.   
The last group of our findings relates to the effects of caffeine on the 
chemosensory activity in the CSN. The pharmacological profile of caffeine 
effects on the chemosensory activity in the CSN is completely different to that 
observed upon the release of CA. The most important corollary of our 
observation that caffeine can inhibit the activity in the CSN is that endogenously 
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released adenosine is cooperating positively in the genesis of the overall output 
of the CB in situations of hypoxia. An intriguing observation is that caffeine, at 
any of the concentrations tested from 1x 10-9 to 10-2 M, did not affect normoxic 
ongoing activity in the CSN; the puzzle arises when this observation is 
compared with those made upon the release of CA. Another clear difference in 
the effects of caffeine at the presynaptic (release of CA) and postsynaptic level 
is the dose-response curve: 10000 times lower caffeine concentrations than 
those required to produce an effect at the presynaptic level were able to 
significantly reduce the activity in the CSN elicited by hypoxia. In addition, there 
were two clear components in the inhibitory action of caffeine on the CSN 
activity, one with a very high affinity (IC50 17.9 nM) and another with low affinity 
(160 µM), the high-affinity component being mediated by A2A receptors and 
being responsible for ≈60% of the total inhibition, and the low-affinity component 
being mediated by A2B receptors and being responsible for the remaining ≈40%. 
As noted above in the description of our findings, the IC50 of this lower 
component is nearly identical to the IC50 of caffeine on the release of CA.  
Based on these observations we would suggest that the high-affinity component 
of the CSN inhibition might be produced by direct action of caffeine on the 
sensory nerve endings themselves, with the low-affinity component being the 
result of the presynaptic action of caffeine. However, we are not implying that 
high concentrations of caffeine are inhibiting the activity in the CSN because 
they inhibit the release of CA; it is well known that many other neuroregulators 
(e.g. ATP) are co-released with CA (Kupfermann, 1991). Nor are we implying 
that the only mechanism for the high-affinity component of the inhibitory action 
of caffeine is a direct action on A2A receptors located in the sensory nerve 
endings: the possibility exists that adenosine via A2A receptors inhibits the high 
conductance anion channel which appears to represent one of the main 
pathways for ATP release (Sabirov and Okada, 2004) that is known to be 
expressed in chemoreceptor cells (Stea and Nurse, 1989). However, all these 
suggestions await future experimental support. A final consideration in this 
discussion on the identity of the receptors involved in the effects of adenosine 
relates to the evident species differences. In a prior study by Prof. C. 
Gonzalez’s laboratory (Rocher et al., 1999) it was shown that adenosine acting 
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via A1 receptors inhibits Ca2+ currents and the release of catecholamines in 
rabbit chemoreceptor cells. We also want to point out that there are two recent 
studies in rat chemoreceptor cells with opposing views on the action of 
adenosine on intracellular Ca2+ levels: Kobayashi et al. (2000a) demonstrated 
that adenosine did not alter [Ca2+]i in cells exposed to normoxia, while Xu et al., 
(2006) showed that adenosine via A2A receptors triggers a small increase in 
intracellular Ca2+ levels. However, the increase in the intracellular Ca2+ 
observed by Xu et al. (2006) seems to be insufficient to reach the threshold to 
evoke a release of neurotransmitters (Vicario et al., 2000b).   
Together our results indicate that caffeine has an inhibitory effect on 
peripheral control of breathing. However, in pre-term infants caffeine has an 
overall stimulating effect on ventilation (Comer et al., 2001). Because it is 
known that caffeine acting at the brain stem respiratory neurons stimulates 
ventilation (Herlenius and Lagercrantz, 1999; Wilson et al., 2004) the inhibitory 
effects on peripheral control of ventilation described herein would indicate that 
the central effects are dominant in infants. The dominance of the central effects 
in newborns could result from the immaturity of the CB at these early stages of 
life (for a review see Gauda et al., 2004b). In adults, where the function of the 
CB is fully expressed, the peripheral inhibitory effect of caffeine would be 
dominant, and inhibition of ventilation would result (Howell and Landrum, 1995). 
This would be particularly noticeable when the ventilation drive depends mostly 
on CB chemoreceptors, as happens in hypoxia.   
In conclusion, chemoreceptor cells express A2B receptors, which 
physiologically contribute towards fixing the level of neurotransmitter release in 
normoxic and low intensity stimulation conditions. Acting at this presynaptic site 
adenosine significantly (≈ 25%) contributes to the CSN activity observed during 
hypoxic stimulation. The CB also expresses A2A receptors, presumably 
expressed in the sensory nerve endings of the CSN, which appear to be 
responsible for nearly 30% of the activity elicited by hypoxia. Overall our 
findings provide an explanation for the observed inhibitory action of caffeine on 
hyperventilation produced by hypoxia.   
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6. CHAPTER 4 – ADENOSINE MODULATES THE RELEASE OF 
CATECHOLAMINES FROM RAT CAROTID BODY CHEMORECEPTORS 
THROUGH AN INTERACTION BETWEEN D2 DOPAMINE RECEPTORS AND 
A2B ADENOSINE RECEPTORS 
 
6.1. Introduction and aim 
 In Chapter 3 (Section 5) we demonstrated that adenosine modulates the 
release of CA from rat CB in basal conditions and in response to low intensity 
stimulus via an action on A2B adenosine receptors. Some previous data on CSN 
activity and ventilation in vivo have also suggested that DA and adenosine 
interact in the CB (Monteiro and Ribeiro, 2000). We postulated that this 
modulatory effect could occur due to an interaction between adenosine A2B and 
dopamine D2 receptors present in glomus cells or intracellularly at the second 
messengers’ level.  Interactions between A2A-D2 receptors are well described in 
the central nervous system (see General Introduction (Section 1.5.2.3.)) and 
these findings prompted us to investigate if interactions between A2B and D2 
receptors could be involved in the modulation by adenosine of CA release in the 
CB using a pharmacological and functional approach. 
 
 
6.2. Materials and methods 
6.2.1. Animals and surgical procedures 
Experiments were performed in adult Wistar rats of both sexes (250-350 
g) obtained from the vivarium of the Faculty of Medicine of the University of 
Valladolid. The Institutional Committee of the University of Valladolid for Animal 
Care and Use approved the protocols. All the surgical procedures were 
performed as previously described in Section 5.2.1.  
For the release of CA experiments (5-12 CBs/experiment) the CBs were 
cleaned free of CSN and nearby connective tissue following procedures 
previously described (Vicario et al., 2000a).  
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6.2.2. Labelling of catecholamine stores: release of 3H-CA 
To monitor the release of CA a radioisotopic method was used, as 
described by Fidone et al. (1982) and Vicario et al. (2000a), and detailed in 
Section 5.2.2.. Specific protocols for stimulus and drug applications are 
provided in the Results. Stimulus included hypoxia with 10% O2-equilibrated 
solutions and high external K+ (30 mM) The agonists and antagonists used 
were: caffeine (a non-selective adenosine antagonist, 1mM), domperidone (a D2 
dopamine antagonist, 0.5 nM - 5 µM), haloperidol (a D2 dopamine antagonist, 
0.01-10 µM),  5’-(N-ethylcarboxamido)adenosine (NECA, an adenosine A2 
agonist; 0.1-100 µM), propylnorapomorphine (a D2 dopamine agonist, 0.02-200 
nM) and sulpiride (a D2 dopamine antagonist,1 µM). After incubation, the 
incubated solutions and the CBs themselves were analysed, as described in 
5.2.2. 
 
 
6.2.3. Drugs and chemicals 
6-methyl-tetrahydropterine, ascorbic acid, caffeine, domperidone, 
haloperidol, NECA, propylnorapomorphine and sulpiride were all obtained from 
Sigma (Sigma-Aldrich, Madrid, Spain). 3H-tyrosine was obtained from 
Amersham (Madrid). Domperidone, haloperidol, NECA and sulpiride were 
prepared as 5 mM stock solutions in DMSO; the final concentration of DMSO 
was always below 1/500 which by itself lacks effects on our preparations.  
Propylnorapomorphine was prepared in a 5 mM stock solution in methanol.   
 
 
6.2.4. Data analysis 
Data were evaluated using Graph Pad Prism Software, version 4 and 
were presented as means ± SEM. Dose-response curves were fitted to 
Sigmoidal dose-response curves and the IC50, EC50 and the Emax values were 
obtained directly from the Sigmoidal dose-response equation.  The significance 
of the differences between the means was calculated using unpaired Student’s t 
test and by One and Two-Way Analysis of Variance (ANOVA) with Dunnett’s 
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and Bonferroni multiple comparison tests, respectively. P values of 0.05 or less 
were considered to represent significant differences. 
 
 
6.3. Results 
 
6.3.1. Effect of NECA, an A2 agonist on the release of 3H-CA from rat 
carotid body 
Caffeine at low concentrations is a non-selective antagonist of adenosine 
receptors (see Introduction, Section 1.7) that inhibits the basal and low intensity 
stimuli evoked release of 3H-CA from CB, but not the release evoked by stimuli 
of higher intensity (Chapter 3, Section 5). Along the same experimental line, we 
have tested NECA, which is an agonist of A2 adenosine receptors, on the basal, 
low intensity (10% O2) (Figure 31, Section 5.3.3.) and high intensity hypoxia 
(2% O2) evoked release of 3H-CA from CB. In the previous experiments on the 
basal and low intensity stimulus evoked 3H-CA released, NECA was tested only 
in one concentration (1uM, see Fig 31) and the pharmacological 
characterisation of the A2B subtype of receptors that modulate the release of 3H-
CA on chemoreceptor cells was performed using more selective agonists and 
antagonists (Chapter 5, Section 5.3.3. ). Therefore, according to our statements 
that the receptor subtype that modulates the release of 3H-CA on 
chemoreceptor cells is A2B (Chapter 5, Section 5.3.3.) this would imply that the 
observed effects of NECA on the release of 3H-CA are due to an action on A2B 
adenosine receptors.  
Figure 37 shows that the effect of NECA during normoxic conditions was 
concentration-dependent and that the increase in the basal release of 3H-CA 
from rat CB had a maximal effect (Emax) of 105.3% and an EC50 of 1.22 µM 
(Figure 37A).  
Previously, we have shown (Figure 31, Section 5.3.3.) that NECA also 
stimulates the release of 3H-CA evoked by moderate hypoxia. Now we show 
that NECA, as was the case with caffeine, was not able to modify the release of 
3H-CA evoked by a higher intensity hypoxia, such as 2% O2 (Figure 37B). 
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Figure 37 Effect of NECA, an adenosine A2 agonist, on the basal release of 3H-CA and 
on the release evoked by 2% O2, from rat carotid body.  A) Dose-response curve for 
NECA (0.1-100 µM) on the basal (normoxic, 20% O2) release of 3H-CA. 0% effect 
corresponds to 1.062 ± 0.06% of the total 3H-CA content. B) Effect of 10 µM of NECA 
on the release of 3H-CA evoked by 2% O2. 0% corresponds to 1.669 ± 0.44 % of total 
3H-CA content. NECA was applied for 30 min between min 30 and 60 of the protocol in 
the experiments in basal conditions. In the experiments for the effect of NECA in 
hypoxia, the drug was applied in periods prior, during and after the hypoxic stimulation. 
Hypoxic stimulus was applied for 10 min. Data represent means ± SEM (n= 5-6).  
 
 
6.3.2. Reversion of the inhibitory effect of caffeine on the 3H-CA by a D2 
antagonist, sulpiride 
 Sulpiride (0.1-10 µM), which is a D2 dopamine receptor antagonist, did 
not modify the basal release of 3H-CA from rat CB (data not shown), but applied 
in a concentration of 1 µM, it produces an increase of 106.1 and 163.5% in the 
release of 3H-CA evoked by 30 mM K+ and 10% O2, respectively (Figure 39A). 
The fact that sulpiride induced an increase in the release of 3H-CA evoked by 
moderate hypoxia and 30 mM K+ confirms the existence of D2 dopamine 
autoreceptors in CB chemoreceptor cells that control the release of CA by a 
negative feedback mechanism. Despite the absence of effect of sulpiride on the 
basal release of 3H-CA from CB, its effect on the evoked release of 3H-CA by 
low intensity stimulus prompted us to investigate if this antagonist could abolish 
the inhibitory effect of caffeine (1 mM) on the evoked release of 3H-CA from rat 
CB. It was observed that 1 µM of sulpiride almost completely abolished the 
inhibitory effect of caffeine on the basal response (data not shown) and on the 
release of 3H-CA evoked by 30 mM K+ (Figures 38B and 38C), suggesting that 
adenosine receptors interact with D2 dopamine autoreceptors to control the 
release of CA from rat CB. 
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Figure 38 Effect of sulpiride on the release of 3H-CA evoked by 30 mM extracellular K+ 
and by 10% O2 (A) and reversion of the inhibitory effect of caffeine on the release of 
3H-CA from rat carotid body (B,C). A. Sulpiride (1µM) was applied 10 min prior to and 
during the stimuli application, and potentiated the response elicited by both stimuli. 0% 
effect corresponds to 1.915 ± 0.293 and to 1.990 ± 0.277% of total 3H-CA content 
respectively, in the absence and in the presence of sulpiride. B. Time course of the 
effect of sulpiride on the inhibitory effect of caffeine on the release of 3H-CA evoked by 
30 mM K+. Samples collected each 2 min. Caffeine and sulpiride were applied jointly at 
10 min and 6 min before, during, and 2 min after the application of the stimuli. C. 
Sulpiride (SULP; 1 µM) almost completely reverts the inhibitory effect of 1 mM of 
caffeine (CAF) on the evoked release of 3H-CAs.  0% effect corresponds to 0.382 ± 
0.058 in the absence of drugs and 0.318 ± 0.094 in the presence of caffeine and 0.388 
± 0.172 % of total 3H-CA content, in the presence of sulpiride and caffeine, 
respectively. * P < 0.05;** P < 0.01 One and Two-Way ANOVA with Bonferroni´s multi-
comparison test. Vertical bars represent means± SEM 
 
 
 
 
 
6.3.3. Effect of D2 antagonists on the release of 3H-CA release by rat 
carotid body and its potentiation with NECA 
Since sulpiride did not modify the basal release of 3H-CA, we tested 
other D2 dopamine receptor antagonists, domperidone and haloperidol.  
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Domperidone (0.5 nM - 5 µM) and haloperidol (0.01-10 µM) increased the basal 
release of 3H-CA from rat CBs in a concentration-dependent manner (Figure 
39A). Maximal increases (Emax) of 123.5% and 122.3% on the basal release of 
3H-CA occurred with 5 µM of domperidone and 10 µM of haloperidol, 
respectively. The EC50 were 81 and 147 nM for domperidone and haloperidol, 
respectively. The effect of haloperidol was also tested on the release of 3H-CA 
evoked by moderate hypoxia (10% O2). As in normoxic conditions haloperidol 
increased the release of 3H-CA in hypoxia in a concentration-dependent 
manner (Figure 39B) with a lower Emax (110.1%) and a higher EC50 (462 nM). 
The effect of NECA, an A2 agonist, on the release of 3H-CA produced by 
haloperidol both in normoxia and moderate hypoxia is shown in Figure 40.  
 
 
 
A B 
 
Figure 39 Dose-response curves for the effect of domperidone and haloperidol, D2 
dopamine antagonists, on the release of 3H-CA from rat CB. A. Effect of domperidone 
and haloperidol in normoxic conditions. 0% effect in normoxic conditions corresponds 
to 0.927 ± 0.10% and to 1.010 ± 0.09% of the total 3H-CA content for haloperidol and 
domperidone, respectively. B. Effect of haloperidol on the release of 3H-CA in normoxic 
conditions and in response to moderate hypoxia (10% O2). 0% effect for the effect of 
haloperidol in response to 10% O2 corresponds to 5.563 ± 0.58% of the total 3H-CA 
content. Values represent means ± S.E.M.  
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Figure 40 Potentiation of haloperidol, a D2 dopamine receptor antagonist, effect on 3H-
CA release from CB by NECA, an A2 adenosine receptor agonist in (A, B) normoxic 
conditions (20% O2) and (C,D) in response to moderate hypoxia (10% O2). In B and C 
the dotted lines represent the absolute values of the sum of the both drugs (NECA and 
haloperidol) applied separately in normoxia and hypoxia, respectively. Note that the 
effect of potentiation is synergistic and not additive. 0% effect corresponds to 0.927 ± 
0.10% and to 5.563 ± 0.58% in normoxia and hypoxia, respectively. NECA was applied 
for 30 min between min 30 and 60 and haloperidol for 20 min between min 40 and 60 
of the experimental protocol. Values represent means ± S.E.M. 
 
 
It can be observed (Figure 40A and C) that the application of 10 µM (10 
times the EC50 observed for the stimulation of 3H-CA) of NECA moves the dose-
response curve for the effect of haloperidol on basal and low intensity hypoxic 
release of 3H-CA from the CB to the left. In Figure 40 B and D we can also 
observe that the potentiation of the effect of haloperidol by NECA in normoxia 
and moderate hypoxia is synergistic and not additive, since the effect of both 
drugs applied jointly is smaller than the sum of the effects of the drugs applied 
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separately. Maximal increases (Emax) and EC50 for the effect of haloperidol on 
the release of 3H-CA from CB in normoxia and moderate hypoxia in the 
presence and absence of NECA are represented in Table 6. 
 
 
Table 6 Effect of NECA (10 µM) on the efficacy and potency of haloperidol, a D2 
antagonist, in stimulating the release of CA from rat carotid body. 
 
Physiological 
stimulus 
Drugs EC50 Emax 
Haloperidol 147 nM 122.3 ± 13.0 
20% O2
NECA + Haloperidol 78 nM 161.5 ± 9.2 
Haloperidol 462 nM 110.1 ± 10.8  
10% O2 NECA + Haloperidol 79 nM 152.7 ± 12.7 
NECA: 5’-(N-ethylcarboxamido)adenosine. Emax: maximal increase (%) in the release of 3H-CA 
(mean ± SEM). EC50: drug concentration that produced 50% of maximal effect. NECA by itself in 
this concentration caused 87.35 ± 10.73% increase in 3H-CA (over control). 
 
 
6.3.4. Inhibitory effect of the D2 agonist, propylnorapomorphine, on the 
release of 3H-CA from carotid body and its reversion by NECA 
In order to investigate whether the interaction between D2 and A2B 
receptors that modulate the release of 3H-CA in chemoreceptor cells would be 
antagonistic, we tested NECA on the effect of a D2 agonist, 
propylnorapomorphine, on the release of this neurotransmitter from rat CB in 
normoxia and moderate hypoxia (see legend of Figure 41 for experimental 
protocol).  
As expected, propylnorapomorphine (0.02-200 nM) inhibited the basal 
release of 3H-CA (20% O2) and the release in response to moderate hypoxia 
(10% O2) in a concentration-dependent manner (Figure 41A). The maximal 
inhibitory effects (Emax) and IC50 of propylnorapomorphine in normoxia and 
moderate hypoxia are shown in Table 7.  
To demonstrate the antagonistic interaction we applied 10 µM of NECA 
on the effect of propylnorapomorphine in normoxia and moderate hypoxia, and 
it was observed that NECA attenuated the inhibitory effect of the D2 agonist on 
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the release of 3H-CA from the CB in normoxia (Figure 41B) and in response to 
10% O2 (Figure 41C). 
 
 
A 
C
 B
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 41 Effect of propylnorapomorphine (N-Apo) on the release of 3H-CA from the 
carotid body in normoxic conditions and in response to moderate hypoxia (10% O2) in 
the absence (A) and in the presence of NECA (B and C). A. Dose-response curves for 
N-Apo in normoxia and moderate hypoxia. P>0.05 B. Attenuation of the inhibitory effect 
of N-Apo by 10 µM of NECA, and abolishment of the inhibitory effect of N-Apo with 100 
µM of NECA in normoxia. C. Attenuation of the inhibitory effect by 10 µM of NECA in 
response to moderate hypoxia. 0% effect corresponds to 1.716 ± 0.28% and to 4.231 ± 
0.50 % of total 3H-CA content in normoxia and hypoxia, respectively. 
Propylnorapomorphine was applied for 30 min between min 30 and 60 and NECA for 
20 min between min 40 and 60 of the experimental protocol. Values represent means ± 
S.E.M.  
 
 
It can also be observed that the inhibitory effect of 200 nM 
propylnorapomorphine on the basal release of 3H-CA from chemoreceptor cells 
is completely abolished if a concentration of 100 µM of NECA is used (Figure 
41B). Examining panels B and C of Figure 41, it appears that the attenuation of 
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the inhibitory effect of propylnorapomorphine by NECA is due to a displacement 
of the dose-response curves for the release of 3H-CA to the right, both in 
normoxia and moderate hypoxia, suggesting that an antagonistic interaction 
between D2 and A2B receptors exists on chemoreceptor cells in the CB that 
control the basal release and low intensity stimulus evoked release of CA.  
 
 
Table 7 Effect of NECA on the efficacy and potency of propylnorapomorphine, a D2 
agonist, in inhibiting the release of CA from rat carotid body. 
 
Physiological 
stimulus 
Drugs IC50 Emax 
N-Apo 1.67 nM 40.50 ± 5.1 
20% O2
10 µM NECA + N-Apo 2.69 nM 21.56 ± 6.2 
N-Apo 2.32 nM 55.79 ± 4.7  
10% O2 10 µM NECA + N-Apo 5.29 nM 37.2 ± 6.4 
NECA: 5’-(N-ethylcarboxamido)adenosine. N-Apo: propylnorapomorphine. Emax: maximal % of 
inhibition over the control (mean ± SEM). IC50: drug concentration that produced 50% of the 
maximal inhibition. 
 
 
6.3.5. Effect of ionomycin on the release of 3H-CA by carotid body 
modified by propylnorapomorphine and NECA 
 In the discussion of Chapter 5 we suggested that A2B receptors operate 
at the CB in the last steps of the stimulus-secretion coupling process, since 
caffeine (and the other agents tested) produces identical effects in the response 
elicited by high K+ (a non-specific depolarising stimulus) and hypoxia. In order 
to investigate at which step of the stimulus-secretion process the interactions 
between A2B and D2 are involved, we studied these antagonistic interactions on 
the release of 3H-CA evoked by ionomycin. Ionomycin alters the permeability of 
cells, producing an increase in intracellular Ca2+ and, as a consequence, 
induces a Ca2+ dependent vesicular release of CA (for a review see Dedkova et 
al., 2000). This effect can be observed both in figure 42A on the time course of 
the 3H-CA release (Figure 42A) as in the magnitude of the increase, in Figure 
42B, where the application of 5 µM of ionomycin increased the release of 3H-CA 
from rat CB by 8.78 ± 1.10%. The application of 200 nM of 
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propylnorapomorphine decreased the 3H-CA release from CB evoked by 
ionomycin by 44% (Figure 42B).  
  
 A B
 
Figure 42 Inhibitory effect of propylnorapomorphine, a D2 agonist, on the ionomycin 
evoked release of 3H-CA from CB and reversion of the inhibitory effect by NECA. Panel 
A shows the time course for the effects of 200 nM propylnorapomorphine (N-Apo) and 
the reversion of this effect by 10 µM of NECA on the release of 3H-CA evoked by 5 µM 
ionomycin. Ionomycin was applied for 10 min between min 40 and 50 of the 
experiment. N-Apo and NECA were applied 10 min prior and 20 min after stimulation 
with ionomycin. 0% corresponds to 1.946 ± 0.36, 1.49 ± 0.235 and 1.914 ± 0.36 % of 
3H-CA total content respectively for ionomycin in the absence and in the presence of N-
APO and N-APO plus NECA. Panel B shows means ± S.E.M. of the effect of N-Apo in 
the absence and in the presence of NECA on ionomycin evoked release of 3H-CA from 
CB.  *P<0.05, **P<0.01; One-Way ANOVA with Dunnett’s multi-comparison test.   
 
 
When we tested the effect of NECA on the inhibitory effect of 
propylnorapomorphine on 3H-CA release evoked by ionomycin we observed 
that the application of 10 µM of NECA completely reversed the inhibition (figure 
43A and B). These results suggest that A2B and D2 receptors interact to 
modulate the release of 3H-CA from rat CB between the steps of Ca2+ entry and 
increase in intracellular free Ca2+, and the activation of exocytosis and 
neurotransmitter release, of the stimulus-secretion coupling process. 
 
 
 
6.4. Discussion 
 These results provide pharmacological evidence that adenosine A2B 
receptors and dopamine D2 receptors, that are co-located in chemoreceptor 
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cells, interact in order to modulate the release of CA from rat carotid body 
chemoreceptor cells. In fact, we have found that antagonists of dopamine D2 
receptors facilitate the release of CA from rat chemoreceptor cells, this effect 
being prevented by antagonists of A2B adenosine receptors and potentiated by 
agonists for the receptor. Furthermore, we have found that agonists of 
dopamine D2 receptors inhibit the release of CA from rat chemoreceptor cells, 
this effect prevented by an agonist for A2B receptors, suggesting the existence 
of an antagonistic receptor-receptor interaction between A2B receptors and D2 
receptors in chemoreceptor cells.  
 
Although our model used whole CBs, the results with the D2 dopamine 
antagonists, sulpiride, haloperidol and domperidone, in normoxia, moderate 
hypoxia and in response to a moderate depolarising stimulus, are compatible 
with the presence of D2 dopamine autoreceptors in the rat CB chemoreceptor 
cells, as previously described in the rabbit (Dinger et al., 1981; Fidone et al., 
1991; Basson et al., 1997). These autoreceptors would control the release of 
CA from rat CB chemoreceptor cells by a negative feedback mechanism.  
Contrary to the effects of haloperidol and domperidone on the basal release of 
3H-CA, sulpiride did not modify release of CA in normoxia an effect that could 
be due to the action of this antagonist on other subtypes of dopamine receptors 
(Jaworski et al., 2001; Asaumi et al., 2006).  
This study found some differences between the effects of D2 receptor 
agonists and antagonists on the release of CA from CB chemoreceptor cells in 
normoxia and moderate hypoxia. The smaller effect of haloperidol on CA 
release from chemoreceptor cells in response to moderate hypoxia, in 
comparison with response to normoxia, can only be explained if haloperidol is 
not sufficient to antagonise all the D2 receptors present in chemoreceptor cells 
and the endogenous dopamine released from chemoreceptor cells by moderate 
hypoxia can still exert some inhibition at D2 receptors by the negative feedback 
mechanism diminishing the CA release. A contrary result, but in agreement with 
more pronounced inhibitory effects in stimulated preparations, was found for the 
effect of the D2 agonist, propylnorapomorphine, on the release of CA in 
normoxia and moderate hypoxia. The more pronounced inhibitory effect of 
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propylnorapomorphine observed in moderate hypoxia, compared with normoxia, 
can be explained by the increased release of DA in response to hypoxia.  
We would like to mention at the onset that throughout the discussion are 
going to attribute all the effects of NECA, which is an A2 adenosine receptor 
agonist to an effect on A2B adenosine receptors. In the previous (Figures 31, 32 
and 33) and current (Figure 38) chapters of this thesis we have observed that 
NECA induces the release of 3H-CA from CB. Since the effect is not mimicked 
by DPCPX in concentrations that affect A1 receptors, or by CGS21680 and HE-
NECA (A2A selective agonists), we have concluded that A2B adenosine 
receptors modulate the release of 3H-CA from rat CB.    
We have also found that the absence of effect of NECA under high 
intensity stimulation is in agreement with the previously described effect of 
caffeine on release of 3H-CA from rat carotid body chemoreceptor cells in 
response to high intensity stimulus (Chapter 3, Section 5). Under high intensity 
stimulation conditions, adenosine would lose its effectiveness for two reasons: 
first, the release of adenosine itself tends to decrease with hypoxias of higher 
intensity, (Chapter 1, Section 3; Conde and Monteiro, 2006) and second, the 
high levels of DA in the surrounding milieu (released by a high intensity 
stimulus) would saturate D2 receptors masking the effects of adenosine on D2 
receptors.  
 
Receptor-receptor interactions can be synergistic and antagonistic in 
character and can be cooperative. When two different agonists to different 
receptors are combined they interact to enhance the efficacy of the combination 
(synergy) or to diminish the efficacy (antagonism). Alternatively, the agonist 
may not interact, and the effect of combination is obtained by adding the effects 
of each drug used individually (additivity) (Albritton et al., 2005; Fuxe et al. 
2007). The fact that activation of D2 receptors with propylnorapomorphine is 
diminished with increased concentrations of NECA, which activates A2B 
receptors in the chemoreceptor cells in the CB (see Chapter 3, Section 5), 
demonstrates that we are in the presence of an antagonistic interaction 
between D2 and A2B receptors. With the results herein described and the 
protocols used in this work we cannot discern the location of the interaction, nor 
can we establish if the interaction is a functional coupling between A2B and D2 
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receptors, or at adenylyl cyclase level, or at both sites.  Nevertheless, we can 
suggest that a functional coupling between A2B and D2 receptors in 
chemoreceptor cells could exist, as is described in the central nervous system 
(mostly in the striatum) between D2 and A2A receptors (Ferre et al., 1997; Hillion 
et al., 2002; Canals et al., 2003).  
Dopamine D2 receptors are expressed in chemoreceptor cells and co-
localized with TH mRNAs in the same cells of the CB (Gauda et al., 1996). We 
found that A2B adenosine receptors are also co-localized with TH in 
chemoreceptor cells (Conde et al., 2006) meaning that D2 dopamine receptors 
and A2B receptors are co-located in chemoreceptor cells and can interact to 
modulate the release of CA. 
 The interactions previously described between dopamine and adenosine 
in the CB observed when monitoring CSN activity in the cat (Ribeiro and 
McQueen, 1983) and ventilation in the rat (Monteiro and Ribeiro, 2000) have 
defined D2 as the dopamine receptor involved, but could not identify the subtype 
of A2 adenosine receptor participating in the interaction (see Introduction, 
Section 1.5.2.3.). Our data indicate that the subtype of adenosine receptor is 
the A2B adenosine receptor. We cannot exclude the possibility that interactions 
between D2 and A2A receptors also exist in the CB. Nevertheless, the interaction 
herein observed is in agreement with the potentiation of the inhibitory effect of 
dopamine by adenosine observed in ventilation in the rat (Monteiro and Ribeiro, 
2000).  
In the current series of experiments, we have not specifically examined 
the mechanism of interaction, nonetheless some conclusions can be drawn and 
we believe that the model presented in Figure 43 reasonably fits our 
observations. D2 autoreceptors in chemoreceptor cells form a negative 
feedback controlling the release of CA from chemoreceptor cells in the rabbit 
(Fidone et al., 1991; Basson et al., 1997) and in the rat (current results, Figures 
37A and 38). A2B adenosine receptors should be coupled to D2 receptors, this 
coupling resulting in a decrease in the affinity of D2 receptors for DA; through 
this coupling, endogenously released adenosine would be tonically activating 
the release of CA from chemoreceptor cells as it hinders the inhibitory action of 
DA. On the inhibition of A2B receptors with caffeine, full inhibitory power of D2 
receptors appears, and thereby the decrease in CA release. Indeed, the 
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activation of A2B adenosine receptors with NECA decreases the affinity of the D2 
receptor agonist, propylnorapomorphine in CB chemoreceptor cells. Under 
intense stimulation, adenosine would lose its effectiveness due to the two facts 
cited above. 
 
   
  
 
 
 
 
 
 
 
 
Figure 43 Mechanisms postulated for the interaction between A2B and D2 receptors in 
chemoreceptor cells that modulate the release of CA from rat carotid body (see text). 
AC – adenylyl cyclase; cAMP -  3’,5’-adenosine monophosphate 
 
We cannot exclude an interaction at the adenylyl cyclase level, since 
both the receptors exert opposite actions on adenylyl cyclase and therefore on 
cAMP levels (Figure 43). In fact, the potentiation of the effect of haloperidol on 
the release of CA from chemoreceptor cells by NECA (Figure 39), the combined 
effect being smaller than the sum of effects of the two drugs applied separately, 
suggests that in part (but not totally) the interaction can occur at this level. 
Indeed, in some preparations, it is described that this type of interaction 
between receptor-receptor and at second messenger level can co-exist, like in 
striatal slices in vitro (Svenningsson et al., 1998) and in cells of Chinese 
hamster ovary (Kull et al., 1999). However, experiments to measure cAMP 
levels in the CB in order to clarify if interactions at second messenger level exist 
would require additional work. To investigate and confirm the existence of an 
antagonistic interaction between A2B receptor and D2 receptor in the plasmatic 
membrane of chemoreceptor cells in the CB, experimental studies for analysing 
receptor collocation and co-trafficking, including co-clustering and co-
internalisation, with computer assisted image analysis are needed. Important 
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methodologies for analysis of collocation and co-trafficking of receptors would 
be atomic force or confocal microscopy. 
  
 This type of coupling between autoreceptors and A2B receptors is not 
unique to chemoreceptor cells. Talaia et al. (2005) found that adenosine acting 
via A2B receptors augments the release of noradrenaline from the sympathetic 
endings innervating the vas deferens, this effect being abolished by yohimbine, 
a blocker of presynaptic α2-adrenoreceptors. This type of interaction, in which 
A2B receptors control the release of dopamine, was previously observed in the 
rat striatum by Okada et al. (1996). They observed that CGS 21680 did not 
affect striatal extracellular dopamine levels, but stimulatory and inhibitory effects 
of the A2A agonist and antagonist, DMPA and DMPX, respectively, were 
observed when A1 receptors were blocked, suggesting that A2B receptors 
modulate the release of dopamine in the striatum under A1 blockade.  
  
 We have discussed, and previously suggested (Chapter 3, Section 5) 
that A2B receptors are coupled towards the last steps in the stimulus-secretion 
coupling process, since caffeine and the drugs that mimic its effects have 
produced similar effects on the response elicited by high K+ (a non-specific 
depolarising stimulus) and by hypoxia. In an attempt to discover at which step of 
the stimulus-secretion process the interactions between A2B and D2 receptors 
are involved, we have studied this interaction on the release of 3H-CA evoked 
by ionomycin. Ionomycin is a calcium ionophore, and it is generally assumed 
that these substances directly facilitate the transport of Ca2+ across the plasma 
membrane. The Ca2+ signal induced by the Ca2+ ionophores, and in this case by 
ionomycin consists of three components: the first component is due to the 
activation of Ca2+ influx through native Ca2+ channels and is sensitive to drugs 
which inhibit the receptor-operated Ca2+ influx; the second component 
originates from phospholipase C-dependent mobilisation of Ca2+ from 
intracellular stores; and the third ionophoric component is very small at low 
concentrations of the ionophores (Himmel et al., 1990;  Dedkova et al., 2000). 
The Ca2+ signal induced by ionomycin that produces an increase in Ca2+ 
intracellular concentrations, originating the release of neurotransmitters 
eliminates an effect of the interaction between D2 and A2A receptors on the 
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entire hypoxic transduction cascade until step 6 in our study. The fact that 
NECA abolishes the inhibitory effect of propylnorapomorphine on the ionomycin 
evoked release of 3H-CA supports the above suggestion and indicates that the 
interaction between the A2B and D2 receptors present in CB chemoreceptor cells 
modulating CA release is between the step 6 and step 7 of the stimulus-
secretion coupling process (see Figure 4 or Chapter 3 discussion for 
transduction cascade of hypoxic signalling). Nevertheless, clarification of the 
intimate mechanisms of interaction and action on the exocytotic process would 
require additional experiments. 
 
To summarise, we can assume that an antagonistic interaction between 
A2B and D2 receptors exists in the CB that modulates the release of CA from 
chemoreceptor cells.  
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7 – CHAPTER 5 – EFFECT OF CHRONIC CAFFEINE INTAKE ON THE 
CAROTID BODY CHEMOSENSORY ACTIVITY IN CONTROL AND CHRONIC 
HYPOXIC RATS 
 
7.1. Introduction and aim 
Acute administration of caffeine caused an inhibition in carotid body 
chemoreceptor activity due to the antagonism of adenosine A2A and A2B 
receptors (see Chapter 3, Section 5). The absence of data on the effects of 
chronic caffeine on CB function prompted us to study the effects of chronic 
caffeine consumption and therefore the permanent blockage of adenosine 
receptors on the peripheral control of breathing and on ventilation. We also 
aimed to investigate the role of adenosine in chronic hypoxia, through the 
permanent blockade of adenosine receptors (chronic caffeine intake).  
To study the effects of chronic caffeine intake on carotid body 
chemosensory activity in control and chronically hypoxic animals we have: 
assessed the function of chemoreceptor cells by measuring the content, 
synthesis and release of catecholamines and the expression of TH as well as 
the release of adenosine and ATP; determined the functional activity of the 
intact organ by measuring the chemosensory activity in the CSN in normoxia, 
and acute hypoxia and hypercapnia; and assessed the global effect measuring 
the ventilatory responses to acute hypoxia and hypercapnia. In some cases 
SCG were used as control preparation to assess the specificity of the effects of 
chronic hypoxia, chronic caffeine intake and both in CB chemoreceptor function. 
 
 
7.2. Materials and methods 
7.2.1. Chronic caffeine intake in control and chronic hypoxic animals  
The experiments were performed in Wistar rats of both sexes aged 3 
months (200-350g) obtained from vivarium of the Faculty of Medicine of the 
University of Valladolid. The control animals were maintained at a normal 
atmosphere (room air: 20 - 21% O2). With respect to the chronically hypoxic 
rats, they were kept for 15 days in a chamber equilibrated with a gas mixture of 
11 -12% O2 in 88-89 % N2; PO2 ≈ 90 mmHg N2 (hypoxic atmosphere) with a flow 
of 3L/min (Figure 44). To study the chronic caffeine intake we subdivided the 
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groups of controls and hypoxic rats into two (with and without caffeine), and 
kept the rats drinking 1g/L of caffeine for 15 days (Figure 44), according to the 
protocols commonly used to chronically treat animals with caffeine (Gasior et 
al., 2002; da Silva et al., 2003; Karcz-Kubicha et al., 2003). 
Another group of control and chronically hypoxic animals treated with 
caffeine for 8 days only were inserted into the study in order to investigate the 
effect of caffeine and the significance of adenosine on ventilation during a short 
period of chronic hypoxia. The study design, including the definition of the 
groups, was equal to that represented in Figure 44 but for only 8 days.  
 
 
 
 
Room Air – 20% O2 Atmosphere 15 days 0 Control Group - N 
 
 
 
 
 
 
 
 
 
 
0 15 days Room Air with 1g/L caffeine intake 
12% O2  - hypoxic atmosphere 0 15 days 
12% O2  with 1g/L caffeine intake 15 days 
Experiments 
0
Normoxic/Caffeine 
Group - NC 
Chronic hypoxic 
group - H 
Chronic 
hypoxic/caffeine 
group - HC 
 
Figure 44 Experimental design with time courses and the paradigms to which rats 
were submitted, and the definition applied to the distinct groups of animals.  
 
 
The accumulation of CO2 and water vapour inside the chamber was 
avoided by air renewal and by the presence on the ground of the chamber of a 
layer of soda lime granules.  Each 4 days the chamber was opened to be 
cleaned and restocked with water and food. After each cleaning cycle, a high 
flow of gas was employed in order to drop quickly the PO2 in the chamber. The 
temperature and PO2 in the chamber were monitored with a humidity 
thermometer and by an oximeter, respectively, and the animals were always 
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kept with a seasonal day/light rhythm, with temperature controlled between 23-
26ºC. The Institutional Committee of the University of Valladolid for Animal Care 
and Use approved the protocols.   
For the experiments aimed to measure endogenous CA content and 
synthesis of 3H-CA we used 4-8 CBs/experiment and 4-8 SCGs/experiment. In 
the experiments where the release of endogenous ATP, adenosine and CA 
were analysed, 4 CBs were used in each experiment, due to the small 
dimensions of the CB (≈50 µg, Conde et al., 2006a) and the limit of detection of 
the techniques used. The CBs and SCGs were cleaned of nearby connective 
tissue following procedures previously described (Vicario et al., 2000a, Chapter 
3, Section 5). For the recording of CSN activity we followed the procedure 
described in Section 5.2.3.. In all instances animals were killed by an 
intracardiac overdose of sodium pentobarbital. 
 
 
Figure 45 Photography of the equipment used to 
produce a hypoxic atmosphere and the chamber 
into which animals were inserted to be submitted to chronic hypoxia.  
 
 
7.2.2. Measurement of tissue catecholamines content 
 CBs and SCG were cleaned and transferred to cold Eppendorf tubes 
containing 80 µl and 200 µl of 0.4 N perchloric acid, respectively, and after a 
few minutes in acid, the CBs and SCGs were weighed using an electrobalance 
(Supermicro, Sartorius), and glass-to-glass homogenized at 0-4 ºC. The 
homogenates of CBs and SCGs plus an aliquot of 40 µl and 100 µl, 
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respectively, of 0.4 N perchloric acid, used to quantitatively collect the tissue 
homogenate, were centrifuged (10 min; 0-4 ºC) in a microfuge (Beckmann, 
Madrid). The CA content in the tissues was quantified by HPLC as described in 
Section 7.2.3. 
 
 
7.2.3. Labelling of CA stores to measure the rate of synthesis of 3H-CA 
The stores of CA in the CB and in SCG were labelled by incubating the 
organs in a solution containing tyrosine, the natural precursor of CA, labelled 
with tritium (3,5-3H-tyrosine, Amersham). 4 to 8 CBs were placed in small glass 
vials containing 0.5 ml of Tyrode solution and placed in a shaker bath at 37 ºC. 
The concentration of 3H-tyrosine was 30 µM and its specific activity was 6 
Ci/mmol. In addition, the incubating solution contained 100 µM 6-methyl-
tetrahydropterine and 1 mM ascorbic acid, cofactors for tyrosine hydroxylase 
and dopamine-β-hydroxylase, respectively (Fidone & Gonzalez, 1982). 
Incubation lasted 2h.   
On completion of the labelling period, the CBs and SCG were transferred 
to vials containing 10 ml of ice-cold precursor-free Tyrode solution to wash out 
the 3H-tyrosine present in the extracellular space for a period of 5 min. 
Afterwards the CBs and SCG were transferred to cold Eppendorf tubes 
containing 80 µl and 200 µl of 0.4 N perchloric acid, respectively, and after a 
few minutes in acid, the CBs and SCGs were weighed using an electrobalance 
(Supermicro, Sartorius), and glass-to-glass homogenized at 0-4 ºC. The 
homogenates of CBs and SCGs plus an aliquot of 40 µl and 100 µl, 
respectively, of 0.4 N perchloric acid, used to quantitatively collect the tissue 
homogenate, were centrifuged (10 min; 0-4 ºC) in a microfuge (Beckmann, 
Madrid). 3H-CA synthesised and free 3H-tyrosine present in the tissues were 
measured in the supernatants, and 3H-tyrosine incorporated into proteins was 
measured in the pellets.   
3H-tyrosine incorporated into proteins was determined by liquid 
scintillation spectrometry of the pellets resulting from centrifugation of the acid 
homogenates of the CB and SCG. Free 3H-tyrosine accumulated by the CBs 
and SCGs during the period of synthesis was also measured by liquid 
scintillation counting: an aliquot of the supernatants was counted and the 
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radioactivity present in it minus radioactivity in the form of 3H-CA was taken as 
free intracellular 3H-tyrosine.   
For the analysis of endogenous unlabelled and 3H-labeled CA in the 
tissue extracts and for the analysis of the endogenous release of CA, aliquots 
(10-100 µl) of supernatants were directly injected into an HPLC system 
composed of a Milton Roy CM 400 pump, a Waters C18 (particle size 4 µm) 
column, a Waters U6K injector, a Bioanalytical Systems LC-4A electrochemical 
detector (set at a holding potential of 0.75 mV and a sensitivity of 1 to 5 nA). 
The signal coming out of the detector was fed to an analogue to digital 
converter controlled by Peak Sample Chromatography System Software (Buck 
Scientific, East Northwalk, CT, USA). Identification and quantification of 
endogenous CA in tissue samples were done against external standards. In the 
case of the synthesis experiments, identification of 3H-catechols was similarly 
done against external standards, but quantification was made by collection of 
the HPLC column effluents correspondent to the peaks of interest and 
scintillation counting of the collected effluents.   
 
 
7.2.4. Endogenous release of ATP, adenosine and CA from carotid body  
The CBs were incubated in 500 µl in Tyrode containing EHNA (25 µM), 
an inhibitor of adenosine deaminase, tyrosine (20 µM), ascorbic acid (1 mM) 
and 6-methyl-tetrahydropterine (100 µM), the last two substances being 
cofactors of dopamine-β-hydroxylase and tyrosine hydroxylase, respectively. 
The incubation mediums were kept at 37ºC and continuously bubbled with 20% 
O2/5% CO2/75% N2 saturated with water vapour, except when hypoxic stimuli 
were applied. The solutions were renewed at each fixed time, as described 
above in the protocol, and all fractions collected except in the 1st and 4th period.  
 
 5 2 31 4 6
 
Time  
(min) 
0                     15               25            35                               55             65            75
20% O2  20% O2 20% O2 20% O27% O2 2% O2 
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The collected fractions were acidified with 300 µl of PCA 3M. At the end 
of the experiment the CBs were immersed in 100 µl of PCA 3M and weighed. 
The collected fractions were kept for 10 min at 0 ºC and then centrifuged at 
12000 g for 10 min (4 ºC). The supernatant was recovered and 200 µl were 
reserved to quantify CA. The nucleotides (ATP and adenosine) were also 
extracted from the supernatant as described in Section 3.2.6.. Endogenous CA 
release was quantified by HPLC with electrochemical detection (Section 7.2.4), 
adenosine by HPLC with UV detection (Section 3.2.7) and ATP by a 
bioluminescence luciferin-luciferase assay (Section 7.2.5.). 
 
 
7.2.5. Quantification of ATP by bioluminescence luciferin-luciferase assay 
 For ATP quantification 100 µL of the samples were added to 100 µL of 
luciferin-luciferase (FLE50, Sigma) and to 2 mL of buffer (in mM: HEPES 20; 
MgCl2 25; Na2HPO4 5). The reaction begins when the enzyme is added to the 
mixture. The samples were analysed in triplicate for 1 minute by 
bioluminescence using a luminescence counter (Beckham). Quantification of 
endogenous ATP released by CB was done against external standards. 
 
 
7.2.6. Western blot analysis of tyrosine hydroxylase expression in the 
carotid body  
 CBs and SCGs were homogenized in Zurich medium (Tris-HCl 10 mM; 
EDTA 1 mM; NaCl 150 mM; Triton X-100 1%; Sodium cholate 1%; SDS 0.1%) 
and a cocktail of protease inhibitors. Protein concentrations of the homogenates 
were measured by a Micro-BCA protein Assay (Pierce, Spain). Samples of the 
homogenates and the pre-stained molecular weight markers (Precision, 
BioRad, Spain) were separated by SDS-Page (10% with a 5% concentrating 
gel) under reducing conditions and electro-transferred to polyvinylidene 
difluoride membranes (0.45 µM, Millipore, Spain). After blocking for 1 hour at 
room temperature with 5% milk in Tris-buffer saline, pH 7.4 containing 0.01% 
Tween 20 (TTBS) (BioRad, Spain), the membranes were incubated overnight at 
4 ºC with a mouse anti-TH (1:20000, Abcam, Cambridge, UK). After 3 washing 
periods of 10 min with TTBS the membranes were incubated with anti-mouse 
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HRP (1:10000, Sta Cruz Biotechnology, USA) in TTBS for 1 hour at room 
temperature. After 3 washes of 10 min with TTBS the membranes were 
incubated with enhanced chemiluminescence (ECL, Sta Cruz Biotechnology, 
USA). The density of the bands on Western blots was quantified by a PDI 
Scanner and by Origin 7.0.   
The membranes were then re-probed and tested for ß-actin 
immunoreactivity (bands in the ≈ 45 kDa region) in order to compare and 
normalise the expression of TH with the amount of protein loaded. Briefly, the 
membranes were washed several times with TTBS, and then incubated for 2 
hours at room temperature with anti-mouse ß-actin (1:5000, Sigma, Madrid, 
Spain). After 3 washing periods of 10 min with TTBS the membranes were 
incubated with anti-mouse HRP (1:10000, Sta Cruz Biotechnology, USA) as 
previously described.  
 
 
7.2.7. Recording of carotid sinus nerve activity 
The CB-CSN preparation was transferred to a recording chamber 
mounted on a dissection microscope (Nikon) and superfused (37 ºC) with 
bicarbonate/CO2 buffered saline (in mM: NaCl 120; NaHCO3 24; KCl 3; CaCl2 2; 
MgCl2 1.1; glucose 5; pH 7.40). Recordings of single or few fiberfibres of CSN 
were made as described in section Section 5.2.3.. The CSN chemosensory 
activities in response  to hypoxic and hypercapnic stimulation were achieved by 
perfusing the preparations with solutions equilibrated with gas mixtures 
containing 0% or 5% O2 + 5% CO2 + balanced N2 and 20% O2 + 20% CO2 + 
balance of N2, respectively.   
 
 
7.2.8. Whole-body plethysmographic recordings of ventilatory responses 
in response to hypoxia and hypercapnia  
Ventilation was measured in conscious freely moving rats by whole body 
plethysmography. The system (Emka Technologies, Paris, France) consisted of 
5-litre methacrylate chambers continuously fluxed (2 l/min) with controlled 
temperatures within the thermo-neutral range (22-24ºC). Tidal volume (VT; ml) 
respiratory frequency (f; breaths/min (bpm)) and minute ventilation (VE; 
 118
Functional significance of adenosine in carotid body chemoreception 
PhD thesis, Silvia Vilares Conde  
 
ml/min/Kg) were measured. Briefly, the rats were placed in the 
plethysmographic chamber and breathed room air for at least 30 min until they 
adapted to the chamber ambient and acquired a standard resting behaviour. 
Thereafter we started recording the ventilatory parameters according to the 
protocols used. For normoxic rats the protocol consisted of:  
 
 
 
 
16 2 15141 3 1 2 1 
 
 
0     10     20    30      40     50    60                               120   130        150   160    170   180  min
 
For chronic hypoxic animals the protocol consisted of: 
 
 
 
26 2 724 2 3 2 
 0        10         20       30        40                                 100      110        130        140        150    min
 
 
The numbers correspond to: 1) 20 % O2; 2) 12% O2; 3) 10% O2; 4) 7% O2; 5) 
20% O2 + 5% CO2; 6) 100% O2; 7) 12 % O2 + 5% CO2. All the gases were 
balanced with N2 and applied at a flow of 2 l/min.  
The pressure change within the chamber reflecting tidal volume (VT) was 
measured with a high-gain differential pressure transducer. Ideally the 
frequency of pressure fluctuations is identical to breathing movements; spurious 
fluctuations of the pressure due to animal movements were electronically 
rejected. The amplitude of the pressure oscillations is proportionally related to 
VT; a calibration of the system by injections of 0.2 to 0.5 ml air into the chamber 
allowed a direct estimation of VT. Pressure signals were fed to a computer for 
visualisation and storage for later analysis with EMKA software.  
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7.2.9. Drugs and chemicals 
6-methyl-tetrahydropterine, ascorbic acid, adenosine, ATP, caffeine and 
dopamine were obtained from Sigma (Sigma-Aldrich, Madrid, Spain). 3H-
tyrosine was obtained from Amersham (Madrid, Spain). Adenosine, ATP and 
dopamine were prepared as 5 mM stock solutions in water. The monoclonal 
tyrosine hydroxylase antibody was purchased from Abcam (Cambridge, UK) 
and the mouse antibody ß-actin from Sigma (Madrid, Spain). The horseradish 
peroxidase (HRP)-conjugated anti-mouse IgG was purchased from Santa Cruz 
Biotechnol (USA).  
 
 
7.2.10. Data analysis 
The amount of CA, ATP and adenosine endogenously released from 
CBs was expressed in pmol/mg tissue after the division of the absolute values 
obtained by four (four CBs used in each incubation) and corrected for the 
volume used and the medium weight of the 4 CBs. Data were evaluated using 
Graph Pad Prism Software, version 4 and were presented as mean ± SEM. The 
significance of the differences between the means was calculated by One and 
Two-Way Analysis of Variance (ANOVA) with Dunnett’s and Bonferroni multiple 
comparison tests, respectively. P values of 0.05 or less were considered to 
represent significant differences. The density of the bands on Western blots 
was quantified by a PDI Scanner and by Origin 7.0. 
 
 
7.3. Results 
 There was a stable intake of caffeine throughout the experiment in rats 
chronically exposed to caffeine and chronically exposed to both caffeine and 
hypoxia. The caffeine was added in the drinking water at a concentration of 1 
mg/ml. The daily caffeine intake was 82.01 ± 6.34 (mg/rat/day) in rats exposed 
for 2 weeks to normoxia with chronic caffeine ingestion, and 79.37 ± 2.04 
(mg/rat/day) in rats chronically exposed for 2 weeks to caffeine and hypoxia. 
Water consumption in control groups was similar to caffeine-drinking rats and 
the rats presented comparable weights. These values of caffeine are 
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comparable to those described for caffeine consumption in rats with similar 
chronic caffeine treatment (Gasior et al., 2002; da Silva et al., 2003; Karcz-
Kubicha et al., 2003). 
At the outset of the results we would like to mention that in normoxic rats 
all the experimental basal levels were considered levels in response to 20% O2. 
For chronically hypoxic rats we performed all the control experiments (basal 
levels) in 12% O2, since the animals were maintained for 8 (for 
plethysmographic recordings) or 15 days in an atmosphere of 12% O2.  The 
gases were mixed with 5% CO2 if the experiments were performed in vitro.  
We would like to mention that, in an attempt to explain some of the 
differences between the results in chronic hypoxia and chronic hypoxia plus 
chronic caffeine in the CA dynamics, and since the weights of the CBs in these 
conditions vary so much, we have also expressed all graphs as pmol/CB 
obtaining the same profiles of variation with the same significances. We chose 
to represent all graphs as pmol/mg tissue.  
 
 
7.3.1. Effect of chronic caffeine intake on carotid body and superior 
cervical ganglion weight in control and chronic hypoxic rats 
Figure 46A shows the effect of chronic hypoxia, chronic caffeine intake, 
and the effect of caffeine intake on rats submitted to chronic hypoxia, on the CB 
weight. In 16 control CBs (normoxic animals) the mean CB weight was 49.94 ± 
2.95 µg, this value being very similar to that previously described by Conde et 
al. (2006a). The value found for control CBs was not different to that of 
normoxic rats submitted to chronic caffeine treatment (50.07 ± 4.81 µg; n = 15). 
Chronic hypoxia doubled the weight of rat CB, reaching weights of 98.79 ± 4.55 
µg (n= 14). Interestingly, the animals that were submitted to both treatments, 
chronic hypoxia and chronic caffeine intake, presented CB weights smaller than 
the chronically hypoxic ones, 67.80 ± 5.01 µg (n= 15), suggesting that caffeine 
can reverse or prevent the enlargement of CB produced by chronic hypoxia.  In 
order to investigate if these modifications produced by chronic hypoxia and by 
chronic hypoxia applied conjunctly with chronic caffeine intake were specific of 
the CB, we also weighed the SCGs of the same animals, and we observed that 
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none of the treatments, nor the application of both conjunctly modified the 
weight of SCGs (Figure 46B). 
 
 
A B 
   
Figure 46 Effect of chronic caffeine intake, chronic hypoxia and both treatments jointly 
applied, on the weight of CBs (A) and SCGs (B). Data represent means ± SEM. 
*P<0.05;***P<0.001; One - Way ANOVA with Bonferroni multi-comparison test. N – 
normoxic rats, NC - normoxic submitted to chronic caffeine intake, H – chronic hypoxic 
rats, HC – chronic hypoxic rats submitted to chronic caffeine intake. 
 
 
7.3.2. Effect of chronic caffeine intake on CA content of the carotid body 
in control and chronic hypoxic rats 
Figure 47 shows the mean content of CA, DA and norepinephrine (NE), 
in CB of the rats of the different groups; data are expressed as pmol/mg tissue. 
Mean DA content in control CB (Group N) was 311.1 ± 57.60 pmol/mg tissue (n 
= 10) (Figure 47A). Chronic caffeine intake in normoxic rats did not modify the 
DA content (322.3 ± 32.76 pmol/mg tissue, n = 8) in the CB.  
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Figure 47 Effects of chronic caffeine 
intake, chronic hypoxia and both 
treatments applied together on the 
content of catecholamines and 
dopamine (DA)/norepinephrine (NE) 
ratios. A and B show absolute levels 
of DA and NE in the CBs of the distinct 
groups (N - normoxic rats, NC - 
normoxic rats plus chronic caffeine, H 
- chronic hypoxic rats, HC- chronic 
hypoxic rats with chronic caffeine 
ingestion. C shows that the DA/NE 
ratios increased only when the 2 
chronic treatments were applied 
conjunctly. The dihydroxyphenyl acetic 
acid (DOPAC) content of the CB was 
included to estimate the ratios as it is 
the only CA catabolite present in 
significant amounts. Data represent 
means ± SEM of n individual values 
given in the drawing. One - Way 
ANOVA with Bonferroni multi-
comparison test; *p<0.05, **p<0.01, 
***p<0.001 corresponds to comparison 
made between the normoxic group 
and all the other groups. ## P<0.01 
comparisons made between group H 
and group HC 
 
 
 
 
 
 
B 
C
A
 
Exposure of rats to chronic hypoxia for 15 days increased the DA content 
of CB by 126.8%, reaching a value of 705.7± 54.42 pmol/mg tissue (n =8). 
When rats were treated with both paradigms (group HC) the DA content 
increased respectively 228.2% and 44.7% when compared with normoxic rats 
and with chronic hypoxic rats (Figure 47A).  
In all chromatograms a small amount of dihydroxyphenyl acetic acid 
(DOPAC, the main catabolite of DA), representing between 0.5 and 2% of the 
DA, was also detected (not shown) and was added to DA to calculate the ratio 
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(DA+ DOPAC/NE) (Figure 47C). NE levels were similar in normoxic rats and in 
the group NC with contents of 88.99 ± 13.03 pmol/mg tissue and 92.84 ± 5.9 
pmol/mg tissue, respectively (Figure 47B). Chronic hypoxia also increased the 
levels of NE to 207.8 ± 14.58 pmol/mg tissue. However, contrary to DA, the 
exposure to both paradigms (group HC) did not cause significant statistical 
changes in NE levels when compared with group H. Figure 47C shows mean 
(DA+DOPAC)/NE ratios in all paradigms. It is evident that the rat CB is a 
dopaminergic organ in all paradigms studied, and that the dopaminergic quality 
increases when rats are exposed to chronic hypoxia conjunctly with chronic 
caffeine intake. Thus, in the CBs of the control animals the (DA+DOPAC)/NE 
ratio was 3.96 ± 0.32, this ratio being significantly increased and reaching 
values of 6.53 ± 0.42 in the organs of rats exposed to chronic hypoxia and 
chronic caffeine. 
 
 
7.3.3. Effect of chronic caffeine intake on CA synthesis and CA turnover 
time in the carotid body of control and chronic hypoxic rats 
The rate of 3H-CA synthesis in CB of rats exposed to the different 
paradigms as well as the amount of free 3H-tyrosine present in the tissue and 
the amount of 3H-tyrosine incorporated into proteins, and the turnover time of 
DA and NE are shown in Figure 48. The rate of synthesis was calculated as 
described in Section 7.2.3. and the turnover time was estimated by dividing 
endogenous content by the rate of CA synthesis (i.e. pmol/CB)/[(pmol/CB)/hour] 
or pmol/mg tissue/[(pmol/mg tissue)/hour].  The rate of 3H-NE synthesis in 
control CB was 1.82 ± 0.32 (n = 8) pmol/mg tissue/hour. In groups NC and H, a 
small, non-significant tendency to decrease to values of 1.27 ± 0.17 (n = 7) and 
1.22 ± 0.19 (n = 6), respectively can be observed. In the group HC, the value 
shows a clear tendency to increase, reaching rates of 2.65± 0.36 (n = 8) 
pmol/mg tissue/hour in the CB, that was not significantly different from the 
control group (N), but was statistically different from group H.  
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Figure 48 Effect of chronic 
caffeine intake, chronic 
hypoxia and both on (A) 
the synthesis rate of 
catecholamine (CA), and 
accumulation of the natural 
precursor tyrosine and (B) 
turnover time in the CB in 
normoxic animals (N) and 
in rats submitted to 
different paradigms 
(normoxic rats with chronic 
caffeine intake – NC; 
chronic hypoxic rats – H; 
chronic hypoxic rats with 
chronic caffeine intake – 
HC). ***P<0.01 Normoxic 
rats vs. all other paradigms; 
group vs. HC. Two-Way 
ANOVA with Bonferroni 
multi-comparison test. Data 
represent means ± SEM of 
n individual values given in 
the drawing.  
  
B
##P<0.01,###P<0.001 H 
 
 
 similar pattern was noticeable with the rate of appearance of 3H-
DOPA
 
A
C and with the incorporation of free 3H-tyrosine into the tissue. The 
pattern for the rate of synthesis of 3H-DA was different since chronic hypoxia 
induced a statistically significant increase of 85.8%, reaching a value of 58.81 ± 
5.06 pmol/mg tissue/hour (n = 6). The application of chronic caffeine conjunctly 
with chronic hypoxia produced a further increase in the rate of synthesis of 3H-
DA to a value of 118.58 ± 11.8 pmol/mg tissue/hour relative to control value and 
to the value of group H. In Figure 48B we present the turnover time for DA and 
NE with all paradigms. While, in the case of DA, no significant changes in the 
turnover time were observed, being around 9-12 h in all conditions tested, in the 
case of NE there was a statistically significant increase in the NE turnover time 
with chronic hypoxia exposure: in control CBs (group N) the turnover time was 
52 h and in group H it reached 171 hours (p < 0.001). The application of the 
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both treatments together, chronic hypoxia and chronic hypoxia plus chronic 
caffeine return the NE turnover time to a value similar to the control (66 hours).  
 
 
7.3.4. Effect of chronic caffeine intake on CA content, CA synthesis and 
CA turnover time in superior cervical ganglia of control and chronic 
hypoxic rats 
To investigate whether these alterations observed in the CA metabolism: 
content, synthesis and turnover time, and in the (DA+DOPAC)/NE ratio were 
specific to the CB, we performed the same experiments in SCGs in the same 
experimental conditions.  
Figure 49 shows mean contents of CA, DA and NE in SCGs and the ratio 
(DA+DOPAC)/NE in control rats (group N) and in rats exposed to chronic   
hypoxia, chronic caffeine or both. Figure 49A and B shows that exposure to 
chronic hypoxia did not modify the levels of DA and NE in the SCG. In the same 
manner, the exposure to both paradigms conjunctly (group HC) did not modify 
the levels of both CA when compared with groups N and H.  
 
 
A B C
 
Figure 49 Effects of chronic caffeine intake (NC), chronic hypoxia (H) and both 
treatments (HC) on the content of catecholamines (CA) and on dopamine 
(DA)/norepinephrine (NE) ratios in SCGs. A and B represent absolute levels of DA and 
NE in the SCGs. N - normoxic rats. C  DA/NE ratios for the different paradigms. The 
dihydroxyphenyl acetic acid (DOPAC) content of the SCG was included to estimate the 
ratios as it is the only CA catabolite present in significant amounts. Data represent 
means ± SEM of n individual values given in the drawing. @P<0.05, corresponds to 
comparison between the NC group and all the other groups; One-way ANOVA with 
Bonferroni multi-comparison test. 
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The exposure to a chronic caffeine treatment in normoxic rats produced a 
decrease in both DA and NE levels in SCGs that was not statistically different 
from the controls, but was significantly different from the values in groups H and 
HC. Figure 49C shows the (DA+DOPAC)/NE ratios in SCGs in response to all 
paradigms. It can be observed that SCG is preferentially a noradrenergic organ, 
and that the exposure to chronic hypoxia, chronic caffeine or both treatments 
applied together does not modify the (DA+DOPAC)/NE ratios. 
The 3H-CA rate of synthesis and the turnover time for NE and DA in 
SCGs in all paradigms is represented in Figure 50. The chronic intake of 
caffeine did not modify the rate of synthesis of either NE or DA (Figure 50A), but 
produced an increase in the turnover time of NE and decreased the DA turnover 
time (Figure 50B).  
Chronic hypoxia exposure as well as the intake of caffeine conjunctly 
with chronic hypoxia did not modify either the rate of synthesis of DA or NE, or 
the turnover time of DA in SCGs. However, both paradigms increased the 
turnover time of NE (Figure 50A and B). The absence of significant alterations 
in the DA metabolism in SCGs in all the experimental conditions tested would 
indicate that the alterations in DA metabolism produced by chronic hypoxia and 
by the ingestion of caffeine during chronic hypoxia are characteristic of CB. 
 
A B
Figure 50 Effects of chronic caffeine intake (NC), chronic hypoxia (H) and both 
treatments (HC) on (A) the synthesis rate of catecholamines (CA), and accumulation of 
the natural precursor tyrosine and (B) turnover time in the SCGs in normoxic animals 
and in rats submitted to the different paradigms. *P<0.05, ***P<0.01 Normoxic rats vs. 
all other paradigms; ##P<0.01, ###P<0.001 H group vs. HC. Two-Way ANOVA with 
Bonferroni multi-comparison test. Data represent means ± SEM of n individual values 
given in the drawing. 
 
 127
Functional significance of adenosine in carotid body chemoreception 
PhD thesis, Silvia Vilares Conde  
 
 
7.3.5. Effect of chronic caffeine intake on DA, ATP and adenosine release 
evoked by acute hypoxia, from carotid body in control and chronic 
hypoxic rats 
 Figure 51 illustrates the effects of chronic caffeine intake, chronic hypoxia 
and both treatments applied together on the basal release of endogenous DA, 
ATP and adenosine from rat CB.  In the protocol used to study the effect of 
acute hypoxia on the release of these neurotransmitters, in addition to the 
periods correspondent to hypoxic stimulus application, we incubated the CBs 
for 4 periods of 10 min in 20% O2 or 12% O2 respectively, depending on 
whether the rats were normoxic or hypoxic (control values), and decided to 
selected the second period of 20% O2 or 12% O2 (C1, period 2 of the protocol 
described in Section 7.2.3) to calculate the basal release of these 
neurotransmitters, since the first one is considered a recovery period that allows 
CBs to recover from the surgery. 
Figure 51A shows that chronic hypoxia increased the basal release of DA 
from rat CB by 145.9% relative to the control value (49.47 ± 6.52 pmol/mg 
tissue, n = 6). Chronic caffeine intake did not modify the basal release of DA 
from the CB either in normoxic rats or in chronic hypoxic rats. 
A different pattern was noticeable for the effect of chronic caffeine intake 
on the release of ATP from the CB of normoxic and chronic hypoxic rats (Figure 
51B). Basal value of ATP released from CB in normoxic rats was 81.55 ± 13.71 
pmol/mg tissue (n = 6). A tendency to increase to a value of 108.40 ± 8.01 
pmol/mg tissue (n = 8) was observed for ATP basal release in normoxic rats 
submitted to chronic caffeine ingestion. Nevertheless this increase was not 
significant. Chronic hypoxia did not modify the basal release of ATP from rat 
CB, and this treatment applied in conjunction with chronic caffeine intake was 
also incapable of modifying ATP basal release (Figure 51B).  
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Figure 51 Effects of chronic caffeine intake (NC), chronic hypoxia (H) and effect of 
both treatments applied together (HC) on the basal endogenous release of DA (A), 
ATP (B) and adenosine (C) from rat CBs in comparison with normoxic (N) animals (n = 
6). NC (n = 7); H (n = 5); HC (n = 6). Note that basal release corresponds in normoxic 
rats to the release in response to 20% O2 and in chronic hypoxic animals to the release 
in response to 12% O2. *P<0.05, ***P<0.01 Normoxic rats vs. all other paradigms. One-
Way ANOVA with Bonferroni multi-comparison test. Data represent means ± SEM. 
 
The pattern of basal adenosine release contrasts with the release of DA 
and ATP (Figure 51C). Chronic caffeine intake in normoxic rats did not modify 
the basal release of adenosine when compared with control rats (220.6 ± 26.15 
pmol/mg tissue, n = 6 vs. 220.0 ± 224.05 pmol/mg tissue, n = 7). However, 
chronic hypoxia exposure decreased the release of adenosine from the CB by 
51.7 %. The chronic caffeine intake applied conjunctly with chronic hypoxia did 
not modify the basal levels of adenosine present in extracellular medium 
relative to the levels found in group H.  
Figures 52, 53 and 54 show the effects of acute hypoxia on the release 
of DA, ATP and adenosine in control CB and in CB submitted to the different 
paradigms. Note that the basal release of DA diminished from C1 to C2 (see 
experimental protocol in Section 7.2.4., i.e. after the 1st acute hypoxic stimulus 
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in all the experimental conditions studied. In contrast, the levels of adenosine 
and ATP released in basal conditions were similar in C1 and C2.  
 
 A B 
Figure 52 Effects of chronic caffeine intake (NC and HC) on the endogenous release 
of dopamine (DA) from CB in response to acute hypoxia (7% and 2% O2) in rats 
submitted to (A) normoxia (N and NC) and (B) chronic hypoxia (H and HC). C1 and C2 
represent basal values before the application of the acute hypoxic stimulus, 
corresponding to the release of DA from CB in response to 20% O2 in normoxic rats 
and 12% O2 in chronic hypoxic rats. N (n = 6); NC (n = 7); H (n = 5); HC (n = 6). * 
P<0.05, **P<0.01; Two-Way ANOVA with Bonferroni multi-comparison test 
corresponding to the comparison with C1 or C2.  
  
 
Concerning the release of endogenous DA in response to acute hypoxia, 
it can be observed that 7% O2 produces a statistically significant increase of 
72.1% and 43.4 % in the release of DA from CB of both control rats (80.00 ± 
19.1 pmol/mg tissue) and rats exposed to chronic hypoxia (157.8 ± 30.41 
pmol/mg tissue), respectively. However, chronic caffeine intake produced higher 
statistically significant increases of 125.8% and 64.6% in the DA released from 
CB in normoxic and chronically hypoxic rats in response to 7% O2 (Figure 52A 
and B). In response to a more intense hypoxic stimulus, 2% O2, chronic hypoxic 
exposure does not modify the increase in the release of DA from CB when 
compared with control values (123.36% increase in controls vs. 119.17% 
increase in chronic hypoxic rats).  
The treatment with chronic caffeine did not alter the release of DA 
evoked by 2% O2 in control rats and in rats exposed to chronic hypoxia (Figure 
52B). These results are in agreement with the acute effects of caffeine on 
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peripheral chemoreceptors described in Chapter 3 and suggest that caffeine 
and thereby adenosine receptors are involved in the response to moderate 
hypoxias, that is, hypoxias that are compatible with life. 
The effects of chronic caffeine intake and chronic hypoxia on the release 
of ATP evoked by acute hypoxia (7% and 2% O2) are represented in Figure 53A 
and B. It can be observed that moderate (7% O2) and intense hypoxia (2% O2) 
increase the release of ATP from the CB of control rats by 73.0% and 88.1%, 
respectively. Chronic caffeine ingestion did not modify the evoked release of 
ATP from rat CB in any of the hypoxias studied, increasing the release in 
response to 7% O2 by 68.9% and in response to 2% O2 by 77.5 % (Figure 53A).  
 
 
A B
 
Figure 53 Effects of chronic caffeine intake (NC and HC) on the release of ATP from 
CB in response to acute hypoxia (7% and 2% O2) in rats submitted to (A) normoxia (N 
and NC) and to (B) chronic hypoxia (H and HC). C1 and C2 represent basal values 
before the application of the acute hypoxic stimulus, corresponding to the release of 
ATP from CB in response to 20% O2 in normoxic rats and 12% O2 in chronically 
hypoxic rats. N (n = 6); NC (n = 7); H (n = 5); HC (n = 6).  * P<0.05, **P<0.01; Two-
Way ANOVA with Bonferroni multi-comparison test corresponding to the comparison 
C1 or C2. Data represent means ± SEM.  
 
The pattern of ATP release induced by acute hypoxia was very distinct in 
CBs from rats submitted to 15 days of chronic hypoxic exposure. As can be 
observed in Figure 53B, neither 7% O2 nor 2% O2 were sufficient stimuli to 
evoke a significant release of ATP from CB in chronic hypoxic rats, suggesting 
that ATP is not a crucial neurotransmitter for the response to acute hypoxia 
during chronic hypoxic exposure. Chronic caffeine ingestion during chronic 
hypoxia exposure revert the effect of chronic hypoxia on the release of ATP 
 131
Functional significance of adenosine in carotid body chemoreception 
PhD thesis, Silvia Vilares Conde  
 
evoked by acute hypoxic stimulus (Figure 53B). Acute 7% O2 and 2% O2 
induced an increase of 96.2% and 63.6% in ATP release from CB of rats 
treated with chronic caffeine during hypoxic exposure.  
Figure 54 are illustrates the effects of chronic hypoxia and chronic 
caffeine intake and both paradigms applied together on the release of 
adenosine from CB evoked by 2 acute hypoxias of distinct intensity, 7% and 2% 
O2. It can be observed, as previously described by Conde and Monteiro (2006) 
in controls rats, that moderate hypoxias release more adenosine than high 
intensity hypoxias, the values not having any statistical difference (Figure 54A). 
Nevertheless, it can be observed that in chronic hypoxic conditions the increase 
in adenosine release from CB is proportional to the intensity of acute hypoxia 
applied (Figure 54B).  
 
 
A B
 
Figure 54 Effects of chronic caffeine intake (NC and HC) on the release of adenosine 
from CB in response to acute hypoxia (7% and 2% O2) in rats submitted to (A) 
normoxia (N and NC) and to (B) chronic hypoxia (H and HC). C1 and C2 represent 
basal values before the application of the acute hypoxic stimulus, corresponding to the 
release of adenosine from CB in response to 20% O2 in normoxic rats and 12% O2 in 
chronic hypoxic rats. N (n = 6); NC (n = 7); H (n = 5); HC (n = 6) * P<0.05, **P<0.01; 
Two-Way ANOVA with Bonferroni multi-comparison test corresponding to the 
comparison with C1 or C2. Data represent means ± SEM.  
 
As can be observed in Figure 54B, in chronic hypoxia, CB releases more 
adenosine, in response to an acute hypoxic stimulus, than in control conditions: 
increases of 230.95% and 372.0% in the release of adenosine, in response to 
7% and 2% O2, respectively, were observed. However, these increases can be 
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due to the reduction of adenosine basal levels. Chronic caffeine intake 
produced non-significant higher increases of 100.9% and 73% in the release of 
adenosine evoked by 7% and 2% O2 from the CBs of normoxic rats. However, 
the ingestion of caffeine applied conjunctly with chronic hypoxic exposure 
produced non-significant smaller increases in the release of adenosine by the 
acute hypoxia (153.74% in response to 7% O2 and 335.88% in response to 2% 
O2) when compared with chronic hypoxic rats.  
 
 
7.3.6. Effect of chronic caffeine intake on tyrosine hydroxylase expression 
in the carotid body of control and chronic hypoxic rats 
 The mRNA coding for TH is upregulated in CB chemoreceptor cells 
within the first few hour of hypoxia (Czyzk-Krzeska et al., 1992) increasing 
approximately 3 times in the CB with chronic hypoxia exposure (Wang et al., 
1998; Bisgard, 2002; Ganfornina et al., 2005). Kobayashi and Milhorn (1999) 
postulated that adenosine could modulate CB gene expression and since 
caffeine is an antagonist of adenosine receptors it would be expected that 
chronic caffeine intake as well as the application of chronic hypoxia with chronic 
caffeine in the rats would alter the expression of TH in the CB.  
We decided to use a semi-quantitative technique, Western-Blot, to study 
the effect of chronic caffeine intake on the expression of TH in the CB of 
normoxic and chronic hypoxic rats.  
As illustrated in Figure 55, using mouse anti-TH antibody, and expressing 
the TH immunoreactivity relative to the immunoreactivity to ß-actin, we found 
that chronic caffeine intake induced a non-significant statistical increase in TH 
expression in normoxic CBs (P = 0.1). It can be observed that chronic hypoxia 
increased the TH expression in the CB 2.8 times, which is in agreement with the 
data previously found by Wang et al. (1998). Ingestion of caffeine during the 
chronic hypoxia exposure produced a higher increase (3.3 times) relative to the 
controls, but not significantly different from the value obtained in chronic 
hypoxia. These results demonstrate that chronic caffeine did not induce 
significant alterations in the expression of TH in either normoxic or chronic 
hypoxic rats. 
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Figure 55 Tyrosine hydroxylase (TH) immunoreactivity in the CB and in SCGs in 
control rats (N) and in rats submitted to different treatments: chronic caffeine intake 
(NC), chronic hypoxia exposure (H) and chronic caffeine + chronic hypoxia (HC). A 
Western Blot comparing TH immunoreactivity, corresponding to 60 KDa band, when 
comparing CBs and SCGs (controls and submitted to different paradigms). A re-
probing of the membranes with an anti-ß-actin antibody, corresponding to the 42 KDa 
band is shown below the gel for TH. B shows the average relative TH immunoreactivity 
in the CB (n= 3) in the different paradigms expressed in relation to ß-actin 
immunoreactivity. ** P<0.01; One-Way ANOVA with Dunnett’s multi-comparison test, 
comparing all the groups with control group. Data represent means ± SEM. 
 
 
7.3.7. Effects of chronic caffeine intake on carotid sinus nerve activity 
evoked by hypoxia and hypercapnia in control and chronic hypoxic rats  
The next group of experiments was designed to study the effect of 
chronic caffeine intake, chronic hypoxic exposure and both paradigms applied 
together on the overall output of the CB measured as CSN chemosensory 
activity. Figure 56 illustrates the results obtained in all the experimental 
conditions cited above. Although it is not evident from Figure 56 A and B that 
chronic hypoxia increased the basal CSN chemosensory activity, mean basal 
CSN chemosensory activity increased 80.64% with chronic hypoxia exposure 
(Figure 56C). Chronic caffeine intake did not modify the basal CSN 
chemosensory activity in either normoxic or chronic hypoxic animals (Figure 
56C). Mean basal activity for each paradigm was: control - 5.42 ± 0.81 
impulses/s; normoxic rats with chronic caffeine ingestion – 5.10 ± 0.66 
impulses/s; chronic hypoxic rats – 9.76 ± 0.89 impulses/s; chronic hypoxic rats 
with chronic caffeine ingestion – 8.76 ± 0.61 impulses/s. 
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In order to correct the activity of CSN in response to any given stimulus, 
the activity was expressed as times over basal.  
At the onset of this section we would like to mention that the values of % 
of O2 in the recordings of the CSN activity do not correspond to the values of O2 
for the in vitro experiments. This difference is based on the exchange of gases 
that exists between the superfusion medium and the atmosphere in the opened 
chamber where the CSN activity is recorded. For example, 2% O2 corresponds 
to a PO2 of ≈ 22 mmHg, but Tyrode solution equilibrated with 0% O2 in the 
superfusion chamber is at a PO2 of ≈ 25 mmHg (Conde et al., 2006a).    
Figure 56D shows that exposure to chronic hypoxia did not modify the 
activity of CSN in response to moderate and intense hypoxia, 5% and 0% O2, 
respectively, but the response to hypercapnic-acid stimulus (20% CO2, pH = 
6.8) was significantly reduced by 49%. It can be observed that chronic caffeine 
intake in normoxia produced a tendency to augment the responses to hypoxia, 
inducing non-significant increases of 25.5% and 33.6% in the activity of CSN in 
response to moderate and intense hypoxia, 5% and 0% O2, respectively.  
However, treatment with chronic caffeine does not modify the CSN 
chemosensory activity induced by hypercapnia. Chronic caffeine applied 
conjunctly with chronic hypoxia clearly attenuates the CSN chemosensory 
responses both to hypoxia and to hypercapnia.  
As can be observed in Figure 56D the application of both paradigms 
significantly reduces the response to 5% O2, by 61.2% and 55.0% in relation to 
normoxic and chronic hypoxic rats, respectively. CSN chemosensory activity in 
response to 0% O2 was significantly inhibited by 66.8% and 61.9% when 
compared with normoxic and chronic hypoxic rats. The response to hypercapnia 
was almost completely abolished, the values being reduced by 87.2% and 
75.2% in comparison to normoxic and chronic hypoxic rats. These results 
indicate that chronic application of caffeine also has an inhibitory effect on CSN 
activity that is even higher in chronic hypoxic rats than when applied acutely in 
normoxic rats.  
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Figure 56 Effects of chronic caffeine intake on the carotid sinus nerve (CSN) activity in 
normoxic and chronic hypoxic rats. A) Typical recording of the frequency of action 
potentials of CSN in response to N2 in normoxic and chronic hypoxic rats. B) Typical 
recording for the effect of chronic caffeine ingestion on the frequency of actions 
potentials of CSN in response to N2 in chronic hypoxic rats. Arrows indicate the period 
of application of acute hypoxic stimulus (N2). Panels C, D, E and F represent, 
respectively, means of basal CSN activity, means of increases in peak frequencies, 
latency times and time to peak in control rats (N), in normoxic rats with chronic caffeine 
ingestion (NC), in rats exposed to chronic hypoxia (H) and in chronic hypoxic rats after 
chronic caffeine ingestion (HC). Data represent means ± SEM of n individual values 
given in the drawing. *P<0.05, **P<0.01, ***P<0.001 vs. control values; #P<0.05, 
##P<0.01 vs. chronic hypoxic values 
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For each given stimulus we also measured the latency of the response 
and the time to peak response. The latencies range from 15 to 22 sec for 
moderate hypoxia, 13 to 25 sec for intense hypoxia and from 12 to 20 for 
hypercapnia (Figure 56E). The times to peak ranged between 35 and 56 sec in 
moderate hypoxia, 48 and 63 sec in intense hypoxia and 27 and 54 sec in 
hypercapnia (Figure 56F). No statistical differences in these two parameters 
were found between all the paradigms studied. 
 
 
7.3.8. Effects of chronic caffeine intake on the ventilatory responses 
induced by hypoxia and hypercapnia in control and chronic hypoxic rats 
 The next group of experiments was designed to assess the effect of 
chronic caffeine intake on the ventilatory responses (frequency, tidal volume 
and minute volume) to hypoxia and hypercapnia in control and chronic hypoxic 
rats.  
 Since some controversies exist about the sensitisation phenomena and 
the period of time to its appearance (see Introduction) we decided to study the 
ventilatory responses to hypoxia and hypercapnia in rats submitted to 8 and 15 
days of chronic hypoxia.  
In figure 57A we can observe that in control animals the breathing 
frequency increased with increasing intensity of hypoxia (12% and 10% O2), 
except for the highest hypoxic intensity (7% O2) tested, where a small reduction 
in the response can be seen. The same pattern was observed with exposures 
of 8 and 15 days to chronic hypoxia although breathing frequencies in 12% O2 
decreased with the increasing time of hypoxic exposure. At 8 days of hypoxic 
exposure the breathing frequency decreased significantly by 19% in 12% O2 
compared with the control response for the same hypoxic intensity (128.17 ± 
3.75 bpm); at 15 days of hypoxia the response diminished significantly by 33% 
to a value of 86.22 ± 1.78 bpm, these values being very similar to those 
obtained in the control rats in 20% O2 (84.91 ± 1.73 bpm). The breathing 
frequencies in response to acute hypoxia of 10% and 7% O2 in rats exposed to 
8 days of hypoxia were not significantly modified when compared with the same 
responses in control rats. However, a clear tendency towards an increase in the 
breathing frequency in response to 7% O2 was observed (Figure 57A), 
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suggesting an increased sensitivity to high intensity acute hypoxias in the rats 
exposed to 8 days of chronic hypoxia. As can be seen in Figure 57B, the tidal 
volume in the several O2 intensities tested does not change significantly in any 
of the paradigms i.e. after 8 or 15 days of hypoxic exposure, although, with 
chronic hypoxia, a tendency towards an increase in response to acute hypoxic 
challenges, mainly after 15 days, can be observed. When the ventilatory 
responses are analysed in terms of minute volume (VE) (Figure 57C) and 
corrected to the rat’s weight, the non-significant increases in acute hypoxia 
observed in tidal volume became significant.  
Basal values for chronic hypoxic animals (values during 12% O2) are 
even higher (773.93 ± 56.61 (ml/min)/kg) than the value of VE for normoxic rats 
in response to the same hypoxic challenge (702.52 ± 29.09 (ml/min)/kg). It can 
also be noted that the pattern of increase in minute ventilation with the 
increasing hypoxic intensity observed in control rats was not modified in any of 
the chronic hypoxias tested (8 and 15 days), being even more accentuated in 
both chronic hypoxias. Therefore, we can say that chronic hypoxic rats showed 
an increase in ventilation in both basal conditions and in response to acute 
hypoxia. Concerning the response to acute hypercapnia, rats exposed to 8 days 
of hypoxia exhibited a statistically significant increase of 46.7% in minute 
ventilation when compared to control rats (1081 ± 62.35 (ml/min)/kg, n = 14). 
However, exposure to 15 days of hypoxia reverted this sensitisation to a value 
of 1253 ± 108.7 (ml/min)/kg (n = 10).   
All these data taken together suggest that acclimatisation of the 
chemoreceptors to hypoxia was already apparent after 1 week of chronic 
hypoxia but was more accentuated after 2 weeks, as hypoxic ventilatory 
response is increased at this period of time (Figure 57C).  
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Figure 57 Effect of 8 and 15 days exposure to hypoxia (12% O2) on the ventilatory 
responses to acute hypoxia (10 and 7% O2) and hypercapnia (5% CO2). Ventilatory 
responses to acute hypoxia were assessed as (A) frequency, (B) tidal volume and (C) 
minute volume (VE). D) Effect of acute application of hypercapnia on minute ventilation 
in control rats and in rats exposed to 8 and 15 days of hypoxia. Acute hypoxias and 
hypercapnia were applied for 10 minutes in accordance with the protocols described in 
Section 7.2.8. Minute volume values were corrected to the rat’s weights. *P<0.05 vs 
control values; #P<0.05 8 days hypoxic exposure vs. 15 days of hypoxic exposure. 
Data represent means ± SEM. 
 
The fact that caffeine is an active substance widely consumed across the 
world, and that at concentrations ingested by humans it antagonises adenosine 
receptors, led us to study the effect of chronic caffeine intake on ventilation in 
control and chronic hypoxic animals. The effect of chronic caffeine intake was 
studied in the ventilatory responses to several hypoxic intensities, 12%, 10% 
and 7% O2 in normoxic rats and 10% and 7% O2 in rats submitted to a 
atmosphere of 12% O2 (12% O2 in chronically hypoxic animals is considered the 
basal value) and in response to acute hypercapnia, 5% CO2. In normoxic rats, 
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chronic caffeine intake during 8 days did not produce any alterations in the 
pattern of hyperventilation in response to acute hypoxias, when compared with 
control rats (Figure 58A). Chronic ingestion of caffeine for 15 days in normoxic 
rats seems to follow the same pattern except for a facilitation of the response to 
a high intensity hypoxia, 7% O2, with the chronic caffeine intake producing a 
significant increase of 34.8% in minute ventilation, when compared with the 
same response to 7% O2 in control rats (Figure 58A). This result means that 
chronic caffeine intake can facilitate the ventilatory responses to high intensity 
hypoxias in normoxic subjects. In animals that were exposed to an atmosphere 
of 12% O2 for 8 or 15 days, the chronic intake of caffeinedid not modify the 
ventilatory responses to the different acute hypoxias tested in any of the groups 
(Figure 58B). 
Figure 59 shows the effect of chronic caffeine intake (8 or 15 days) on 
the ventilatory responses to hypercapnia, 5% CO2, in normoxic rats and in rats 
submitted to 8 and 15 days of chronic hypoxia. 
 
A 
 
 
Figure 58 Effects of chronic 
caffeine intake on minute volume 
(VE) in response to acute 
hypoxias of several intensities 
(12%, 10% and 7% O2) in 
normoxic animals (A) and in 
animals submitted to chronic 
hypoxia for 8 and 15 days (B). 
Acute hypoxias were applied for 
10 minutes in accordance with     
the protocols described in 
Section 7.2.8. Basal value for 
hypoxic animals was considered 
to be the VE in 12% O2. 
**P<0.01; chronic caffeine intake 
for 15 days vs. controls. Data 
represent means ± SEM.  
B 
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It is evident that chronic caffeine (8 or 15 days) intake did not significantly 
modify minute volume either in normoxic rats (Figure 59A) or in rats exposed to 
chronic hypoxia for 8 days. Nevertheless, the intake of caffeine in rats exposed 
to an atmosphere of 12% O2 for 15 days significantly increased minute volume 
in response to acute hypercapnia by 57.9% (Figure 59B), suggesting that 
hypoxic ventilatory responses were not altered by chronic caffeine consumption 
in chronic hypoxic rats but hypercapnic ventilatory responses were. 
 
 
 
A B
  
Figure 59 Effects of chronic caffeine intake on minute volume (VE) in response to 
hypercapnia (5%CO2) in (A) normoxic rats and in (B) rats exposed to an atmosphere of 
12% O2 for 8 and 15 days. (n = 6-9) Hypercapnia was applied for 10 min in accordance 
with the protocol described in Section 7.2.8. **P<0.01; chronic caffeine intake for 15 
days vs. control. Data represent means ± SEM. 
 
 
 
7.4. Discussion  
 In this section we used a combination of neurochemical and physiological 
techniques to evaluate CB output measured as CSN chemosensory activity and 
ventilatory responses, as well as CB neurotransmitter (ATP, DA and adenosine) 
dynamics in chronic hypoxia. These methodologies allowed us to conclude that 
in chronic hypoxia: O2 sensitivity is increased; that the exposure to this 
paradigm elicits acclimatisation; and that adenosine is essential for the CB 
chemoreception in chronic hypoxia, being one of the neurotransmitters involved 
in the increased O2 sensitivity and contributing to the VAH. 
 In all the experimental protocols, chronic hypoxia was applied for a 
period of 15 days, although increases in ventilatory hypoxic response were 
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observed after an 8-day exposure to chronic hypoxia. However, our paradigm of 
15 days of chronic hypoxia was validated i.e. after this period of exposure we 
achieved an increased CB O2 sensitivity, as ventilatory hypoxic response, as 
well as CSN basal discharges in response to hypoxia, was increased. 
 The effects of chronic caffeine intake were also studied as a tool to 
evaluate the contribution of adenosine receptors/adenosine to the increased O2 
sensitivity observed in chronic hypoxia. At the outset of the discussion we 
should state that we have attributed all the effects of chronic caffeine ingestion 
during chronic hypoxia to an inhibition of adenosine receptors, since the 
concentrations of caffeine ingested are compatible with this inhibition and not 
with other cell targets (Section 1.7., Figure 14). In fact, for the inhibition of the 
other cellular caffeine targets, such as phosphodiesterases and ryanodine 
receptors, toxic doses of caffeine that are not compatible with life are needed. In 
accordance with our statements, all the effects of caffeine observed imply that, 
in all cases, they are due to an inhibition of adenosine receptors and therefore, 
in the rest of the discussion we will not make a specific distinction between the 
effects of caffeine or adenosine. 
Since nothing is known about chronic effects of caffeine on the activity of 
CB chemoreceptors, in this chapter we have used chronic caffeine consumption 
in order to permanently block adenosine receptors in the CB and to obtain a 
situation that is similar to what happens with the long-term consumption of this 
xanthine in humans, predominantly in the occidental countries (see Introduction, 
Section 1.7).  
At the onset of the discussion we would also like to mention that with the 
different experimental approaches used to measure the CB output, CSN 
chemosensory activity and ventilation, we can assess the contribution of the 
central nervous system to the responses in chronic hypoxia. We also studied 
the effects of chronic hypoxia and chronic caffeine on neurotransmitter 
dynamics. Since DA is one of the CB’s better-characterised neurotransmitters, a 
detailed characterisation of CA dynamics (endogenous release, content, 
synthesis, turnover time) in chronic hypoxia and after/with chronic caffeine 
consumption was performed in the current study. In an attempt to clarify the 
importance of ATP in chronic hypoxia as suggested by He et al. (2006) and to 
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investigate the role of adenosine in this situation, the endogenous release of 
both neurotransmitters was studied.   
In an attempt of simplify the discussion of this chapter the results are 
going to be summarised in a table and discussed as followed: 1) effects of 
chronic hypoxia 2) and the effects of chronic caffeine ingestion in control and 
chronic hypoxic animals.  
 
 
7.4.1. Effects of chronic hypoxia on CB function 
This study showed that chronic exposure to hypoxia elicits 
acclimatisation, as hypoxic ventilatory response (HVR) is increased and the 
CSN discharges, both basal and in response to acute hypoxia are higher, but 
the percentage of increase remains equal. Chronic hypoxia produced profound 
changes in CB weight, and CB CA metabolism, as well as in basal release of 
DA and adenosine in the CB, these alterations being important to the observed 
acclimatisation to chronic hypoxia (Table 8). The increased release of 
adenosine in response to acute hypoxia suggests a role for this nucleotide in 
the responses to acute hypoxic challenges during chronic hypoxic exposure 
(Table 8).  
Ventilatory acclimatisation to hypoxia (VAH) is defined as the time-
dependent increase in ventilatory responses to acute hypoxic challenges lasting 
from several hours to months (Bisgard, 1994, 1995, 2000; Powell et al., 2000a; 
Powell, 2007). After 8 and 15 days of hypoxic exposure rats were acclimatised, 
the acclimatisation being more pronounced after 15 days, as the increase in the 
HVR is higher than in rats submitted to 8 days of exposure. These results are in 
agreement with the described VAH in the rat in which breathing increases after 
some hours or days of hypoxic exposure persisting at least 14 days (Olson and 
Dempsey, 1978). These acclimatisation phenomena were also observed in the 
responses of CSN to acute hypoxia in chronic hypoxic rats, in which chronic 
hypoxia exposure increase basal frequency of discharge and the frequency of 
action potentials in acute hypoxic challenges but does not change the 
percentage of increase in CSN discharges, these responses being in 
accordance with the previous findings by Chen et al. (2002b) and He et al. 
(2005; 2006) in the rat.  
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Neurochemical and 
physiological parameters 
 
Normoxia +  
Chronic 
caffeine 
Chronic 
hypoxia 
(15 days) 
Chronic 
hypoxia + 
Chronic 
caffeine 
CBs weight = ↑ = 
NE = ↑ ↑ 
DA = ↑↑↑ ↑↑↑ CA content 
DA/NE ratio = = ↑↑↑ 
NE = = ↑↑ 
CA synthesis 
DA = ↑↑↑ ↑↑↑ 
NE = ↑ = CA turnover 
time DA = = = 
DA = ↑↑ ↑↑ 
ATP =↑ = = 
NTs basal 
release 
adenosine = ↓↓ ↓↓ 
DA ↑ ↓ ↑ 
ATP = ↓↓ ↑ 
NT release 
with 7% O2 
hypoxia adenosine = ↑↑ ↑ 
DA = = = 
ATP  ↓↓ ↑ 
NT  release 
with 2% O2 
hypoxia Adenosine = ↑↑ ↑↑ 
TH expression = ↑↑ ↑↑ 
basal = ↑↑ ↑↑ 
5%O2 = ↑ = ↓↓ 
N2 = ↑ = ↓↓ 
CSN 
chemosensory 
activity 
20%CO2 = ↓ ↓↓↓ 
basal = ↑ ↑ 
hypoxia ↑↑ ↑↑ ↑↑ 
Minute 
Ventilation 
 5% CO2 = = ↑↑ 
Table 8 Effects on neurochemical and physiological parameters that include CB 
neurotransmitters, ATP, DA and adenosine, dynamics (content, synthesis, basal and 
evoked release), CSN activity and ventilation in rats submitted to chronic caffeine 
intake (1g/l) for 15 days, in rats exposed a hypoxic atmosphere of 12% O2 for 15 days 
and in rats exposed to both situations. Parameters that are altered when compared 
with rats exposed to chronic hypoxia are marked in red. ↑, ↑↑, ↑↑↑, ↓ and ↓↓ - 
correspond to significant increases or decreases in comparison with normoxic rats, ↑, 
↑↑, ↑↑↑, ↓↓, and ↓↓↓ - significant increases or decreases in comparison with chronically 
hypoxic rats. 
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7.4.1.1. Effect of chronic hypoxia on morphology and neurotransmitter 
dynamics in the carotid body 
As previously described in the General Introduction of this work, chronic 
hypoxic exposure induces several morphological and neurochemical 
modifications in the CB, like a hypertrophy and hyperplasia of the CB and an 
increased CB CA content and turnover time and an increased DA basal release. 
In the current work we have confirmed these results and we have also observed 
that chronic hypoxia did not modify ATP basal release, and that it decreases 
adenosine basal release, these phenomena being accompanied by a 
maintained and non-significant small decrease in DA release in response to 
intense and mild hypoxia respectively. Chronic hypoxia also decrease ATP 
release in response to mild and intense acute hypoxia and produce an increase 
in the release of adenosine in both acute hypoxic conditions. Increased DA 
metabolism, as well as TH expression and DA basal release, would increase 
extracellular levels of DA thereby providing a decrease in D2-mRNA and/or 
desensitisation or down-regulation of D2 receptors, explaining the stimulation of 
CB chemoreceptors and the increased O2 sensitivity in chronic hypoxia. 
However, the maintained DA release in response to intense hypoxia is not 
compatible with this hypothesis, as well as the finding that mRNA levels of D2 
receptors increase after 7 days of chronic hypoxia (Huey and Powell, 2000). 
These findings are in accordance with the DA-mediated inhibition of ventilatory 
response induced by chronic hypoxia observed in rats (Huey et al., 2000) and 
suggest that the alterations in DA metabolism and release are not sufficient to 
explain VAH in rats.  
The absence of effects of chronic hypoxia in the basal release of ATP 
and the fact that in chronic hypoxic conditions acute hypoxic tests did not 
induce the release of ATP from rat CB, suggest that this neurotransmitter is 
probably not involved in the increased O2 sensitivity observed in chronic 
hypoxia, contrary to what has previously been suggested by.He et al. (2006). 
Given these differences in the release of DA and ATP in response to 
acute hypoxia in the CB of chronic hypoxic rats and the knowledge that the 
release of DA is totally vesicular and ATP is also almost totally vesicular, these 
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results could suggest that DA turnover time will be higher than ATP turnover 
time.  
 The increased release of adenosine in acute hypoxia of mild and intense 
intensities in chronic hypoxic rats (Table 8) is in agreement with the increased 
frequency of CSN actions potentials observed in chronic hypoxia and thereby 
with the increased ventilatory hypoxic response observed in chronic hypoxia. It 
is important to note that the pattern of increase in adenosine release, that is 
higher in response to moderate and mild hypoxia than with intense hypoxias 
(Conde and Monteiro, 2006), in normoxic rats was switched in chronic hypoxia. 
Thus, in chronic hypoxia, adenosine release from chemoreceptor cells is 
proportional to stimulus intensity. These findings are consistent with increased 
adenosine in PC12 cells in chronic hypoxia (Kobayashi et al., 2000b) and 
suggest a role for adenosine in the enhanced O2 sensitivity observed in chronic 
hypoxia. Knowing that adenosine is a product of ATP catabolism, and that in 
chronic hypoxia the levels of adenosine released in response to acute hypoxia 
are elevated and the levels of ATP are diminished, we can postulate that this 
can be due to an increased activity of ecto and endo 5’-nucleotidases with a 
preferential utilisation of adenosine in these situations. In fact, in PC12 cells, it 
is known that cytoplasmatic and ecto-5’-nucleotidase activity are increased 
during chronic hypoxia (Kobayashi et al., 2000).  
 
 
7.4.1.2. Effect of chronic hypoxia on the carotid body output 
Chronic hypoxia, as previously described by other authors (Banard et al., 
1987; Nielsen et al., 1988; Vizek et al., 1987), increases CSN basal 
chemosensory activity.  Chronic hypoxia also increases CSN discharges in 
response to hypoxia, although when the values are corrected to basal activity, 
the increase is unaltered when compared with normoxic rats. The increase is 
consistent with an increase in adenosine levels released by acute hypoxic 
challenges in chronic hypoxia.  
Olson and Dempsey (1978) described that chronic hypoxia elicited 
hyperventilation in the rat over 14 days. We have observed an increase in 
hypoxic ventilatory response both in rats exposed to 1 week or 2 weeks of 
chronic hypoxia, and an absence of effect of hypercapnia in eliciting VAH. The 
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last data are consistent with the earlier findings of Bisgard et al. (1986b) where, 
using a preparation in which CB was isolated from systemic circulation, they 
showed that hypercapnia did not induce ventilatory acclimatisation in goats.  
 
 
7.4.2. Effects of chronic caffeine ingestion on rat CB function 
 
7.4.2.1. In control animals  
In this study we have also demonstrated that chronic caffeine intake for 
15 days did not alter the CB basal function significantly. In contrast, chronic 
caffeine intake facilitated the response to hypoxia as it increased minute 
ventilation and showed a tendency to increase the CSN discharges and DA 
release, while maintaining adenosine and ATP release induced by acute 
hypoxia (Table 8).  
The absence of effects of chronic caffeine intake in the CB basal 
conditions in normoxic rats are in agreement with the existence of the minor 
negative consequences of chronic caffeine intake previously described (see 
Fredholm et al., 1999).  The treatment with chronic caffeine has maintained DA 
and adenosine dynamics in basal and hypoxic conditions, maintaining also the 
release of ATP in response to hypoxia, increasing the basal levels of this 
neurotransmitter’s release non-significantly. This increase in CB basal ATP 
release suggests that adenosine modulates the release of ATP, as happens in 
the rat medial habenula nucleus (Robertson and Edwards, 1998) and in the vas 
deferens (Driessen et al., 1994). Therefore, a more extensive study must be 
performed in order to confirm this hypothesis and to characterise the receptors 
responsible for this modulation. 
The existence of a facilitation in the response to acute hypoxia that is not 
significant in CSN chemosensory activity but is significant in minute ventilation 
means that chronic caffeine has an excitatory effect on respiration due to a 
combined excitatory effect on peripheral and central chemoreceptors, in which 
central chemoreceptors play a major participatory role. The excitatory effect of 
caffeine, and thereby inhibitory action of adenosine, in response to hypoxia on 
central chemoreceptors has been previously described in infants by several 
authors (Aranda and Turmen, 1979; Bairam et al., 1997; Herlenius and 
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Langercrantz, 1999). However, it has been suggested that this effect is 
depressed in adults due to a dominance of peripheral hypoxic response when 
CB expression is completely mature (Gauda et al., 2004).  
The observed inhibitory effects of adenosine mean that the response of 
peripheral chemoreceptors to hypoxia in rats that ingested chronic caffeine is 
not preponderant to the central chemoreceptor response. These effects of 
chronic caffeine in response to hypoxia contrast with the findings that in un-
anaesthetised monkeys acute caffeine significantly attenuated CB-mediated 
hyperventilation while animals were breathing 10% O2 (Howell and Landrum, 
1995), but are in agreement with the described opposite effects of acute and 
chronic treatments with caffeine (Jacobson et al., 1996) observed, for example, 
in brain ischaemia (Dux et al., 1990; Rudolphi et al., 1989).   
 
 
7.4.2.2. In chronic hypoxic rats 
In order to assess the role of adenosine in VAH to chronic hypoxia we 
permanently blocked adenosine receptors with chronic caffeine ingestion. When 
rats were submitted to chronic caffeine intake during chronic hypoxia they 
developed even higher increases in CA metabolism. The application of both 
treatments together did not alter the basal CSN chemosensory activity but 
diminished the CSN discharges in response to hypoxia. The observed 
excitatory effect of adenosine (inhibitory effect of chronic caffeine) in CB output 
is compensated at central chemoreceptors as the minute ventilation in basal 
conditions and in response to hypoxia remains unaltered in rats exposed to 
chronic hypoxia (Table 8).   
 
The first fact that we want to discuss is the partial reversion of the 
hyperplasia of CB observed in chronic hypoxic animals. It is known that 
adenosine is involved in neovascularisation and angiogenesis via A2A and A2B 
receptors in endothelial cells in pigs, rats and humans (see e.g. Dubey et al., 
2002; Montesinos et al., 2004) and it is known that chronic hypoxia induces the 
formation of new vessels in the CB (Laidler and Kay, 1978; McGregor et al., 
1984; Pequinot et al., 1984; Heath et al., 1985) via an increased expression of 
VEGF. The fact that caffeine, which is a non-selective adenosine receptor 
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antagonist, abolishes almost completely all the CB hyperplasia means that 
adenosine could be mediating the neovascularisation and therefore the 
hyperplasia of the CB in chronic hypoxia.  
 
The second point to discuss is the higher increase in CA metabolism in 
the CB of chronic hypoxic rats with chronic caffeine ingestion (Table 8). These 
significant increases in DA content, synthesis, DA/NE ratio and DA endogenous 
release in response to mild hypoxia can be explained by the permanent 
blockage of A2B adenosine receptors present in chemoreceptor cells that control 
the release of dopamine from these cells (Chapter 3, Section 5). If A2B receptors 
were blocked, D2 receptors could exhibit their maximal inhibitory pattern, 
decreasing the DA released from chemoreceptor cells. Thus, through the 
negative feedback mechanism, the response of the cell would be an increase in 
DA synthesis in order to obtain a higher DA content to release more DA, as is 
observed in our results (Table 8). The increase in DA endogenous release that 
is observed in response to a mild hypoxia but not in response to an intense 
hypoxia can be explained by the interaction between A2B-D2 receptors being 
functional at moderate and mild hypoxias (Chapters 3 and 4, Section 5 and 6) 
i.e. in hypoxias that are compatible with life, but not being responsible for 
controlling the release of dopamine in response to an intense stimulus. These 
results lead us to the conclusion that the interaction between A2B and D2 
receptors is present, being functional in chronic hypoxic rats and contributing to 
the control of DA release in this situation. The fact that chronic caffeine 
increases DA metabolism and release in chronic hypoxia, through the 
permanent inhibition of A2B - D2 receptor interaction, can be extremely 
important, since, pathologically, a correlation between caffeine intake and the 
increased CA levels is described in sleep apnoea (Bardwell et al., 2000).  
Chronic treatment with caffeine did not alter ATP basal release from rat 
CB but reversed the reduction of ATP levels released from CB in response to 
acute hypoxic stimulus during chronic hypoxia. These results suggest that, 
during chronic hypoxia, adenosine inhibits the release of ATP from rat CB 
probably via A2A receptors, as described in the rat medial habenula nucleus 
(Robertson and Edwards, 1998). A more detailed study with specific 
pharmacological tools must be performed in order to study how adenosine 
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controls the release of ATP during chronic hypoxia and to assess the role of 
ATP itself on the hypoxic ventilatory response in chronic hypoxia. 
 Chronic caffeine intake in chronic hypoxia did not alter basal release of 
adenosine or the release evoked by mild or intense hypoxia in comparison with 
rats exposed to chronic hypoxia, suggesting that adenosine is not responsible 
for its own release i.e. that the release of adenosine from chemoreceptor cells 
does not seem to be totally controlled by a negative feed-back mechanism 
through adenosine receptors. These results are in agreement with the previous 
findings that acetylcholine via nicotinic receptors with α4 subunits modulate, in 
part, the release of adenosine from CB (Chapter 2, Section 4).  
 
 Basal CSN chemosensory activity observed in chronically hypoxic rats 
was unaltered with the chronic caffeine ingestion. These data conform with 
those previously demonstrated, that in normoxic rats acute application of 
caffeine did not alter the basal chemosensory activity of CSN (Chapter 3, 
Section 5). As occurs with acute caffeine application in normoxic rats, chronic 
caffeine significantly attenuatedthe CSN responses to acute hypoxic and 
hypercapnic challenges by approximately 60% and 75% (Table 8), respectively, 
in chronic hypoxic rats. Therefore we can establish a correlation between the 
acute application of caffeine in normoxic rats and the chronic application of 
caffeine in chronic hypoxic rats, and say that possible the adenosine effects 
observed (i.e. caffeine inhibition of CSN chemosensory activity) in chronic 
hypoxic rats are due to an action on A2A and A2B adenosine receptors in the CB. 
These data demonstrate that adenosine is essential for the CB chemoreception 
in chronic hypoxia, being one of the neurotransmitters involved in the increased 
O2 sensitivity and contributing to the VAH. These roles are in agreement with 
the suggestion that adenosine released in acute hypoxia could stimulate A2 
receptors in the CB to increase ventilation (Walsh and Marshall, 2006) in 
chronic hypoxic rats.  
 
 Despite the reduction in CSN chemosensory activity in response to acute 
hypoxia and hypercapnia, similar increases in hypoxic ventilatory responses 
were observed in chronic hypoxic rats that ingested caffeine chronically (table 
Table 8). However, acute hypercapnic challenge was capable of inducing VAH 
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in these rats. These results suggest that VAH in chronic caffeine rats is 
compensated by central chemoreceptors, this suggestion being compatible with 
the VAH elicited by the acute application of hypercapnia. An enhanced 
responsiveness of CSN respiratory centres have been described as an increase 
in CSN gain in the hypoxic ventilatory response (Powell et al., 2000b), as 
doxapram (chemoreceptor stimulant) increases ventilation in subjects 
acclimatised for 2-3 weeks, this effect being due to greater ventilatory output of 
CNS, since doxapram effect on CB is unchanged by chronic hypoxia (Forster et 
al., 1974). An increased CNS gain of the hypoxic ventilatory response was also 
observed in phrenic nerve activity measurements in rats in which chronic 
hypoxia increased the CNS gain (Dwinell and Powell, 1999). Therefore, chronic 
caffeine can interfere with the chronic hypoxic interactions between central and 
arterial chemoreflexes, allowing central chemoreceptors to exert a more 
pronounced effect and compensate the inhibition of arterial chemoreceptors in 
order to produce the same increased hypoxic ventilatory response.  
 In conclusion, adenosine is essential for CB chemoreception in chronic 
hypoxia, being one of the neurotransmitters involved in the increased O2 
sensitivity and contributing to the VAH. Adenosine is involved in the 
neovascularisation and remodelling that is responsible for CB hyperplasia 
observed during chronic hypoxia. Adenosine release in response to acute 
hypoxia is increased in chronic hypoxia and contributes to CSN chemosensory 
activity elicited by acute hypoxia and thereby to the increased hypoxic 
ventilatory response. Our data establish a role for adenosine as one of the 
neurotransmitters responsible for VAH in chronic hypoxia.   
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8. GENERAL DISCUSSION 
 
Adenosine both in acute and chronic hypoxic conditions has, by itself, an 
excitatory role in CB chemosensory activity and contributes to the 
chemoexcitatory effect of other neurotransmitters like ACh and ATP. It acts 
directly on adenosine A2A receptors present postsynaptically in CSN and it 
controls the release of dopamine presynaptically via A2B receptors in 
chemoreceptor cells. We also conclude that A2B -D2 adenosine/dopamine 
interactions at the CB could explain the increase in CA metabolism caused by 
chronic ingestion of caffeine during chronic hypoxia.  
 
Knowing that the carotid body contains several neurotransmitters, 
namely ACh (Fitzgerald and Shirahata, 1996; Fitzgerald, 2000), NE (Mir et al., 
1982), DA (Gonzalez et al., 1994), SP (McQueen, 1980; Hanson et al., 1986), 
ATP (Buttigieg and Nurse, 2004; Conde and Monteiro, 2006b) and adenosine 
(Monteiro and Ribeiro, 1987, 1989; Runold et al., 1990) and since, at the 
moment, there does not exist a consensus on the precise role of each 
substance as mediator between chemoreceptor cells and the sensory endings, 
it is important to aim to clarify the role of adenosine in response to hypoxia, both 
in control and in chronic hypoxic animals. In this work we have tested the 
hypothesis that adenosine is a “synaptic transmitter” at the chemoreceptor 
cell/sensory fibre synaptic complex of the carotid body. We have collected 
evidence that fulfill the criteria (McLennan, 1963) for adenosine as a primary 
neurotransmitter.  
The first of these criteria reads: A substance must occur in sufficient 
quantity in structures from which it will be released. Adenosine is present in all 
cells. It is an ATP precursor and an ATP catabolite and therefore it is not 
necessary to demonstrate its presence in the chemoreceptor cells. However, in 
Chapter 1, Section 3 we have reported that adenosine is released in basal 
conditions by CB, this release being increased in conditions of presynaptic 
activation (Figure 17), like hypoxia. We have also described a reduction in 
adenosine CB content during hypoxia (Figure 17). Since adenosine is present in 
all cells, it is possible that hypoxia can also release this mediator from other CB 
cell types aside from chemoreceptor cells. However, as we have shown (Figure 
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19), moderate hypoxia is not a strong enough stimulus to evoke adenosine 
release from other cell types. It is reasonable to assume that it is the pool of 
adenosine present in chemoreceptor cells that is reduced after hypoxia. 
The second criterion requires: The structures must possess an enzyme 
system for synthesis of the transmitter. Adenosine can be synthesized 
extracellularly or intracellularly by ATP catabolism through nucleotidases (Latini 
and Pedata, 2001; Zimmermann et al., 1998) or by the hydrolysis of S-
adenosylhomocysteine (Figure 9). Beyond ATP catabolism, another source of 
extracellular adenosine is cAMP that can be released by secretory cells and 
converted by extracellular phosphodiesterases in AMP and then by a 5’-
ectonucleotidase into adenosine (for a review see Fredholm et al., 2001). It is 
known that ATP is present in the CB in the rat (Buttigieg and Nurse, 2004; 
Conde and Monteiro, 2006), in the cat (Acker and Starlinger, 1984; Obeso et 
al., 1986) and in the rabbit (Verna, 1990) being released in response to acute 
hypoxia (Figure 54, Buttigieg and Nurse, 2004; Conde and Monteiro, 2006). The 
presence and CB content of cAMP has also been described in several species, 
such as the rat (Batuca et al., 2003; Chen et al., 1997; Monteiro et al., 1996) 
and rabbit (Perez-Garcia et al., 1990; 1991) and it is known that CB cAMP 
content increases in response to CB physiological stimulus, hypoxia (Perez-
Garcia et al., 1990; 1991; Chen et al., 1997; Batuca et al., 2003) that can lead 
to an increased production of adenosine. In this work we have shown that the 
blockade of ATP extracellular catabolism reduced the levels of adenosine 
present in incubating milieu both in normoxia and hypoxia (Figure 21). The 
reuptake mechanisms, defined in the case of adenosine as a bi-directional 
equilibrative nucleoside transport system, are present in chemoreceptor cells, 
as the concentrations of adenosine released from CB were modified in the 
presence of ENT inhibitors (Figure 21). Therefore, it can be assumed that 
chemoreceptor cells possess adenosine synthesising enzymes.  
A third criterion requires: There must be an enzymatic system for 
inactivation of the transmitter. Adenosine has a short half-life (<10 s) (Moser et 
al., 1989) and is converted by adenosine deaminase (EC 3.5.4.4) to inosine.  
Adenosine deaminase is present in the CB as the concentrations of adenosine 
released from CB are higher in the presence of the adenosine deaminase 
inhibitor, EHNA (Conde and Monteiro, 2002). The reuptake mechanisms, as 
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described above in criterion 2, are also present in the CB, as the concentrations 
of adenosine released from CB were modified in the presence of ENT inhibitors 
(Figures 20 and 21). Enhanced postsynaptic effects when the inactivation 
enzymes (ADA) or reuptake mechanisms (ENT) are blocked have been 
previously described by Monteiro and Ribeiro (1989) in vivo in the rat, where 
EHNA and dipyridamole mimicked the excitatory effect of adenosine on 
respiration, an effect attributed to CB chemoreceptors since it is abolished after 
CSN section. 
The fourth criterion requires that: Small amounts of suspected 
neurotransmitter must mimic the action of normal stimuli. By recording the 
primary reflex response, ventilation, or neural activity from chemoreceptor fibres 
in the CSN, it has previously been shown that exogenously applied adenosine 
and inhibitors of adenosine metabolism mimic the responses generated by 
hypoxia (McQueen and Ribeiro, 1983; Monteiro and Ribeiro, 1987; 1989; 
Runold et al., 1990). 
A fifth criterion requires: During activity the transmitter should be 
detectable in extracellular fluid around the synapses. This work (Chapter 1, 
Figure 17) reports the first evidence that adenosine is released from CB. 
Adenosine is released during normoxic conditions and the amount released 
increases significantly under acute hypoxic conditions both in control animals 
and in chronic hypoxic animals (Figures 17 and 55; Conde and Monteiro, 
2006b).  
A sixth criterion requires: Postsynaptic actions can be antagonised with agents 
considered to be specific to the transmitter’s receptors. In this work we have 
used specific and non-specific antagonists to the several subtypes of adenosine 
receptors on the neural chemosensory activity of CSN and in all cases we found 
that these antagonists decreased the CSN chemosensory activity induced by 
acute hypoxia, and therefore, by adenosine (Figures 36 and 37).  The same 
inhibition of CSN chemosensory activity was also observed in chronic hypoxic 
animals treated with caffeine (non-selective antagonist of adenosine receptors), 
in which animals respond less to acute hypoxia and to hypercapnia than control 
rats (Figure 57).  
The last criterion requires: Actions of the transmitter should be enhanced 
by drugs that block inactivating enzymes. Monteiro and Ribeiro (1989) have 
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observed that the exogenous excitatory effect of adenosine on ventilation is 
mimicked by EHNA and dipyridamole, inhibitors of adenosine deamination and 
uptake, respectively.  
Fulfilment of these criteria leads us to the conclusion that adenosine is a 
primary transmitter in the hypoxic CB chemoreception process (Figure 61). 
Apart from its role in hypoxic chemotransduction, adenosine also seems to be 
involved in the chemoreception mechanism initiated by substances like nicotine 
and acetylcholine that apparently mimic the excitatory effects of hypoxia on 
CSN activity and/or ventilation. It would be important to know if adenosine is 
also involved in the responses of CB to hypercapnia/acidosis. In this work we 
have focused only on the functional significance of adenosine in the hypoxic 
chemosensory process in control and chronic hypoxic animals, in view of the 
fact that hypoxia is the most important physiological stimulus of CB 
chemoreceptors and previous findings suggested a role for this substance in 
hypoxia. Nevertheless, to develop this work it would be important to investigate 
the functional significance of adenosine in the hypercapnic/acidosis 
chemoreception processes in order to establish a role for adenosine as a 
primary neurotransmitter in CB chemoreceptors for all natural stimuli.  
Apart from this role as primary neurotransmitter, adenosine in the CB 
also works as neuromodulator, since it controls the release of CA from 
chemoreceptor cells via A2B adenosine receptors (Figure 61) in control rats and 
probably in rats exposed to chronic sustained hypoxia. Therefore, adenosine is 
involved in the response of chemoreceptor cells to hypoxia both pre- and post-
synaptically, controlling the release of other neurotransmitters and also acting 
directly on its receptors, A2A, to stimulate CSN fibres to produce the central 
hyperventilatory response. Nevertheless, A2A adenosine receptors present at 
postsynaptic level were only characterised pharmacologically and it would be 
interesting perform experiments in order to visualise these receptors using 
confocal microscopy or electron microscopy in the CSN.  
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Figure 60 The possible mechanism of action of neurotransmitters involved in the 
chemosensory response to acute hypoxia in the carotid body. AC – adenylyl cyclase; 
Ado – adenosine; CSN – carotid sinus nerve; DA – dopamine; ENT1 – Equilibrative 
nucleoside transport system type I; Nic – nicotinic receptors. 
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Recently it has become consensual that ATP and ACh are the two 
neurotransmitters responsible for hypoxic CB chemotransduction, in view of the 
fact that application of nicotinic and P2 receptor antagonists clearly block the 
postsynaptic CB hypoxic response, suggesting that ATP and ACh are co-
released from chemoreceptor cells (Zhang et al., 2000). In fact, the existence of 
nicotinic receptors (Shirahata et al., 1998) and P2X2/P2X3 (Nurse and Zhang, 
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2001; Prasad et al., 2001) at postsynaptic level in the petrosal ganglion suggest 
that ATP and ACh could be the primary neurotransmitters responsible for the 
hypoxic chemoresponse. Nevertheless, more recently it has been suggested 
that ACh in the CB apparently comes from nerve endings instead of 
chemoreceptor cells, since the mRNA of ChAT was not detected in the 
chemoreceptor cells, but in the sensory nerve endings, autonomic microganglia 
and in petrosal neurons (Gauda, 2002; Gauda et al., 2004) and therefore the 
action of ACh could be on nicotinic receptors present in chemoreceptor cells, 
such as nicotinic receptors with α4 subunits (Chapter 2, Section 4). In addition, it 
has been shown that the combined blockade of nicotinic and purinergic 
receptors only reduce the CB chemosensory responses to hypoxia by 50% and 
60% (Reyes et al., 2007a; 2007b). Zapata (2007) suggesting that ATP is indeed 
an excitatory agent for carotid body chemoreceptors, and that that the joint 
participation of ACh and ATP contributes to, but does not entirely explain, the 
transfer of information between chemoreceptor cells and sensory nerve 
endings. Therefore, it is reasonable to postulate that ACh will act as 
neuromodulator of adenosine and ATP release, adenosine and ATP being the 
primary neurotransmitters responsible for CB acute hypoxic responses. 
However no experiments have been yet performed in the presence of both 
adenosine and ATP (non-hydrolysable) antagonists in acute hypoxic conditions 
in order to see if a complete blockade of CSN chemoresponses is achieved.  
 
 
 Up to this point in the General Discussion of this work we have focused 
on the role of adenosine CB chemosensory response to acute hypoxia because 
the greatest part of the study was performed to investigate the functional 
significance of adenosine in this situation. However, in the last chapter we have 
started to look at the role of adenosine CB chemosensory activity in chronic 
hypoxic rats.  
Basic/experimental approaches to chronic hypoxia are based on the 
period of time that an individual is submitted to low PaO2. However, this may 
not translate directly into clinical situations where chronic hypoxia is interpreted 
in terms of reversibility of the low PO2. In our studies we have considered 
chronic hypoxia as a period of 8 or 15 days and we should mention that in 
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clinical practice this period of time corresponds, for example, to some 
pneumonia situations or to the acute respiratory distress syndrome, that are 
considered acute respiratory failures (Hudson and Steinberg, 1998).  
Furthermore we should point out that we have used these periods of time 
because after some hours of low PO2 gene expression has been already 
apparent, leading to profound morphological as well as biochemical changes in 
the CB, that are consistent with an increased sensitivity of CB chemoreceptors 
to acute hypoxia (Barnard et al., 1987) and with some pathological conditions, 
like COPD, asthma or pulmonary fibrosis.   
  
 At the outset of the discussion of our data on chronic hypoxia we 
should state that we have attributed all the effects of chronic caffeine ingestion 
during chronic hypoxia to an inhibition of adenosine receptors, since the 
concentrations of caffeine ingested are compatible with this inhibition and not 
with other cell targets (Section 1.7). In accordance with our statements, the 
implication is that all the effects of caffeine observed are due to an inhibition of 
adenosine receptors and therefore, in the rest of the discussion we will not 
make a specific distinction between the effects of caffeine or adenosine. 
 Knowing that chronic hypoxia produces changes in the CB at several 
levels, neurochemical, histological, etc., it is possible that these 
neurotransmitters do not have the same importance in the hypoxic 
chemotransduction process in chronic hypoxic animals. Our results led us to the 
conclusion that adenosine is involved in the CB sensitisation observed during 
chronic hypoxia, since caffeine, an adenosine receptor antagonist, produced 
neurochemical alterations in CB that led to decreased CSN activity in response 
to hypoxia and hypercapnia. Therefore, we can suggest that adenosine is also a 
key neurotransmitter contributing to the hypoxic chemoreception process in the 
CB of chronic hypoxic animals. The results obtained in this thesis are in 
apparent contradiction with the results obtained by He et al. (2006). They 
suggest that ATP is one of the neurotransmitters that contribute to ventilatory 
acclimatisation to hypoxia observed during chronic hypoxia, since we have 
observed that acute hypoxic stimuli of moderate and high intensity did not 
induce ATP release in chronic hypoxic animals. The fact that chronic hypoxia 
abolished acute hypoxic ATP release means that ATP cannot be one of the 
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neurotransmitters involved in the increased hypoxic sensing observed during 
chronic hypoxia.  
 In chronic hypoxic animals adenosine is responsible for nearly 60% of 
the activity elicited by hypoxia, this value being higher than that observed for the 
contribution of this mediator to the hypoxic chemotransduction process in 
control animals (≈ 50%) (Chapter 3, Section 5). Nevertheless, since caffeine 
cannot completely abolish the hypoxic CSN chemosensory activity, other 
excitatory neurotransmitter(s) must be involved in the hypoxic chemosensory 
process during chronic hypoxia. The results obtained by He et al. (2005) have 
excluded ACh as an important neurotransmitter in chronic hypoxia, since 
nicotinic and muscarinic antagonists failed to decrease hypoxic CSN 
chemosensory activity and the results presented here exclude ATP as the 
primary neurotransmitter involved in acclimatisation. Therefore, experiments 
must be performed in order to find the neurotransmitter(s) that, with adenosine, 
is responsible for the hypoxic chemosensory process during VAH.  
 
 We cannot conclude the discussion of this work without focus on its 
limitations. The major limitation was the lack of studies on expression of the 
different subtypes of adenosine receptors, nucleoside transporters and 
nucleotidases during chronic hypoxia and chronic caffeine consumption. This 
point is extremely important since it is of common knowledge that chronic 
treatments alter, down- or up-regulating, the expression of several proteins. In 
our point of view, would be extremely important to perform studies on the 
expression of A2A and A2B receptors, ENT1 and ENT2 equilibrative nucleoside 
transporters and expression of 5’-ectonucelotidase as well as cytoplasmatic 
nucleotidases, in order to look more closely at adenosine metabolism and 
transport during chronic hypoxia and in presence of chronic caffeine, in order to 
consolidate the role of adenosine in the acute hypoxic response. This issue will 
be addressed in the near future.  
 In order to establish a role for adenosine in the carotid body and not 
only in chemoreception in response to hypoxia, we must investigate the role of 
adenosine in CB responses to hypercapnia and acidosis as well. Therefore, the 
same neurochemical approaches, like the study of adenosine metabolism, 
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transport and release must be taken in order to see if adenosine is involved in 
the response to acute hypercapnic and acidosis stimuli. 
 Knowing that adenosine is one of the mediators involved in the hypoxic 
ventilatory response observed during chronic hypoxia and since the 
involvement of ACh and ATP in the VAH have been excluded, we have to 
explore the possibility of SP or 5-HT as neurotransmitters involved in the 
hypoxic ventilatory response in chronic hypoxia.  
  
 Finally we should mention that this work consolidates the role of 
adenosine as a primary neurotransmitter in hypoxic sensitivity of CB and opens 
up new possibilities for the role of adenosine in chemoreception in several CB-
associated pathologies, leading us to several future projects. It is known that 
patients with OSA are high consumers of caffeine and that in an initial phase of 
the disease try to pass up the symptoms with an increased coffee ingestion. 
Several times, caffeine consumption has been correlated with elevated blood 
pressure (Jeong and Dimsdale, 1990; Green et al., 1996; Rakic et al., 1999) 
and there is a suggestion that caffeine augments blood pressure and total 
peripheral resistance in response to stressors (Sung et al., 1994; Pincomb et 
al., 1996). Nevertheless, more recent studies suggest that caffeine does not 
seem to be a factor that contributes to the positive correlation between OSA 
and hypertension (Bardwell et al., 2000; Robinson et al., 2003) although it 
remains unclear if coffee contributes to the hypertension observed in this 
disease. An augmented carotid body sensory response to acute hypoxia has 
been observed in adults suffering from OSA (Peng and Prabhakar, 2004; Rey et 
al., 2004), like the response observed here in chronic sustained hypoxia. We 
also know that increased CB activity leads to an increased sympathetic 
activation that produces hypertension (Timmers et al., 2004). If the mechanisms 
underlying the increased hypoxic sensitivity during chronic intermittent hypoxia 
were similar to those observed during chronic sustained hypoxia, adenosine 
would be one of the neurotransmitters responsible for this increased sensitivity, 
explaining the increased plasma levels of adenosine observed in OSA patients 
(Saito et al., 2002), and the ingestion of caffeine would not contribute to the 
hypertension observed in patients with OSA. In order to test these hypotheses 
the same experimental design that we have applied to study the role of 
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adenosine in chronic sustained hypoxia must be performed in animals 
submitted to chronic intermittent hypoxia.   
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9. CONCLUSIONS 
 
1. CB chemoreceptor sensitivity to hypoxia could be related to its low threshold 
for the release of adenosine because: 
a. Moderate acute hypoxia (10% O2) increased adenosine concentrations 
released from the CB by 44% but was not a strong enough stimulus to 
evoke adenosine release from SCG and arterial tissue; 
b. In the CB approximately 40% of extracellular adenosine came from 
extracellular catabolism of ATP, both under normoxic (20% O2) and 
moderate hypoxic conditions. Low PO2 conditions trigger adenosine 
release through activation of the NBTI-sensitive equilibrative nucleotide 
transport system. 
2. ACh modulates the release of adenosine/ATP from CB in moderate hypoxia 
suggesting that the excitatory role of ACh in chemosensory activity includes 
indirect activation of purinoreceptors by adenosine and ATP, which strongly 
supports the hypothesis that ATP/adenosine are important mediators in 
chemotransduction, since: 
a. The activation of ACh nicotinic receptors at the CB in normoxia 
stimulates the release of adenosine (max 36%) that apparently comes 
mainly from extracellular degradation of ATP. The increase in the amount 
of adenosine in the CB induced by hypoxia was partially antagonised by 
ACh nicotinic receptor antagonists. 
b. The pharmacological characterisation of the ACh nicotinic receptors 
involved in the stimulation of adenosine release revealed that ACh 
nicotinic receptors with α4 and ß2 receptor subunits are involved. 
3. Adenosine modulates the release of CA from rat CB chemoreceptor cells via 
A2B receptors, based on the following data: 
a. Caffeine, a non-selective antagonist of adenosine receptors, inhibits 
the CA normoxic release and that evoked by stimuli of low intensity, 
being ineffective on the release elicited by stronger stimuli.  
b. The effectiveness of DPCPX, MRS 1754 in mimicking caffeine effects 
and the absence of effect of SCH 58621 on the induced release indicated 
that caffeine effects were mediated by A2B receptors present 
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presynaptically, since they co-localise with tyrosine hydroxylase in 
chemoreceptor cells in rat CB.  
4. Acute caffeine inhibited the CSN chemosensory activity elicited by hypoxia by 
52%, an effect mediated by postsynaptic A2A and presynaptic A2B adenosine 
receptors, indicating that chemosensory activity elicited by hypoxia is controlled 
by adenosine. 
5. The theory of an antagonistic interaction between A2B and D2 receptors, 
described in the CB for the first time, was supported by the findings that: 
a. The dopamine D2 antagonist, sulpiride, increased the release of CA 
from chemoreceptor cells and attenuated the inhibitory effect of caffeine 
on CA release;  
b. The dopamine D2 antagonists, domperidone and haloperidol, 
increased basal and evoked release of CA from chemoreceptor cells 
confirming the presence of D2 autoreceptors in the rat CB that control the 
release of CA through a negative feed-back mechanism; 
c. Propylnorapomorphine, a D2 agonist, inhibited basal and hypoxic 
release of CA, this effect being attenuated by NECA, a non-selective 
adenosine agonist.  
The interaction between A2B and D2 receptors can also occur at second 
messenger level, as it was observed that NECA potentiates the effect of 
haloperidol on the release of CA from chemoreceptor cells both in basal 
conditions and in response to moderate hypoxia. 
6. Using a combination of neurochemical and physiological techniques we have 
demonstrated that chronic caffeine treatment in normoxic rats does not 
significantly alter the basal function of CB, assessed as the dynamics of their 
neurotransmitters, dopamine, ATP and adenosine, and the CSN chemosensory 
activity. In contrast, chronic caffeine intake facilitated the response to hypoxia 
as it increased the ventilatory response and showed a tendency for CSN 
chemosensory activity to increase and increase DA and ATP release.  
7. After a period of 15 days of chronic hypoxia, acclimatisation occurs as 
ventilatory hypoxic response was increased and CSN basal discharges and in 
response to hypoxia were increased. The alterations in DA metabolism, as well 
as in the CB basal release of DA, ATP and adenosine, could contribute to the 
observed acclimatisation to chronic hypoxia. The increased release of 
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adenosine in response to acute hypoxia suggests a role for this mediator in 
maintaining and increasing the ventilatory responses to acute hypoxic 
challenges during chronic hypoxia. Acute hypoxia-induced release of ATP was 
diminished in CH. Nevertheless, chronic caffeine treatment brings ATP release 
in acute hypoxia in CH to levels similar to the control, suggesting that adenosine 
can modulate the release of ATP during chronic hypoxia. 
8. CA metabolism, assessed as expression of TH, and content, synthesis and 
release of CA, was increased in chronic hypoxic rats also submitted to 15 days 
of chronic caffeine treatment.  
9. Chronic caffeine treatment did not alter the basal CSN chemosensory activity 
in chronic hypoxic rats but the responses to mild and intense hypoxia and 
hypercapnia were diminished. This inhibitory effect of chronic caffeine on CB 
output is compensated for by central mechanisms, as the minute ventilation 
parameter in basal conditions and in response to acute hypoxic challenges 
remains unaltered in rats exposed to chronic hypoxia for 15 days. 
 
 In summary: 
1 – In both acute and chronically hypoxic conditions, adenosine has an 
excitatory role in the CB chemosensory activity, acting directly on adenosine 
A2A receptors present postsynaptically in CSN, as well as controlling the release 
of dopamine presynaptically via A2B receptors in chemoreceptor cells.  
2 – A2B -D2 adenosine / dopamine interactions at the CB could explain the 
increase in CA metabolism caused by chronic ingestion of caffeine during 
chronic hypoxia. 
3 – In terms of ventilatory response to acute hypoxia during acclimatisation to 
hypoxia, the inhibitory action of caffeine mediated by peripheral chemoreceptors 
was compensated for by its excitatory effect at SNC.  
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